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Introduction 
1. INTRODUCTION 
 
Transmissible gasteroenteritis virus (TGEV) and human coronavirus (HCoV) belong to the 
Coronaviridae family which has two genera: coronavirus and torovirus. Together with the 
Arteriviridae, the Coronaviridae form the order Nidovirales (latin nidus, nest) and produce 
mRNAs in an extensive nested-set arrangement. 
 
TGEV (strain Purdue)§ and HCoV (strain 229E)§ are group-1 coronaviruses that are 
most closely related to feline infectious peritonitis virus (FIPV), avian infectious bronchitis 
virus (IBV), and murine hepatitis virus (MHV), representing the prototypes of the 
coronavirus groups III and II, respectively.  
1.1 Infections / Diseases  
Coronaviruses cause common respiratory and enteric diseases in humans and domestic 
animals (Myint, 1995; Johnston & Holgate 1996). HCoV is one of the main causes of upper 
respiratory tract infections ('common colds') in humans, but also lower respiratory tract 
illness and gastroenteritis have been reported (Zhang et al., 1994; Myint, 1995). TGEV is 
mainly associated with profuse, watery gastroenteritis in piglets, which frequently causes 
severe dehydration and death within 2 to 5 days after infection (for reviews, see Enjuanes & 
van der Zeijst, 1995; Saif & Wesley, 1999). Other members of this family are IBV, the first 
coronavirus to be isolated from the domestic fowl, bovine coronavirus (BcoV), turkey 
coronavirus (TCV), FIPV, canine coronavirus (CCV) and porcine epidemic diarrhoea virus 
(PEDV). MHV and porcine haemagglutinating encephalomyelitis virus (HEV) are well-
known causative agents of neurological diseases. 
1.1.1 Viral host ranges  
Coronaviruses have relatively restricted host ranges, infecting only their natural hosts and 
closely related animal species. Occasionally, cross-species infection by coronaviruses occurs. 
Interestingly, the host range of coronaviruses is associated with the receptor usage. 
                                                 
§ All the studies in this work are based on these strains. 
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1.1.2 Virus attachment 
The first step in viral infection is the binding of the virus to target cells. Several 
coronaviruses including IBV, BCoV, and some strains of MHV and HCoV, can cause 
hemagglutination (Sugiyama & Amano, 1980; Schultze et al., 1990; Zhang et al., 1994). The 
binding residue on the cell surface is a 9-O-acetylated neuraminic acid moiety of 
glycoproteins or glycolipids (Schultze et al., 1990), although different coronaviruses may 
prefer different structural isoforms of 9-O-acetylated neuraminic acid.  
 
1.1.3 Receptors 
For the establishment of viral infection, more specific binding between virus and cell is 
required for the coronaviruses, which involves a specific virus receptor molecule on the cell 
surface. There is a rough correlation between receptor expression and the susceptibility of a 
cell type to virus infection (Benbacer et al., 1997). 
 
The receptors for TGEV, FIPV and HCoV have been identified as aminopeptidase N 
(APN) of the porcine, feline and human species, respectively (Delmas et al., 1992; Yeager et 
al., 1992; Benbacer et al., 1997). APN is a member of the membrane-bound metallopeptidase 
family and is widely distributed on diverse cell types. It is particularly expressed on the brush 
border membrane of enterocytes.  
 
TGEV also binds to a recently described 200kDa protein at the surface of the 
enterocytes on the villi of the small intestine (Weingartl & Derbyshire, 1994). The virus is 
resistant to the low pH of the stomach and passes to the small intestine where it infects the 
columnar epithelial cells covering the distal portion of the villi in jejunum and ileum. 
Coronavirus receptors are discussed in tabular form in Table 1.1. 
 
1.1.4 Effect of age on infection 
There is a clear relationship between TGEV pathogenicity and the age of the infected animal. 
The transmission of TGEV in older animals is by ingestion of contaminated material and in 
young piglets by the lactating sows. Contamination originates from faeces, milk and aerosols 
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generated in the respiratory tract. The adult swine needs 104-fold more virus infection than 
that required infecting a neonate (Regula et al., 2000). 
 
Table* 1.1. Coronavirus receptors 
Virus  Receptor Distribution 
of receptor 
Tropism of the 
virus 
Associated diseases 
(Serogroup 1) 
HCoV 229E  
TGEV (pig) 
FIPV (cat) 
CCV (dog) 
APN  
APN  
APN  
APN 
Widely  
Widely 
Widely 
Respiratory and 
enteric tract 
hepatocytes 
Respiratory tract 
Common cold, respiratory, 
enteric, hepatitis, neurologic, 
enteric infection  
Common cold 
(Serogroup 2) 
HCoV OC43 
MHV (mouse) 
BCoV (cow) 
Sialic acid  
Bgp (Ig superfamily) 
9-O-acetyl-
neuraminic acid 
Widely 
Widely  
Widely 
Respiratory tract Common cold, respiratory, 
enteric, hepatitis, neurologic 
enteric infection 
 
(Serogroup 3) 
IBV (chicken) ?   Respiratory, hepatitis 
*Table taken from the review article by Schneider-Schaulies (2000). 
 
1.1.5 Penetration and uncoating 
The mechanism of coronavirus entry into target cells is still under debate. Early electron 
microscopic studies showed virus particles inside lysosome-like vesicles near plasma 
membranes. This suggested that the virus enters the cell by endocytosis ('viropexis') (David-
Ferreira & Manaker, 1965). Other studies suggested that the virus enters cells by direct 
fusion between virion and the plasma membranes (Dougheri et al., 1976). The exact 
mechanism of virus entry may depend on cell types and virus strain. The mechanism of virus 
uncoating, i.e., the release of virion RNA from the nucleocapsid, is also unclear.  
 
1.2 Genome structure of coronaviruses 
The coronavirus genome (Fig. 1.1) is a non-segmented, single-stranded, positive-sense RNA 
that is polyadenylated, and capped. Its size is about 27 to 32 kilobases (Lai & Cavanagh, 
1997), which is remarkably large, compared to the other RNA viruses. The coronavirus 
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replicase gene alone (20-22 kb) is about the same size as an entire picornavirus (~8 kb) and 
vesicular stomatitis virus (~11 kb) genomes added together. In fact, coronaviruses have the 
largest viral RNA genome known to date. It has been speculated that the large size of the 
viral RNA genome employs special mechanisms of RNA synthesis to counter the deleterious 
effects of possible errors during RNA synthesis. The genomic RNA functions as mRNA and 
is infectious. It contains about 7-8 functional genes, 4 or 5 of which encode structural 
proteins. The structural proteins that are found in all coronaviruses, are encoded by genes 
located in the genomic RNA in the order 5'-polymerase-(HE)-S-E-M-N-3', with a variable 
number of other, mostly non-structural and largely non-essential, genes interspersed among 
them. The architecture of these non-structural protein genes varies significantly among 
different coronavirus species.  
 
Fig. 1.1 Overview of the coronavirus genome organization. The 5' end of the genome 
represents the common leader sequence that is also present on each of the subgenomic 
mRNAs. The spike protein (S), integral membrane protein (M), envelope protein (E), and 
nucleocapsid protein (N) are also shown. The replicase gene is comprised of ORFs 1a and 
1b, where the downstream ORF 1b is expressed by (-1) ribosomal frameshifting. 
 
The replicase gene, which encodes all the functions required for viral replication and 
transcription (Thiel et al., 2001), occupies the 5’-terminal two-thirds of the genome and is 
comprised of two open reading frames (ORFs). In relation to the ORFs that encode non-
structural proteins, the coronavirus genome is dominated by the replicase gene, which 
consists of two large ORFs (1a, 1b) encompassing approximately 20,000 nucleotides toward 
the 5' end of the genome.  Expression of the downstream ORF is mediated by (-1) ribosomal 
frameshifting. The replicase gene thus encodes two large polyproteins, pp1a (450kDa) and 
pp1ab (750kDa) that are co- and post-translationally processed by viral proteinases to 
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produce the functional subunits of the viral replication complex (for reviews, see de Vries et 
al., 1997; Ziebuhr et al., 2000). Studies in the coronavirus system consistently revealed that 
the coronavirus main proteinase, Mpro (also called 3C-like proteinase, 3CLpro), cleaves pp1a 
and pp1ab at 11 conserved sites (Ziebuhr et al., 2000). 
 
The divergence from a common ancestor and also RNA recombination appears to be 
a major driving force in the evolution of coronavirus genomes. This appears to have 
introduced plasticity to the coronavirus genome that is exceptional, even among RNA 
viruses. Probably because of the large size, coronaviruses have evolved many genetic 
mechanisms (e.g. genetic recombination and generation of defective interfering (DI) RNAs), 
to maintain their genetic stability. 
 
1.2.1 Major gene products 
 Most groups of positive-stranded RNA viruses of animals produce either a single polyprotein 
or separate non-structural and structural precursor polypeptides that are subsequently cleaved 
by virus-encoded or host-encoded proteinases to produce functional subunits (Dougherty & 
Semler, 1993). In contrast, the nidovirus structural proteins that are encoded in the 3'-
proximal region of the genome are individually expressed from a nested set of subgenomic 
mRNAs generated by a unique discontinuous transcription mechanism (Spaan et al., 1983; 
Lai et al., 1984; van Marle et al., 1999).  
 
The spike glycoprotein (S) is the heavily glycosylated outermost component of the corona 
virion, and has two biological activities important for the virus. It is responsible for the 
attachment of the virus to cells (Collins et al., 1982; Godet et al., 1994; Kubo et al., 1994) 
and for instigating the fusion of the virus envelope with cell membranes. The S protein is 
large, ranging from some 1160 (IBV) to 1452(FCV) amino acids. This protein soars some 20 
nm above the virion envelope, giving the virus a ‘solar corona-like’ appearance under 
negatively stained electron micrographs (Fig. 1.2), from which the name of this virus family 
is derived. 
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The integral membrane glycoprotein (M) is one of the structural proteins that are essential 
for the production of coronavirus-like particles. The M polypeptide comprises 225-230 
amino acids (MW ~ 25 kDa); some members of the TGEV group have additional 30 or so 
residues at the amino terminus, forming a cleavable membrane insertion signal. The protein 
has three membrane-spanning regions in the amino-terminal half. It probably plays a role in 
viral pathogenesis. 
 
The hemagglutinin-esterase glycoprotein (HE) of approximately 424 amino acid residues 
(65 kDa) has been detected in virions of HEV, MHV, HCoV OC43, BCoV, and TCV. Those 
coronaviruses that contain HE in their virions cause hemagglutination much more efficiently 
than those that do not. As its name implies, the HE protein also has esterase activity, 
specifically, it is a neuraminate-O-acetylesterase. The functional significance of HE for 
coronaviruses is not known, and only BCoV requires HE for infectivity. 
 
Fig. 1.2 Coronaviruses are pleomorphic but roughly spherical enveloped particles. They are 
about 120-160 nm in diameter with a characteristic 'fringe' of surface projections (20 nm 
long). Diagram taken from the text book ‘The Molecular Biology of Coronaviruses’ by Lai 
and Cavanagh. 
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The small membrane protein (E) is an additional virion protein. It plays an essential role in 
virion assembly. The E protein in the cell is localized in the perinuclear region, with some 
migrating to the cell surface (Godet et al., 1992, Yu et al., 1994). The E proteins vary from 
84 to 109 amino acid residues, corresponding to molecular weights of 9100 to 12,400 
(Siddell, 1995). 
 
The N protein is a 50 – 60 kDa phosphoprotein which, together with the genomic RNA, 
forms a helical nucleocapsid (RNP). The RNP of coronaviruses has been reported variously 
to be from 9-11 to 14-16 nm in diameter. The N protein varies from 377 to 455 amino acid 
residues in length. It is highly basic and has a high (7-11%) serine content, making it a 
potential target for phosphorylation.  
 
Although from the same family, the coronavirus and torovirus gene products, with 
some limited exceptions, lack sequence similarity. The sizes of the nucleocapsid protein are 
as different as ~ 60 kDa and ~ 18 kDa, and the shape of the helical nucleocapsid structure is 
extended or tubular for the two viruses, respectively. The leader sequence is absent at the 5' 
end of torovirus mRNAs. 
 
1.3 The RNA virus proteinases 
 The RNA virus proteinases have number of features: (i) they may function as discrete 
proteins or, more commonly as proteolytic domains of larger forms, (ii) these larger forms 
themselves may represent alternative processing products, (iii) proteinase activities may be 
different depending upon which type of proteinase domain is present, (iv) as complexes (by 
binding other virus proteins or RNA), their activity or substrate specificity may be modified, 
(v) virus-encoded proteinases may cleave host-cell proteins modifying or inhibiting host-cell 
functions, (vi) their activation may be delayed until a special environment is encountered (i.e. 
during capsid morphogenesis) and (vii) Autocatalytic cleavage can occur in cis or in trans, 
this means, they may cleave in an intramolecular manner (in cis), or in intermolecular 
manner (in trans) - although the catalytic mechanism of such cleavages is the same. 
Processing reactions occurring in cis are rapid as compared to trans reactions. The cis 
cleavage site may be proximal or distal, whereas trans reactions follow second-order kinetics 
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and are more sensitive to inhibitors and to sequence variations flanking the scissile amino-
acid pair. Interestingly, they may exhibit highly specific and regulated proteolysis of other 
virus protein precursor molecules and may control the biogenesis of different, alternative, 
functions from the same precursor (e.g. picornavirus). Additionally, they may have specific 
cellular protein targets which, when cleaved, result in a modification of cellular 
macromolecular processes.  
 
1.4 Accessory proteinases  
All coronaviruses encode between one and three 'accessory' proteinases, which are distantly 
related. TGEV and HCoV encode two accessory proteinases. They are called coronavirus 
papain-like proteinases PL1pro and PL2pro. These accessory proteinases recognize one or two 
sites that are located in the N-terminal half of the replicase polyproteins, cleave peptides that 
have small residues at the scissile bond, have a catalytic dyad involving cysteine and 
histidine (Ziebuhr et al., 1997b) and may employ a variant of the α+β fold that is conserved 
in the papain class of proteinases.  
 
In coronaviruses accessory proteinases, the catalytic Cys and His residues are 
separated by amino-acid segments almost twice the size as compared to other papain-like 
proteinases, making these proteinases the largest in the class of RNA virus proteins. They 
have eight conserved residues, out of which the catalytic Cys-His dyad as well as three 
cysteines are involved in the formation of a zinc finger. The conservation of this structural 
element embedded in the central region of these enzymes clearly discriminates the accessory 
proteinases of coronaviruses from their arterivirus counterparts.  
 
Only very limited information is currently available on the requirements of the 
accessory proteinase-mediated cleavages in other coronaviruses. The substrate specificity of 
the HCoV PL1pro was determined by sequence analysis of the carboxyl-terminal cleavage site 
of p9 (Herold et al., 1998).  Gly was found at the P1 position and the P1' and P5 positions 
were occupied by small uncharged (Asn-112) and basic (Lys-107) residues, respectively. In 
common with the coronavirus main proteinases, the coronavirus accessory proteinases have 
also been shown to deviate significantly from the prototypic cellular enzymes. The accessory 
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nidovirus proteinases mediate only very few cleavages in the relatively divergent, amino-
terminal portion of the replicase polyproteins.  In contrast, the main proteinases are 
responsible for the extensive proteolytic processing of the so-called ‘core replicase’ (Snijder 
& Spaan, 1995).  
 
1.5 Structural aspects  
Sequence comparisons have revealed that the two hydrophobic domains, HD1 and HD2, are 
situated on either side of coronavirus Mpro (Gorbalenya et al., 1989a; Lee et al., 1991; Herold 
et al., 1993; Eleouet et al., 1995); these domains are also conserved in arteriviruses. The data 
from in vitro-translation experiments showed that microsomal membranes are required for 
the efficient autoproteolytic processing of the Mpro from HD1 and HD2, most likely by 
assisting in the proper folding of these proteins (Tibbles et al., 1996; Pinon et al., 1997; 
Schiller et al., 1998). On the other hand, after being released from the polyprotein, the Mpro 
activity does not depend on membranes, or any other cofactor(s), at least for its proteolytic 
activity in vitro (Ziebuhr et al., 1995). It has been suggested that HD1 and HD2 may 
contribute to the intracellular localization of the Mpro itself and, possibly, of the virus 
replication complex in general (Gorbalenya et al., 1989a). Coronavirus replication takes place 
at intracellular membranes and a large number of non-structural, replicase gene-encoded 
proteins contribute to the formation and function of the coronavirus replication complex.  
 
The coronavirus Mpros are the largest proteinases of known RNA viruses. They 
consist of 302–307 amino acid residues, whereas the prototypic poliovirus 3C proteinase 
contains only 182 residues. The unique, C-terminal domain of approximately 100 amino-acid 
residues that appears to be required for proteolytic activity is responsible for the size 
difference. Therefore, a large number of different carboxyl-terminally truncated versions of 
the HCoV Mpro are inactive in assays using synthetic peptides (Ziebuhr et al., 1997a). Also, 
the removal of 28 carboxyl-terminal amino acids from the MHV Mpro abolishes its activity in 
an in vitro translation system (Lu & Denison, 1997). In apparent contrast to the HCoV and 
MHV data, it was recently shown that a recombinant form of the IBV Mpro tolerated the 
introduction of six consecutive His residues near its carboxyl terminus without loss of 
activity (Tibbles et al., 1999). In this experiment, the His tag (His6) was placed into the 
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nearest region of predicted hydrophobicity to the C-terminal processing site to minimize 
interference with the sequences involved in processing. The histidines were kept exposed to 
interact with a purification matrix. There are several speculations on the function of the 
carboxyl-terminal region (Zeibuhr et al., 2000), e.g. (i) maintenance of the overall fold of the 
enzyme, (ii) involvement in catalysis or (iii) substrate recognition, and (iv) a non-proteolytic 
function. 
 
1.6 TGEV and HCoV Mpros 
The viral proteins required for TGEV and HCoV genome replication and transcription are 
encoded by the replicase gene (Eleouet et al., 1995; Penzes et al., 2001). This gene encodes 
two replicative polyproteins, pp1a (447 kDa) and pp1ab (754 kDa), that are processed by 
virus-encoded proteinases to produce the functional subunits of the replication complex 
(reviewed in Ziebuhr et al., 2000). The name "3C-like proteinase" was originally introduced 
because of similar substrate specificities of the coronavirus Mpro and picornavirus 3C 
proteinases (3Cpro) and the identification of Cys as the principal catalytic residue in the 
context of a predicted two-β-barrel fold (Gorbalenya et al., 1989a,b). Meanwhile however, 
several studies have revealed significant differences in both the active sites and domain 
structures between the coronavirus and picornavirus enzymes (Liu & Brown, 1995; Lu & 
Denison, 1997; Ziebuhr et al., 1997a, 2000; Hegyi et al., 2002). Also, the crystal structures 
reported for a number of picornavirus 3C proteinases (Allaire et al., 1994; Matthews et al., 
1994; Bergmann et al., 1997; Mosimann et al., 1997;) have not been useful in predicting the 
three-dimensional structures of coronavirus main proteinases. Because of the large 
phylogenetic distance between the two groups of enzymes, we are using the term coronavirus 
Mpro rather than 3CLpro. 
 10
Introduction 
 
Fig. 1.3  Sequence comparison of coronavirus main proteinases. The alignment was produced 
using CLUSTAL X, version 1.81 (Thompson et al., 1997). The sequences of FIPV (strain 
79-1146), HCoV (strain 229E), BcoV (isolate LUN), MHV (strain JHM) and IBV (strain 
Beaudette) were derived from the replicative polyproteins of the respective viruses whose 
sequences are deposited in the GenBank database (FIPV, AF326575; HCoV, X69721; 
BCoV, AF391542; MHV, M55148; IBV, M95169; TGEV, AJ271965).  
 
Sequence comparisons (Fig. 1.3) and experimental data obtained for other coronavirus 
homologues allows prediction that the mature form of the TGEV Mpro is released from pp1a 
and pp1ab by autoproteolytic cleavage at flanking Gln↓(Ser,Ala) sites (Eleouet et al., 1995; 
Hegyi & Ziebuhr, 2002). Accordingly, these Mpros have 302 amino-acid residues that 
correspond to the pp1a/pp1ab residues 2879 to 3180 for TGEV and residues 2966 to 3267 for 
HCoV. In vivo and in vitro analyses of IBV, MHV, and HCoV Mpro activities have shown 
consistently that these proteinases cleave the replicase polyproteins at 11 conserved sites and, 
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therefore, it seems reasonable to conclude that the Mpro-mediated processing pathways are 
conserved in all coronaviruses.  
 
Previous theoretical studies and experimental data have led to the following 
conclusions (Bazan & Fletterick, 1988; Gorbalenya et al., 1989a,b; Liu & Brown, 1995; Lu 
et al., 1995; Lu & Denison, 1997; Ziebuhr et al., 1995, 1997a, 2000; Seybert et al., 1997; 
Ziebuhr & Siddell, 1999; Ng & Liu, 2000; Hegyi et al., 2002): 
i) Coronavirus main proteinases employ conserved Cys and His residues in the catalytic site. 
In TGEV and HCoV Mpros, these are Cys144 and His41. There has been some debate on the 
existence of a third residue in the catalytic centre. Gorbalenya et al. (1989b) predicted a 
catalytic triad consisting of His 2820, Cys2922 and Glu2843, for coronavirus IBV Mpro. In 
common with picornavirus 3C proteinases, the catalytic center of the coronavirus Mpro is 
predicted to be embedded in a chymotrypsin-like, two-β-barrel structure in which cysteine 
(rather than serine) serves as the principal nucleophile.  
ii) These proteinases have well-defined substrate specificities. All known cleavage sites 
contain bulky hydrophobic residues (mainly Leu) at the P2 position, Gln at the P1 position, 
and small aliphatic residues at the P1’ position. 
iii) They possess a large C-terminal domain of about 100 amino-acid residues that is not 
found in other RNA virus 3C-like proteinases. The characterization of recombinant proteins, 
in which 33, 28, and 34 C-terminal amino acid residues were deleted from the IBV, MHV 
and HCoV main proteinases, respectively, resulted consistently in dramatic losses of 
proteolytic activity, suggesting that the C-terminal domain of Mpro contributes to proteolytic 
activity through undefined mechanisms. 
 
1.6.1 Catalytic center and substrate specificity  
The sequence similarities of the Mpros to prototypic picornavirus 3C proteinases are limited 
to the catalytic region in the profile-versus profile dot-plot cross analysis (Ziebuhr, 2000). 
The catalytic residues of 3C and 3C-like proteinases are superimposed upon a two-β-barrel 
structure consisting of 12 antiparallel β-strands (Bazan & Fletterick, 1988; Gorbalenya et al., 
1989a; Allaire et al., 1994; Matthews et al., 1994; Mosimann et al., 1997).  In 3C and 3C-
like proteinases, Cys replaces the nucleophilic Ser and, in a subset of viruses, Glu replaces the 
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Asp of the catalytic triad found in cellular proteinases (Bazan & Fletterick, 1988; Gorbalenya 
et al., 1989a; Matthews et al., 1994). The coronavirus Mpro seems to lack a conserved acidic 
residue that would be equivalent to the catalytic Asp (Glu) of 3C proteinases. The available 
data strongly suggest that the conserved His and Cys residues represent the general base and 
nucleophile, respectively. 
 
The coronavirus Mpro displays additional features that clearly separate it from other 
virus-encoded 3C-like proteinases, including the arterivirus main proteinase. For example, it 
employs a novel version of the substrate-binding pocket ‘core’ motif, which is 
characteristically Gly-X-His for most other 3C/3C-like proteinases. Thus, the Gly residue of 
this motif (Bazan & Fletterick, 1988; Gorbalenya et al., 1989a, b) is conserved in the vast 
majority of serine and cysteine proteinases with chymotrypsin-like (CHL) folds and only 
very few proteinases tolerate substitutions with small amino acids (Ala or Cys) at this 
position. This conservation pattern indicates a strong selection pressure with regard to the 
space that this specific residue occupies. In contrast, in all coronavirus 3CLpro domains 
studied so far, Gly appears to be replaced by Tyr (Gorbalenya et al., 1989b; Lee et al., 1991; 
Herold et al., 1993; Eleouet et al., 1995) (Fig. 1.3). The Tyr residue of the Tyr-X-His motif 
has not yet been probed by mutagenesis. However, the replacement of the His residue (His-
3127) by Ser completely abolished the proteolytic activity of the HCoV Mpro (Ziebuhr et al., 
1997b). This inactivation was selective since a similar replacement of His-3136, another 
conserved His residue in this region, was not so detrimental (Ziebuhr et al., 1997a). Thus, the 
importance of the Tyr-X-His motif has been confirmed, implying that coronaviruses may 
indeed have accepted a Gly-to-Tyr replacement during evolution. 
 
The above data are also compatible with a model, originally developed and 
substantiated for other 3C/3C-like proteinases (Bazan & Fletterick, 1988; Gorbalenya et al., 
1989a; Allaire et al., 1994; Matthews et al., 1994; Mosimann et al., 1997), that implicates 
His-3127 (and its counterparts in other coronaviruses) in the formation of hydrogen bonds to 
the P1 glutamine side chain of Mpro substrates (Gorbalenya et al., 1989b).  
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The substrate specificity of Mpro resembles that of many other 3C/3C-like proteinases 
(Kräusslich & Wimmer, 1988; Dougherty & Semler, 1993 ; Blom et al., 1996) in so far as the 
P1 position of the substrate is exclusively occupied by Gln and small, aliphatic residues (Ser, 
Ala, Asn, Gly and Cys) are found at the P1' position. However, Asn and Cys are most 
uncommon as P1' residues outside of the coronavirus family, although a P1' Asn is found in 
rhinoviruses (Blom et al., 1996 ) and, in a mutagenesis study, Cys proved to be a tolerable 
substitution in one of the encephalomyocarditis virus (EMCV) 3Cpro sites (Parks et al., 1989). 
In four different coronaviruses, one Mpro cleavage site consistently contains Asn at the P1' 
position (Liu et al., 1997; Lu et al., 1998; Ziebuhr & Siddell, 1999) and, for MHV, a P1' Cys 
residue was predicted for another site (Lee et al., 1991).  
Upon comparison of a large number of cleavage sites, most of which have 
experimentally been confirmed for at least one coronavirus, it is evident that in addition to P1 
and P1', the P2, P3, P4, P2' and P3' positions have a restricted variability. Among these, the 
P2 and P4 positions are most conserved with bulky hydrophobic residues (mainly Leu) at P2 
and Val, Thr, Ser (and Pro) at P4 being clearly favoured (Ziebuhr et al., 2000). The efficiency 
of cleavage at specific sites is likely to be determined by the exact composition of the sites, 
since synthetic peptides mimicking different cleavage sites were processed in competition 
experiments at significantly different rates by the HCoV Mpro (Ziebuhr & Siddell, 1999). In 
view of these data, it seems likely that together with the accessibility of potential cleavage 
sites in the context of the polyprotein, the properties of the cleavage sites themselves 
contribute significantly to the coordinated, temporal release of specific polypeptides from the 
replicase polyproteins. This might lead to the (irreversible) activation or inactivation of 
specific functions in the course of the virus life cycle, as has been demonstrated for a number 
of other positive-stranded RNA viruses. 
1.7 Aims and objectives of this work 
Like many other viral proteinases, the TGEV and HCoV proteinases, are highly effective 
regulators of virus replication and, indirectly, possibly even of virion biogenesis (van Dinten 
et al., 1999). Herein, a crystallographic approach is undertaken with wild-type TGEV Mpro, 
wild type and several mutants of HCoV Mpro and inhibitor complexes in order to arrive at a 
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better understanding of the enzyme's functional properties in protein biosynthesis. A 
prerequisite for this, is the availability of good crystals, which is often a major impediment to 
this type of work. Therefore, the first aim of this work was to determine the optimal 
conditions for crystallization of TGEV and HCoV proteinases. Once the crystallization 
conditions were optimized and diffractable crystals were obtained, the next task was to solve 
the phase problem, to allow construction of three-dimensional models. Many biochemical 
observations have been made over the past years in relation to the enzymes behavior, and 
require rationalization on the basis of its structure. The active-site residue Cys144 requires 
precise investigation vis-à-vis catalytic and substrate-binding/cleavage mechanisms 
employed by the main proteinases of the coronavirus. The TGEV and HCoV Mpros are 
peculiar for their unique C-terminal domain, the function of which is unknown. The novel 
Tyr-X-His motif remains to be structurally explained; there are numerous suggestions as to 
the RNA binding role of these proteins, and a plethora of other unanswered questions. Since 
this work represents the first effort towards the three-dimensional structure of any protein of 
the related families Coronaviridae and Arteriviridae, this work will enable numerous other 
aspects of coronaviruses to be studied, including structural details, the role of many 
conserved residues in maintaining active site geometry, the catalytic dyad, the catalytic 
mechanism, details of substrate specificity, and ultimately the design of inhibitors and targets 
for therapeutic intervention. 
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2. MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Equipments 
A list of laboratory instruments and devices used for this work is given below in Table 2.1. 
Table 2.1 General laboratory devices and their manufacturers 
Equipment      Manufacturer 
Protein purification/concentration/analysis 
Centrifuge – Heraeus Labofuge 400R Heraeus Instruments (Hanau) 
Centrifuge – Heraeus Biofuge plus Heraeus Instruments (Hanau) 
Spectrophotometer – UV Vis Spekol Zeiss (Jena) 
Analytical balance – Sartorius BP 210 D Sartorius (Göttingen) 
Table balance – Sartorius portable PT2100 Sartorius (Göttingen) 
Water purification system – Milli-Qplus 185 Millipore (Eschborn) 
pH Meter – CG 840 Schott Schott (Mainz) 
Gel electrophoresis system Pharmacia (Freiburg) 
Mass spectrophotometer (MALDI-TOF) – Biflex II Bruker (Karlsruhe) 
DLS instrument: DynaPro-801 Protein Solutions Ltd. 
 (Buckinghamshire, UK) 
Crystallization 
Incubator – EHRET KBK 4200 EHRET (Emmendingen) 
Incubator – EHRET KBK 4600 EHRET (Emmendingen) 
Microscope – Olympus SZH10 binocular Olympus (Hamburg) 
Microscope – Zeiss Stemi 1000 binocular Zeiss (Jena) 
Data collection 
X-ray generator, rotating anode – Nonius FR591         Nonius (Delft, The Netherlands) 
Image plate detector – Mar 300           Mar Research (Hamburg) 
Image plate detector – Mar 345            Mar Research (Hamburg) 
Image plate detector – Dip 2030K            Nonius (Delft, The Netherlands) 
Cryostat- Oxford controller 600 series          Oxford Cryosystems (Oxford, UK) 
Air stream cooler – FTS TC84             FTS systems (Stone Ridge, USA) 
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X-ray mirror system – MAC-XOS MacScience (Yokohama, Japan) 
Synchrotron – EMBL Hamburg beamlines X11, 
BW7A 
DESY (Hamburg) 
Synchrotron – Elettra Light Source beamline 5.2 R  ELETTRA (Trieste, Italy) 
Goniometer head – Charles Supper Standard   Charles Supper (Troy, USA) 
Microscope – Leica MZ 8 binocular  Leica (Bensheim) 
Computing 
Indy workstation SGI (Mountain View, USA) 
Onyx graphics workstation SGI (Mountain View, USA) 
O2 graphics workstation SGI (Mountain View, USA) 
Indigo2 graphics workstation  SGI (Mountain View, USA) 
Origin 200 server SGI (Mountain View, USA) 
Digital 433au Compaq (Houston, USA) 
Data cartridges Sony, Maxell (Japan) 
 
2.1.2 Chemicals   
A list of chemicals used for this work is given below in Table 2.2. 
Table 2.2 Chemical items and their manufacturers 
Chemical item Manufacturer* Chemical item Manufacturer* 
Ammonium sulfate Merck IzitTM Hampton Research 
BSA Aldrich MPD Merck 
Carbonic anhydrase Aldrich NaCl Fluka Chemie AG 
Crystallization screen Hampton Research Paraffin oil Merck 
Deionized water Millipore PEG 6K, 10K Fluka Chemie AG 
Dioxane Merck SDS Pharmacia Biotech 
DTT Merck Silicon fluid 200/1 cS oil Merck 
Ethanol Merck Sinapinic acid Aldrich 
1,6-hexanediol Merck TLCK Sigma 
HEPES Fluka Chemie AG Tris Merck 
* more details are given in the text 
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2.1.3 Crystallization materials and cryo-tools 
Centricon Plus-20 centrifugal filter devices and Ultrafree-MC filter units: Millipore 
(Bedford, USA), dialysis buttons, dialysis rings and slide-A-Lyzer dialysis cassettes: Pierce 
(Rockford, USA). Dialysis membranes and sample tubes: Roth (Karlsruhe, Germany), glass 
sample capillaries: GLAS (Berlin, Germany), highly liquid paraffin oil: Merck (Darmstadt, 
Germany), high vacuum grease: Dow Corning (Midland, USA). Magnetic base crystal caps, 
mounted cryoloops, 24-well linbro plates and VDX plates, 22 mm circular siliconized 
coverslips, sealing wax, Crystal Screen 1 and 2, crystal storage vials, cryo canes, magnetic 
crystal wands, curved vial clamps and micro tools: Hampton Research (Laguna Niguel, 
USA). Other basic chemicals were obtained from Sigma-Aldrich Chemie GmbH (Munich, 
Germany) and Fluka Chemie GmbH (Buchs, Switzerland). 
 
2.1.4 Buffers and solutions 
All buffers and solutions were prepared using deionised water at 20°C (Millipore water 
purification system). 
 
Table 2.3 Buffer, protein storage solutions and oil 
Buffer  HEPES pH 8.5 and pH 8.8 
Protein storage solution  (HCoV Mpro) 11mM Tris.HCl pH 8.0, 200mM NaCl, 
0.1mM EDTA, 1mM DTT 
Protein storage solution (TGEV Mpro) 11mM Tris.HCl pH 7.4, 120mM NaCl, 
0.1mM EDTA, 1mM DTT 
Oil mixture  50% paraffin and 50% silicon fluid 200/1 cS 
60% paraffin and 40% silicon fluid 200/1 cS 
70% paraffin and 30% silicon fluid 200/1 cS 
 
2.1.5 Protein samples 
Purified TGEV Mpro, HCoV Mpro wild type and HCoV Mpro ∆301-302 (deletion mutant) were 
kindly provided by Dr. J. Ziebuhr (Institute of Virology and Immunology, University of 
Würzburg, Germany). Low molecular-weight protein standards, Phastgel homogenous gel 
beds and 12.5% SDS buffer strips were from Pharmacia (Freiburg). 
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2.2 Methods 
2.2.1 Proteins 
The purification procedure for recombinant TGEV Mpro (residues 1 to 302) and HCoV 
Mpro∆301-302 (residues 1 to 300) is described by Ziebuhr et al (1997) and Hegyi et al 
(2002). The proteins were expressed in Escherichia coli as an MBP fusion protein and first 
purified by amylose affinity chromatography. The recombinant Mpro was then released from 
the fusion protein by factor Xa cleavage and purified to apparent homogeneity by 
hydrophobic interaction, ion exchange and gel filtration chromatography. The recombinant 
proteinases were finally concentrated to 12.5 and 15 mg/ml (Centricon-YM3, Millipore, 
Eschborn, Germany), respectively. 
  
2.2.2 Selenomethionine-derivatized proteins 
Practical impediments to structure solution from the native protein, compounded by its low 
sequence homology to other known proteinases, persuaded us to produce selenomethionine 
SeMet-substituted Mpro for phase determination using the MAD approach. The SeMet-
derivatized TGEV and HCoV Mpro were also provided by John Ziebuhr. The plasmids, pET-
TGEV Mpro and pET-HCoV Mpro∆301-302, were used to transform the methionine 
auxotrophic 834(DE3) E. coli strain (Novagen, Germany). The SeMet-substituted 
coronavirus proteinases were concentrated to 9.5 mg/ml and 7.1 mg/ml, respectively. 
 
2.2.3 Determination of purity 
Protein purity is a critical factor in crystallization experiments: proteins used for 
crystallization should be as pure as possible and completely homogeneous (McPherson, 
1998). The purity of TGEV Mpro and HCoV Mpro was visually evident from 12.5% SDS 
polyacrylamide gels stained with Coomassie Blue (Lämmli, 1970) (Fig. 2.1). 
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Fig. 2.1 SDS-PAGE gel analysis of the 
TGEV and HCoV Mpro. Both lanes show 
individual single bands of approximate 33 
kDa molecular weight.  
 
 
 
2.2.4 Characterization of purified TGEV Mpro and HCoV Mpro 
2.2.4.1 MALDI Mass Spectroscopy 
Molecular masses of the proteins were verified by MALDI (matrix-assisted laser desorption 
ionization) mass spectroscopy. Mass spectroscopy was performed by Dr. K. H. Gührs (IMB, 
Jena) and Dr. N. Oldham (MPI for Chemical Ecology, Jena) on protein under low salt 
concentration (native protein).  
 
TGEV Mpro: The protein samples were diluted to 5 pmol/µl with 0.1% trifluoroacetic acid 
(TFA), mixed with the matrix (saturated solution of sinapinic acid or α-cyano-4-
hydroxycinnamic acid (Fluka, Germany), 66% acetonitrile in water containing 0.1% TFA), 
and analyzed with a Biflex II workstation (Bruker, Germany). Bovine serum albumin (MW = 
66.431 kDa) was used as the internal mass standard. Protein solution and matrix were mixed 
in equal volume and 1 µl of the sample was applied to the target. Mass spectra were analyzed 
using the analysis software XMASS v5.0 (Bruker, Germany). The mass spectra were 
essential to check the selenium incorporation in SeMet-derivatized TGEV Mpro protein 
before setting up crystallization trials. 
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HCoV Mpro: As the spectrum intensity of desired mass was quite low with the α-cyano-4-
hydroxycinnamic acid, spectroscopy was done with at least two more matrices (sinapinic 
acid and 2,5-dihydroxybenzoic acid) and the internal mass standard carbonic anhydrase (MW 
= 30 kDa) was taken for both native as well as SeMet-derivatized ∆301-302 mutant of HCoV 
Mpro. 
 
2.2.4.2 Dynamic Light Scattering 
The oligomerization state of the protein in solution was analyzed by dynamic light scattering 
(DLS). In the DLS measurement, a beam of monochromatic light was directed through the 
sample to monitor fluctuations in the light intensity scattered by the protein molecules. From 
analysis of the data, the translational diffusion coefficient (DT) of the protein particles in 
solution was obtained. Assuming Brownian motion, this coefficient was converted to the 
hydrodynamic radius, RH, of the protein particles using the Stokes-Einstein equation (RH = 
kbT/6πηDT), where kb represents Boltzmann's constant, T is the absolute temperature in 
Kelvin and η is the solvent viscosity. The hydrodynamic molecular weight of the protein 
particle can be estimated from the measured value of DT using a calibration curve obtained 
from proteins of known mass. DLS analysis was performed at 20 oC using a DynaPro-801 
(Protein Solutions Ltd., Buckinghamshire, UK). The protein samples at 2-5 mg/ml in 100mM 
Tris.HCl pH 7.4 (buffer A) were filtered and centrifuged according to the manufacturer's 
instructions in order to make the solution free from particulate matter. 15-20 readings per 
sample were taken. All DLS analysis was carried out using the Dynamics version 5.24.02 
program (DynaPro control software, Protein Solutions Ltd., UK). A Spectra-Physics 
Millennia II laser operating at 532 nm was used as the light source. The data were analyzed 
using the DynaLS software as described by Moradian-Oldak et al. (1998). Default 
parameters were used in interpreting the statistical results. 
 
2.2.5 Crystallization experiments 
Crystallization of the protein under study is a prerequisite for the entire crystallographic 
work. After the purification of proteins, crystals may be obtained by carefully searching for 
suitable crystallization conditions, which include pH, buffer condition(s), temperature, 
precipitant(s), etc. as variables (McPherson, 1998). The most common set-up to grow protein 
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crystals is the hanging-drop technique, which was used in this work. The technique is based 
on vapor diffusion of water. A few micro-liters of protein solution is mixed with an about 
equal amount of reservoir solution containing the precipitants. A drop of this mixture is put 
on a siliconized microscope glass slide, which covers the depression in a tray. The depression 
is partly filled with the required precipitant solution (reservoir solution: approximately 1 ml). 
Applying grease to the circumference of the depression seals the chamber, before the glass 
slide is put into place (Fig. 2.2). As the precipitant concentration in the drop is lower than in 
the reservoir, water evaporates from the drop and diffuses into the reservoir. As a result, the 
concentration of both protein and precipitant in the drop slowly increases and crystals may 
form. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2.2 Schematic diagram of a hanging drop setup. 
 
TGEV Mpro: Preliminary crystallization trials were conducted using Crystal Screens I and II 
and Additive Screens I and II (Hampton Research, California, USA). The hanging-drop 
vapor diffusion method was used at 4 oC to crystallize wild-type TGEV Mpro. A solution 
containing 12.5 mg/ml protein in 12mM Tris.HCl, 120mM NaCl, 0.1mM EDTA, 1mM DTT 
at pH 7.4 was used. The best crystals (Fig. 3.1A and B) were obtained by using a reservoir 
containing 100mM HEPES pH 8.8, 1.8M ammonium sulphate, 6% MPD, 5mM DTT, with 
4% dioxane added after setting up the drop. Typically, a 2 µl aliquot of the protein solution 
was mixed with an equal volume of the reservoir solution and allowed to equilibrate against 
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1 ml of reservoir solution. Crystals of dimensions ~0.30x0.25x0.30 mm3 grew in about 10 
days. Crystallization plates set up using aged protein (of about 3 weeks after purification) 
gave better-quality crystals than those from freshly purified protein. This may be related to 
the oxidation of Cys144, where the difference density indicates the formation of the sulfinic 
acid (–SO2¯) or sulfonic acid (–SO3¯) derivatives in all TGEV Mpro monomers (Section 
3.4.1).  
 
Crystals of SeMet-derivatized TGEV Mpro were grown under the same conditions as 
for the native protein, but with 2M ammonium sulphate and 8% MPD. These crystals were 
extremely fragile and were difficult to be transferred to a storage buffer or cryogenic buffer 
without severe damage. Fortunately, they could be cooled to cryogenic temperatures after a 
quick rinse with mustard oil. They took two more days than the wild-type crystals to grow 
bigger and diffractable. The size of these crystals was approximately 0.25x0.25x0.20 mm3. 
 
HCoV Mpro: Initial trials for the C-terminal deletion mutant (∆301-302) of HCoV Mpro 
involved the hanging-drop vapor diffusion method at 4, 10 and 15 oC using Hampton Crystal 
Screens I and II. The protein concentration was 15 mg/ml in the protein storage solution 
(11mM Tris.Cl, 200mM NaCl, 0.1mM EDTA, 1mM DTT at pH 8.0). Each well of a Sarstedt 
tissue-culture plate contained 1 ml precipitant and above it 2 µl of a 1:1 mixture of protein 
with well solution.  
   A                                                                    B 
 
 
 
 
 
 
 
 
Fig 2.3 A. Native crystal of HCoV Mpro obtained by the hanging-drop method. The larger 
plates showed inferior diffraction quality. B. SeMet-derivatized crystals of HCoV Mpro. 
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The precipitant contained 15% PEG 6K, 4% 1,6-hexanediol, 5mM DTT, 2% dioxane and 
100mM HEPES pH 8.5. Within three days, microcrystals appeared and in about one week, a 
few big plate-like crystals appeared at 10 oC temperature. The optimal size for X-ray 
diffraction of the crystal was ~0.3x0.1x0.05 mm3. Larger crystals were more fragile and were 
leading to streaky reflections, whereas smaller ones were not diffracting better (Fig. 2.3A, B). 
 
The SeMet-derivatized HCoV (∆301-302) Mpro crystals were also obtained by using 
the hanging-drop method. The protein concentration was 7.1 mg/ml. The reservoir contained 
100mM HEPES pH 8.5, 20% PEG (10K), 2% 1,6-hexanediol and 12% dioxane. The protein 
solution and reservoir were mixed in a 1:1 ratio for the crystallization drop and dioxane was 
added later to the reservoir solution, after setting up the drop. Crystals of about 0.2x0.2x0.05 
mm3 size appeared in about one week. 
 
2.2.6 Characterization of protein crystals 
There are a number of ways to distinguish crystals of salt from protein. (i) The light 
microscope can detect protein crystals in the small crystallization drop using birefringence. 
This way one can differentiate amorphous precipitate from microcrystals in a drop when 
viewed under a microscope. Precipitate does not have birefringent properties while all 
crystals except cubic ones do so. (ii) The second method to verify that crystals are 
proteinaceous, is to analyze them by SDS gel electrophoresis (Lämmli, 1970). (iii) The third 
method is the most commonly used one – Staining with IzitTM (C16H18ClN3S) or methylene 
green. This method was used to identify microcrystals of the TGEV and HCoV proteinases. 
If the crystal is a protein crystal, it turns blue, otherwise it stays opaque. This can simply be 
done by placing 1 µl of IzitTM in the sample drop and waiting for 24 hours. IzitTM is a small 
molecule dye that fills the solvent channels in protein crystals and binds with the protein 
molecules coloring the crystals blue. Salt crystals do not possess these large solvent channels 
thus IzitTM cannot enter the crystal, leaving one with a clear crystal and a blue drop. IzitTM 
works especially well for small microcrystals or for questionable precipitate. Another method 
is (iv) Poking the crystal with a very fine glass rod or glass pipette (drawn over a Bunsen 
burner) or a simple needle. This is the simplest and probably the best test. If the crystal is 
protein, it should disintegrate very easily. Protein crystals are more fragile and brittle than 
 24
  Materials and Methods  
salt crystals that are harder to break. (v) Setting up a "no protein" control drop with the buffer 
(+additives) the protein was in initially, to see if crystals grow without protein. Finally, the 
X-ray diffraction is the most reliable method to verify protein crystals. 
 
2.2.7 Preparation of crystals for data collection 
TGEV Mpro: Elucidation of optimal cryo-conditions involved many trials with conventional 
cryoprotectants, none of which worked. TGEV Mpro crystals could not even survive the dry 
paraffin oil technique (Tunnicliffe and Hilgenfeld, 1999). The following hydrocarbon silicon 
oils were used in cooling experiments: Dow Corning 200/1cS fluid (BDH silicon products), 
highly liquid paraffin (Merck), viscous paraffin (Merck), vacuum-pump oil (Savant SPO1), 
rotary vacuum-pump oil (Leybold 17702), Al’s oil (Hampton Research), mineral oil (Sigma), 
and different combinations of paraffin and silicon oils. Interestingly, a quick rinse at 4oC in 
unrefined mustard oil (mustard seeds oil, Delhi, India) was more successful. Crystals were 
immediately frozen in liquid nitrogen.  
 
HCoV Mpro: These crystals did not need any external cryoprotectant and could be put straight 
from the drop into the stream of liquid nitrogen using a nylon loop (Hampton Research). The 
precipitant contained 20% PEG 10K, which acts as a cryoprotectant itself.  
 
2.2.8 Diffraction data collection 
TGEV Mpro: Diffraction data were collected from crystals held in a stream of cooled nitrogen 
gas at 100 K (Oxford Cryosystems, Oxford, United Kingdom). The loop-mounted crystals 
were fragile and suffered from radiation damage when exposed for longer times to X-rays. 
Native data were initially collected to a Bragg spacing of 3.5 Å on an FR591 rotating copper 
anode X-ray generator (Nonius, Delft, The Netherlands) operated at 40 kV and 100 mA, 
using a 30-cm MarResearch image plate (X-ray Research, Hamburg, Germany). Data beyond 
1.95 Å resolution were subsequently collected (Table 3.2) at 100 K on the X-ray diffraction 
beamline at ELETTRA, Trieste, using a Mar165 CCD detector (detector to crystal distance 
140 mm). 
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HCoV Mpro: Diffraction data were collected from a crystal held in a stream of nitrogen gas at 
100 K (Oxford Cryosystems) using Cu-Kα.radiation generated at 40 kV and 100 mA by an 
FR591 rotating anode X-ray generator (Nonius, Delft, The Netherlands), equipped with a 30-
cm image plate (Mar Research, Hamburg, Germany). The data extended to approximately 3.5 
Å resolution, at an hour exposure per degree and crystal-to-detector distance of 250 mm. The 
low-resolution limit with CuKα radiation made the use of synchrotron radiation mandatory. 
  
In order to optimize the use of synchrotron radiation, data for both TGEV and HCoV 
Mpros were collected in a way (calculated by the program STRATEGY (Ravelli et al., 1997)) 
producing the complete data set with a minimal number of images. The space group and cell 
dimensions from the crystals were derived using the autoindexing routine in DENZO 
(Otwinowski & Minor, 1997). Data integration/reduction and scaling were performed using 
the programs DENZO and SCALEPACK (Otwinowski & Minor, 1997). 
 
2.2.9 Initial attempts to solve the TGEV Mpro structure 
Due to the low sequence similarity to other proteinases, the structure could not be solved 
using conventional molecular replacement techniques. Soaking and cocrystallization mainly 
with Hg, Pt, Au, Ir, Cd, Br compounds and xenon occlusion at 10 bars pressure were tried. 
Unfortunately, none of the 35 heavy atom compounds tried for TGEV Mpro did successfully 
bind to the protein crystal, including xenon and Br. Because it was a long list of trials, 
therefore, the prescreening method of Boggon and Shapiro (2000) was used to run a native 
gel before setting up the crystallization plate. 1 µl of protein with 1 µl of heavy atom 
containing solution was taken and incubated for about 10 min followed by running a native 
gel to look for band shifts. Few mercury compounds and iridium-soaked proteins showed a 
band shift (Fig. 3.4) in the native gel but after cocrystallization and soaking, it was found that 
only mercuric acetate bound partially (the crystals with this compound only, were quite 
isomorphorous to the native ones). However, it was impossible to solve the structure by the 
conventional isomorphous replacement method due to the non-isomorphism between 
different crystals. It was not possible to scale data sets from native and derivatized crystals 
together. Consequently, MAD data sets were collected to 2.9 Å resolution from crystals of 
SeMet-TGEV Mpro at a tunable synchrotron beamline. 
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2.2.10 Multiwavelength anomalous dispersion (MAD) 
MAD Theory: The quantity usually measured in relation to each X-ray reflection is the 
intensity, which is proportional to |F(HKL)|2 and hence it is |F(HKL)| that is determined 
experimentally. This quantity may be called the 'geometric structure factor' as it depends only 
on the positions of the atoms and not on any differences in their scattering behavior. If the 
nature of the scattering, including any phase change, is identical for all atoms, then |F(hkl)| = 
|F(-h-k-l)|. This is known as Friedel's law. However, when the energy range of the X-rays 
used is tuned to match that for the absorbance of a heavy atom, a breakdown of Friedel's law 
results. This phenomenon is known as anomalous scattering and is the basis of MAD 
experiments. In the presence of anomalous scattering atoms in the protein crystal, one can 
utilize two types of signal to calculate phases: the dispersive difference signal (between 
wavelengths, due to the contribution of ∆f’ to the structure factor), and the anomalous signal 
(between Bijvoet pairs, the intensity of Friedel-mate reflections is different due to the 
contribution of ∆f”). These signals are used in a MAD experiment using tunable synchrotron 
radiation, to maximize both the dispersive and anomalous differences. This requires 
collection of at least three data sets, one at each wavelength.  In the MAD method, the 
wavelength dependence of the anomalous scattering is used.  
 
The principle of this method is rather old but it was the introduction of tunable 
synchrotron radiation sources that made it a technically feasible method for protein structure 
determination. Hendrickson and colleagues (1988) were the first to take advantage of this 
approach and use it for solving protein structures. Hendrickson showed that the presence of 
one selenium (Se) atom (atomic number 34) in a protein of not more than approximately 150 
amino-acid residues is sufficient for a successful application of MAD; however, this depends 
very much on the quality of the data. With more Se atoms the size of the protein can, of 
course, be larger. 
 
 27
  Materials and Methods  
 
Fig. 2.4 atic of experimental values for ∆f ' and ∆f " as a function of X-ray energy.  
The wavelengths have to be carefully chosen to optimize the difference in intensity 
betwee
ere the Bijvoet differences are 
∆f ' has its minimum (also called as 'edge', E). 
 where ∆f ' and 
ata collection: MAD data sets for TGEV Mpro were collected around the Se K-edge 
 Schem
 
n Bijvoet pairs and between the diffraction at the selected wavelengths. The 
anomalous scattering factor has a real part (∆f') and an imaginary part (∆f"). Usually, 
diffraction data are collected at three wavelengths (Fig. 2.4): 
(i) First wavelength, where ∆f ' has its maximum and wh
largest (also called 'peak', P). 
(ii) Second wavelength, where 
(iii) Third wavelength, high (H) and/or low energy remotes (L) from the edge
∆f " are small. 
 
D
(12671.32 eV / 0.978470 Å) using a Mar165 CCD detector at beamline BW7A of the EMBL 
Outstation at DESY (Hamburg, Germany). Crystals of the SeMet-derivatized TGEV Mpro 
were isomorphous to the native ones except one crystal. Data were collected including an 
inverse beam sweep (ie. a sweep of data collected with the crystal rotated by 180º with 
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respect to the initial sweep) for the f " maximum and f ' minimum wavelengths, in order to 
guarantee the collection of all possible anomalous pairs.  
 
Three different complete MAD experiments were done on three different SeMet-
substitu
ata integration and scaling were performed using the programs DENZO and 
SCALE
HCoV Mpro: Prior to the MAD experiment with the SeMet TGEV Mpro crystals, ∆301-302 
ted crystals. The first crystal was non-isomorphous, so the data from this crystal 
could not be merged with those obtained from the other crystals, to get high redundancy. A 
four-wavelength experiment was conducted on the second crystal, whereas three-wavelength 
data were collected on the third isomorphous SeMet-derivatized protein crystal. With one, 
out of these two crystals, the peak-wavelength data were collected twice. Data were collected 
up to 2.8 Å resolution, though they were useful only up to 2.9 Å resolution (see Table 3.4).  
 
D
PACK (Otwinowski & Minor, 1997). Self-rotation function calculations, performed 
using the CCP4 suite program ALMN (Collaborative Computational Project Number 4, 
1994), suggested the presence of twofold non-crystallographic symmetry (NCS) axes. They 
were not used for determination of the Se–substructure due to their complexity. In retrospect, 
four independent NCS twofold axes can be found in the asymmetric unit, three within the 
dimers and one relating two dimers (A-B and E-F) (Section 3.2.5.2). 
 
mutant SeMet-derivatized crystals were also tried for a MAD experiment at ELETTRA, 
Trieste, Italy. However, the selenium signal was too weak to solve the structure by direct 
methods. The data sets were collected at four wavelengths. All of them were merged together 
to obtain highly redundant data. This approach was useful for solving the structure by 
molecular replacement, taking TGEV Mpro as a model. Data integration and scaling were 
performed using the programs DENZO and SCALEPACK (Otwinowski & Minor, 1997). 
Self-rotation function calculations were performed using the CCP4 suite program ALMN 
(Collaborative Computational Project Number 4, 1994). 
 
 
 
 29
  Materials and Methods  
2.2.11 Structure determination 
the structure determination was the identification of the 60 TGEV Mpro: The bottleneck of 
selenium positions (6 monomers/a.u., with 10 Se each, were expected). The selenium 
substructure was determined with the SnB v2.0 (Weeks & Miller, 1999) package. SnB is a 
computer program based on a dual-space direct-methods procedure for determining crystal 
structures from X-ray diffraction data. It provides a graphical user interface for (i) computing 
normalized structure-factor amplitudes, (ii) the main phasing algorithm – Shake & Bake 
(Sheldrick, 1990a) and (iii) visualization and molecule-editing facilities 
(http://www.hwi.buffalo.edu/SnB). 
 
Normalized difference structure factors (diffE) (Blessing & Smith, 1999) values were 
computed from the observed anomalous differences using the DREAR suite (Blessing et al., 
1996). All the data sets were scaled together into a single scale file. This file was then used in 
the program SnB v 2.0 to find out the positions of selenium atoms. Initially, only the peak 
wavelength (P1) data set from one crystal was used, but it was not enough to obtain a 
solution by SnB v2.0 (Weeks & Miller, 1999) (see Table 3.5). The redundancy of that data 
set was only 3.8. By increasing the redundancy through merging of various data sets 
increased the precision of the averaged intensities (as described by Rpim; Weiss & Hilgenfeld, 
1997) sufficiently. In this way, the typical bimodal distribution was obtained in the SnB 
histograms indicative of some correct solutions. Taking only two high-energy remote 
(H1+H2) data sets gave 1 solution out of 4000 trials. Two merged peak-wavelength data sets  
(P1+P2) yielded 3 solutions out of 3000 trials; three merged peak-wavelength data sets 
(P1+P2+P3) gave 77 SnB solutions out of 2300 trials. Finally, all three peaks (P1+P2+P3), 
and two edge (E1+E2) wavelength data sets (redundancy = 18; Table 3.5) were merged 
together and then their anomalous differences were processed with the DREAR suite 
(Blessing et al., 1996) to generate normalized difference structure factors (diffE values), 
giving 105 solutions from 5000 trials.   The 1900 target diffE values were used to generate 
20,000 triplet invariants. Between 2300 and 5000 trials were carried out with 120 SnB cycles 
of dual-space refinement on single data sets as well as merged data sets (see Table 3.5). For 
heavy-atom refinement and phase calculation at 2.9 Å resolution, all data sets were merged 
into a single "mtz" file using the CCP4 package (Collaborative Computational Project 
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Number 4, 1994). This file was then used in the program MLPHARE (Otwinowski, 1991) for 
the further refinement of these positions. After refining the positions, solvent flattening and 
NCS averaging was performed and an averaged mask of one of the monomers was obtained 
using the program DM (Cowtan & Main, 1996) that gave interpretable electron density maps. 
Subsequently, a mask was generated using the program MAPMASK (CCP4 suite) and NCS 
matrices were calculated from the selenium positions in each monomer. These matrices were 
improved after each refinement cycle. Full NCS averaging was performed with DM. The 
initial correlation coefficient between the monomers was about 0.48 in DM.  
NCS: Out of the 60-Se SnB solutions, 37 positions obeyed the NCS. A further 11 positions 
CoV Mpro: The structure was solved by molecular replacement (Rossmann, 1990) with the 
.2.12 Indicators of diffraction data quality  
essed by different criteria. One of them is the 
were predicted by the NCS, adding to a total of 48 out of 60 Se positions. Non-
crystallographic symmetry restraints were applied during the initial stages of refinement 
against the 2.9 Å data; these restraints were gradually released as the resolution limit was 
extended to 1.96 Å. NCS averaging was used to generate meaningful estimates for missing 
reflections. 
 
H
software package AmoRe (Navaza, 1994). The refined structure of TGEV Mpro was used as 
the search model after all residues had been replaced by their counterparts in HCoV Mpro and 
bad contacts eliminated. Crystallographic refinement was carried out with the program CNS 
(Brünger et al., 1998a) and alternated with cycles of manual inspection and rebuilding. The 
refinement consisted of cycles of simulated annealing (Brünger et al., 1990) followed by 
conjugate gradient minimization of atomic coordinates and isotropic temperature factors.  
 
2
The quality of the X-ray data is routinely ass
symmetry (Rsym) or merging R factor that arises from the averaging of multiple 
measurements of reflections of the same (h,k,l) and of symmetry-related reflections. The 
second quantity is the ratio of the recorded intensity and its standard deviation, I/σ(I), and the 
third one is the redundancy of the data, i.e., how often a given reflection and/or one of its 
symmetry-related reflections have been observed. The fourth quantity is the completeness of 
the data set, overall and in the highest resolution bin. Of these, Rmerge is inherently dependent 
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on the redundancy of the data. The more often a given reflection is observed, the higher 
Rmerge will be, even though by simple statistical reasoning the average value of the 
measurements will become more accurate (Weiss and Hilgenfeld, 1997; Diederichs & 
Karplus, 1997; Weiss, 2001). To overcome these drawbacks, a redundancy-independent 
merging R-factor (Rrim) and the precision-indicating merging R-factor (Rpim) have been 
proposed (Weiss and Hilgenfeld, 1997; Weiss, 2001). Rrim contains the redundancy N or the 
multiplicity of the observed reflection and is basically the conventional Rmerge made 
independent of redundancy. Rpim also contains the redundancy N and indicates how precisely 
the average measurement has been measured. 
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here Ii is the observed intensity and <I> is the average intensity from multiple 
 the case of TGEV Mpro, it was impossible to solve the structure with one 
wavele
W
measurements. N is the number of times a given reflection has been measured. Rrim  
corresponds to an Rsym that is independent of the redundancy of the measurements.  
 
In
ngth data because of the low redundancy (3.8); also indicated by the worse Rpim value. 
More data sets had to merge together to gain as high redundancy as possible (18.0-fold 
redundancy was achieved) (for details see Table 3.5). The same was done for the HCoV Mpro 
diffraction data sets. All four wavelengths (the MAD experiment failed to solve the phase 
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problem because of very poor selenium signal) were merged together to get a highly 
redundant data set to solve the phase problem by the molecular replacement method.  
 
2.2.13 Model building and refinement of TGEV Mpro and HCoV Mpro
Interpretable electron density maps are essential for guiding a proper model building. This is 
facilitated by drawing contour maps at various density levels. A higher electron density (ρ) at 
a given location (x,y,z) indicates the probable occurrence of an atom. Model building entails 
that these high-density locations are fitted with appropriate atoms. As the model building 
proceeds, it is imperative to ascertain the correctness of the built model at regular intervals. 
This is done in two ways by calculating the difference between the structure factor values of 
the observed (Fo) and calculated (Fc) maps. 
( ) ∑ −++−−=−
lkh
lzkyhxico calceFF
V
zyxmapFcFo
,,
)(2|)||(|1,,:)( απρ  
The map indicates where the model should be adjusted to increase the electron density in this 
region by moving atoms towards that location, and vice versa for the negative density 
regions. 
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α= phase, V = unit cell volume 
The 2Fo-Fc map shows the difference between the actual structure and the model in addition 
to the observed electron density of the model. In this map, the model influence is reduced, 
but not as severely as in the Fo-Fc map.  
 
The initial electron density maps for both TGEV Mpro and HCoV Mpro obtained from 
preliminary phases were interpretable. For both the proteinases, initially the A monomer was 
built manually into the electron density map, then the other monomers were generated at low 
resolution by NCS symmetry operation(s). The TGEV Mpro had 6-fold NCS, which was 
applied at 2.9 Å resolution. The monomer B of HCoV Mpro was generated by two-fold NCS 
operation in a similar manner. A polyalanine model of 90% of a single subunit was built with 
the program 'O' (Jones et al., 1991). Most of the side chains were identified afterwards. The 
known locations of the Se sites allowed the assignment and direction of the peptide chain. 
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Omit map: An important way to overcome phase bias is the use of omit maps. An 
'OMITMAP' is made by removing the residues of interest from the model for calculating the 
phases. In theory, this will allow the phases calculated from the rest of the model to phase the 
area of interest with no bias from the model left out. The method takes advantage of the 
Fourier transform property that every point in real space is influenced by every point in 
reciprocal space, and vice versa. In  TGEV Mpro, the flexible surface loop from residues 216 
to 225, the C-terminus of helix E, the loop region between residues 267 and 276, and the 
segment 294-300 following the C-terminal F helix were not having good electron density. 
Likewise the loop region 46-49; and the region 242-259 of HCoV Mpro were poorly defined. 
Many cycles of the ‘OMITMAP’ procedure finally resulted in good electron density map for 
these regions. 
 
2.2.13.1 Introduction of water molecules into the structure 
A significant part of the model are ordered water molecules. The following criteria were 
employed in the introduction of water molecules in the structure. 
They should represent the residual (Fo-Fc) electron density 4σ above the mean level in the 
electron density map and 1σ above the mean in the 2Fo-Fc map. More importantly they 
should have chemically reasonable distances to potential hydrogen-bond donors/acceptors. 
The improvement of the model was monitored by both the conventional R-factor and Rfree 
(Brünger, 1992a). The B-factor and coordinates for the water molecules were refined in the 
water-picking script of the program CNS. 
 
2.2.13.2 Refinement of the TGEV proteinase structure to high resolution  
Initial rounds of refinement involved a combination of CNS and Arp/warp (Lamzin & 
Wilson, 1997) for the high resolution (1.96 Å) data from TGEV Mpro. The refinement was 
carried out against 95% of the measured data. The remaining 5% that were randomly 
excluded from the full dataset were used for cross-validation by calculating the free R-factor 
(Rfree) to follow the progress of refinement (Brünger, 1992a). The same set of reference 
reflections was used throughout the refinement. The reference set was also excluded from the 
calculation of the electron density maps. 
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The refinement was performed with CNS (Brünger et al., 1998b). The procedure 
included simulated annealing, B-factor and conjugate gradient energy minimization against 
maximum likelihood targets as implemented in the program CNS (Brünger et al., 1998a). 
After each step, 2Fo-Fc and Fo-Fc electron density maps were calculated and the model was 
visualized and rebuilt using the program 'O' (Jones et al., 1991). Rebuilding proceeded by 
systematically checking all the electron density peaks greater than 4σ in the Fo-Fc Fourier 
maps and building the missing residues which were removed during the beginning of 
refinement; the σ cut-off was systematically lowered during the later cycles of refinement.  
 
When the resolution was extended to 1.95 Å, it was found that there were some 
pieces in each of the monomers which were not NCS-related. So later stages of refinement 
cycles were independent of NCS. Final refinement converged to free R factor of 25.6% and a 
crystallographic R-factor of 21.0%.  
 
The crystal structure refinement of HCoV Mpro was done in quite a similar manner as 
for TGEV Mpro structure. The refinement converged to a free R factor of 28.8% and a 
crystallographic R factor of 22.2%. 
 
2.2.14 Assessment/Validation 
The quality and structure analysis of TGEV Mpro and HCoV Mpro: All the monomers in the 
crystal structure of TGEV and HCoV Mpro were compared using the programs ALIGN 
(Cohen, 1997) and LSQKAB (CCP4, 1994). Visual comparisons were made using program 
‘O’ (Jones et al., 1991). Analysis of the crystal contacts was performed using the program 
CONTACT from the CCP4 Suite (1994).    
 
The final models of all structures were validated by the program PROCHECK 
(Laskowski et al., 1993) to check the overall quality using the Ramachandran plot and other 
stereochemical criteria. The errors in the atomic coordinates of the molecular model were 
estimated using a Luzzati plot (Luzzati, 1952). The quality of macromolecular structure-
factor data and their agreement with the atomic model was checked with the program 
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SFCHECK (Vaguine et al., 1999). This indicator takes into account errors in the data, atomic 
displacement factors, quality of the crystal and series termination effects (Blundell & 
Johnson, 1976) and indicates a correlation factor between the observed and the calculated 
structure factor amplitudes. It is relatively independent of the choice of the nominal 
resolution of the data set and should therefore be objective. It is also relatively independent 
of the completeness of the data set. Further inconsistencies were identified using the program 
WHATCHECK (Vriend, 1990). This program checks the quality of protein structures for 
many different kinds of errors. It produces an elaborate report, ranging from trivial bond 
length, torsion angle, and surface checks to highly advanced contact analysis and hydrogen-
bonding network checks. The solvent accessibility of the monomers was calculated using the 
algorithm of Lee and Richards (1971) as implemented in the program NACCESS 
(http://sjh.bi.umist.ac.uk/naccess.html). A solvent probe of radius 1.4 Å was used for the 
accessibility calculations. The inter-subunit contacts and the contacts between the symmetry 
mates were probed by counting the atoms in a sphere of radius 3.8 Å. The electrostatic 
potential surface of the monomer was calculated using the program GRASP (Nicolls et al., 
1991). The molecular diagrams were drawn using INSIGHT II (Biosym/MSI, San Diego, 
California, USA, 1995), Molscript (Kraulis, 1991) and Bobscript (Esnouf, 1999). The 
diagrams were rendered using the program Raster3D (Bacon & Anderson, 1988; Merritt & 
Bacon, 1997). Molscript, Bobscript and Raster3D are the programs of choice to draw the 
three-dimensional models highlighting the secondary structures. Bobscript can additionally 
draw electron density maps around the desired residues.  
 
2.2.15 Sequence analysis and three-dimensional structure search 
Primary structure analysis was carried out with the GCG software suite (Wisconsin package 
version 9.0, Genetics Computer Group (GCG), Madison, USA). Sequence motifs were 
explored using all the domains or by taking only domain III, and taking search patterns as 
defined by the PROSITE dictionary of protein sites and patterns. The PDB files were 
searched for folds similar to domain III using the programs DALI (Holm & Sander, 1993) 
and TOPS (Gilbert et al., 1999). 
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2.3 TGEV Mpro in complex with TLCK 
The amount of protein in the crystal was calculated as 3.48 x 10-10 Moles. This was done 
assuming 12 copies of the protein per unit cell (72.8x160.1x88.8 Å3) and crystal dimensions 
of (300x300x200) x104 Å3. Accordingly, one crystal was soaked overnight in 30 µl of 1mM 
TLCK (Sigma, Germany). The data were collected up to 2.6 Å resolution at using the Joint 
IMB Jena-University of Hamburg-EMBL synchrotron beamline X13 at Deutsches 
Elektronen-Synchrotron, Hamburg, at a wavelength of 0.802 Å at crystal temperature of 
100 K. A diffraction image from the X-ray data collection is shown in Figure 2.5. 
 
 
 
 
 
 
Fig. 2.5 Sample diffraction 
image of TGEV Mpro-TLCK 
crystal. Data collected using 
the Joint IMB Jena-
University of Hamburg-
EMBL synchrotron beamline 
X13 at Deutsches Elektronen-
Synchrotron, Hamburg,  
 
 
 
 
2.3.1 TGEV Mpro-TLCK Structure 
Soaking with TLCK did not change the unit-cell dimensions of the TGEV Mpro-TLCK 
complex crystal. The starting phases were obtained directly from the TGEV Mpro, from 
which water molecules and other ligands were removed.  
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2.3.2 Refinement of the TGEV Mpro-TLCK structure 
The refinement cycles were performed using the program CNS (Brünger et al., 1998a). All 
model building and graphical manipulations were performed with the program 'O' (Jones et 
al., 1991).  
 
2.4 TGEV Mpro-CMK inhibitor complex (substrate analog) 
2.4.1 CMK-Hexapeptide synthesis and Purification: Dr. Parvesh Wadhwani (Institute für 
Molekular biologie, Jena, provided the synthesized, purified and analyzed peptide. The 
peptide synthesis was performed using an Applied Biosystem's 433A peptide synthesizer. 
Conversion of the free C-terminal to the chloromethyketone functionality was performed as 
previously reported (Krantz et al., 1991). 
 
2.4.2 Soaking, data collection and refinement: TGEV Mpro crystals were soaked with 
fivefold molar excess of CMK inhibitor. Crystals were soaked for about 16 hr, quickly rinsed 
into the mustard oil at 4oC for cryo-protection then were taken for the measurement. A full 
data set to 2.2 Å resolution was subsequently collected using the Joint IMB Jena-University 
of Hamburg-EMBL synchrotron beamline X13 at Deutsches Elektronen-Synchrotron, 
Hamburg, at a wavelength of 0.802 Å, at crystal temperature of 100 K. The data were 
processed using DENZO and SCALEPACK programs (Otwinowski and Minor, 1997). The 
structure was refined in many cycles using program CNS (Brünger et al., 1998a). All model 
building and graphical manipulation were performed with the program 'O' (Jones et al., 1991; 
Jones and Kjeldgaard 1995). 
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3 RESULTS AND DISCUSSION 
 
3.1 Crystallization of recombinant coronavirus main proteinases 
TGEV Mpro: The protein solution containing the storage buffer (see Table 2.3) was screened 
for potential crystallization conditions using the commercially available kits from Hampton 
Research. Screening was done at 4, 10, 15, 20 and 30 oC using different pH ranges. The 
experiments were performed using the vapor diffusion method (hanging drop) (Fig. 2.2). 
Purified protein solution containing storage buffer (Section 2.2.1) was mixed with an equal 
volume (1µl) of precipitant solution and equilibrated over reservoir containing 1 ml of the 
latter. Only trials at 4 oC and at alkaline pH (pH 8.8) gave any crystals for TGEV Mpro. The 
microcrystals appeared after many screening rounds. The quality was improved upon 
including an additive like dioxane. Larger pyramidal TGEV Mpro crystals were finally 
obtained using a protocol with optimized conditions (1.8 M ammonium sulfate, 6% MPD, 100 
mM HEPES pH 8.8, 5 mM DTT). 4% dioxane was added later to the reservoir solution only, 
after setting up the drop. It was thus not directly added to the protein drop but was present in 
the equilibration process. The crystals obtained are displayed in Figure 3.1A. SeMet-
derivatized crystals were obtained under similar conditions except for 2 M ammonium sulfate 
and 8% MPD (Fig. 3.1B).  
 
HCoV Mpro: Initial rounds of screening gave clusters of very thin needles for HCoV Mpro. 
Attempts to improve the size and quality by growing crystals in the presence of various 
additives resulted in large plate-like, diffractable crystals of SeMet-derivatized HCoV Mpro, 
after using optimized conditions (20% PEG 10K, 2% 1,6-hexanediol and 12% dioxane, at 10 
oC, 100 mM HEPES pH 8.5) (Fig. 2.3A, B). Numerous problems were encountered during the 
crystallization. Successful crystallization was batch-dependent and even crystallizable batches 
exhibited poor reproducibility. Furthermore, these crystals predominantly displayed severe 
defects including stacking of many plates on one another, cracking, and splitting, branching 
and satellite formations. The optimized crystallization conditions for TGEV and HCoV Mpros 
are given in the Table 3.1. 
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Table 3.1 Optimized crystallization protocols 
HCoV Mpro 15% PEG 6K, 4% 1,6-hexanediol, 6 mM DTT, 0.5% 
ethanol, 100 mM HEPES, pH 8.5, 10 oC* 
SeMet-HCoV Mpro  20% PEG 10K, 2% 1,6-hexanediol, 6 mM DTT, 100 
mM HEPES, pH 8.5, 10 oC* 
TGEV Mpro 1.8 M ammonium sulfate, 6% MPD, 5 mM DTT, 4% 
(v/v) dioxane, 100 mM HEPES pH 8.8, 4 oC* 
SeMet-TGEV Mpro 2 M ammonium sulfate, 8% MPD, 5 mM DTT, 4% 
(v/v) dioxane, 100 mM HEPES pH 8.8, 4 oC* 
* Temperature  
 
Fig. 3.1 A. Native crystal of TGEV Mpro grown by the hanging drop method. The 
approximate dimensions of these crystals are 0.3 x 0.25 x 0.3 mm3. B. SeMet-derivatized 
crystal of TGEV Mpro. 
 
3.2 Structure elucidation 
3.2.1 Native-data acquisiton 
The TGEV Mpro crystals were fragile and suffered from radiation damage when exposed to X-
rays for longer durations. As a result, collecting data at room temperature was difficult. 
Therefore, to cryo-cool the crystals, many conventional and non-conventional cryoprotectants 
were tried (Section 2.2.7), none of which worked. Finally, a quick rinse in crude mustard 
(Brassica compestris) oil (mustard seed oil, Delhi, India) (Fig. 3.2) was successful. Crystals 
were immediately cryo-cooled in liquid nitrogen. To overcome the increased mosaicity 
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problem, the mustard oil was kept at the same temperature as the crystals were grown, i.e. at 
4 oC. 
 
 
 
 
 
 
 
 
Fig. 3.2 The source of mustard oil is seeds from the 
mustard plant (Brassica compestris). 
 
 
Data sets from crystals of native TGEV Mpro diffracting up to 1.95 Å resolution, were 
collected at 100 K on the X-ray diffraction beamline at ELETTRA, Trieste, using a Mar165 
CCD detector (Table 3.2). 
 
The crystals of HCoV Mpro were extremely fragile, thin plates and prone to cracking 
upon handling. Therefore, the specimens could not be transferred to a storage buffer or 
cryogenic buffer without undergoing severe and irreparable damage. Fortunately, crystals 
could be cryo-cooled without any cryoprotectant as the 20% PEG 10K used in the 
crystallization medium acted as a cryoprotectant itself. Data from native-HCoV Mpro crystals 
were difficult to scale and had low redundancy, and were therefore discarded. Subsequently, 
data from the SeMet-derivatized crystals were used to solve the structure. MAD data collected 
at all four wavelengths were merged together (see section 3.2.5) to obtain highly redundant 
data set up to 2.6 Å resolution. 
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3.2.2 X-Ray diffraction data 
TGEV Mpro: The unit-cell dimensions (a = 72.81 Å, b = 160.13 Å, c = 88.96 Å, β = 94.34o) as 
well as the self-rotation function implied that several monomers (4-8) were present in the 
asymmetric unit. The high-resolution native data set obtained at the synchrotron source gave 
diffraction data with an average value of I/σ(I) of 28.0 for all reflections (resolution range 50-
1.96Å) and 3.98 in the highest resolution shell (1.98-1.96 Å). The data set was more than 98%  
complete. A total of 787,522 measurements were made, representing 144,735 independent 
reflections. Data processing gave Rmerge 4.2%, Rpim = 1.8%, Rrim = 4.6%, and a mosaicity of 
0.6o. The Matthews coefficient for 6 molecules per asymmetric unit was 2.53 Å3/Da and the 
solvent content was 51.4% (Matthews, 1968). A summary of the X-ray diffraction data is 
given in Table 3.2.  
 
 HCoV Mpro: Crystals displayed space group P21 with unit cell dimensions a = 53.3 Å, b = 
76.1 Å, c = 73.4 Å, β = 103.7o, and two proteinase monomers in the asymmetric unit. The 
data were collected at the synchrotron source equipped with a Mar 345 detector. Diffraction 
data collected gave average value for I/σ(I) of 16.44 for all reflections (resolution range 25-
2.5 Å) and 9.1 in the highest resolution shell (2.59-2.50 Å). The data were more than 98% 
complete. A total of 228,513 measurements were made, representing 17,533 independent 
reflections. Data processing gave Rmerge = 14.2%, Rrim = 14.2%, Rpim = 3.0%, and a mosaicity 
of 1.8o. The Matthews coefficient for 2 molecules per asymmetric unit was 2.21 Å3/Da and 
the solvent content was 44.4% (Matthews, 1968). Diffraction data are summarized in 
Table 3.2. 
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Table 3.2 Summary of X-ray diffraction data: native crystals 
Diffraction data statistics TGEV Mpro HCoV Mpro
X-ray source Synchrotron radiationa Synchrotron radiationa
Detector Mar CCD Mar 345 
No. of frames 540 600 
Crystal oscillation (o) 0.5 1.0 
Wavelength (Å) 0.99983 0.980122 
Temperature (K) 100 100 
Space group P21 P21
Unit cell parameters (Å, o) a = 72.81, b = 160.13,  
c = 88.96, β = 94.34 
a = 53.3, b = 76.1,  
c = 73.4, β = 103.7 
Resolution (Å)b 50.0-1.96 (1.99-1.96) 25-2.60 (2.69-2.60) 
Completeness (%) 98.2 98.9 
Rmerge(%)b,c 4.2 (22.1) 14.2 (41.2) 
Rrim (%)b,c    4.6 (27.1) 14.2 (43.9) 
Rpim (%)b,c  1.8 (15.2) 3.0 (13.0) 
Redundancy 5.4 12.3 
I/σ(I) 3.4 9.1 
Mosaicity (o) 0.62 1.8 
No. of reflections measured 787,522 216,984 
Unique reflections 144,735 17,533 
a X-ray diffraction beamline at ELETTRA, Trieste, equipped with a Mar CCD detector 
   at the time of HCoV Mpro data collection it was equipped with Mar 345. 
b Highest resolution bin in parentheses 
c For definition, see Section 2.2.12 
 
3.2.3 Initial attempts to structure solution 
HCoV Mpro: Initial attempts to solve the structure were made with HCoV Mpro crystals. The 
amino-acid sequence was submitted for a BLAST search (URL: 
http://www.ncbi.nlm.nih.gov/BLAST) to identify promising homologous three-dimensional 
models, which resulted in 152 hits. The best hit had a score of 60% sequence identity with its 
own family member, however, for none of the family members, there was a three-dimensional 
model in the PDB archive. The rest of the results were with sequence identity below 15% so 
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were not suitable templates for search models. Additionally, these structures did not have 
folds similar to the one predicted by the secondary structure prediction program PHD (Rost & 
Sander, 1993) or a β-barrel fold as predicted by Gorbalenya et al. (1989b). Therefore, 3Cpro 
structures were downloaded from the PDB for three-dimensional superposition of their 
polypeptide backbones. These structures were input into the molecular replacement programs 
AmoRe (Navaza, 1994), Mol-Rep (CCP4 suite, 1994) and EPMR (CCP4 suite, 1994) to solve 
the phase problem. Unfortunately, none of the models taken individually or in combinations 
in a superimposed form gave any suitable template, which could give any useful phase 
information. Soaking and co-crystallization with heavy-atom compounds was also tried 
without any success because of poor binding of the metal ions, compounded by the poor 
quality of the crystals. The next trial was therefore made on the TGEV Mpro crystals, which 
were of better quality and diffracting to higher resolution than HCoV Mpro. 
 
TGEV Mpro: Due to the low sequence identity to other proteinases and complicated by the 
fact that several molecules per asymmetric unit were expected; the structure could not be 
solved using conventional molecular replacement techniques. Thus, phasing methods such as 
multiple isomorphous replacement (MIR), and single or multiple isomorphous replacement 
with anomalous scattering contributions (SIRAS and MIRAS, respectively), were required. 
All these techniques need suitable heavy-atom complexes, prompting heavy-atom soaking 
and screening experiments. Different heavy-atom solutions of varying concentrations were 
added directly to the crystallization drop, following growth of suitable native crystals. 
Crystals were allowed to be soaked for various lengths of time prior to cryo-cooling and 
subsequently, analyzed for potential heavy-atom attachment. Unfortunately, none of the 35 
heavy-atom compounds tried for TGEV Mpro successfully bound to it. To make the search 
productive and timesaving, native polyacrylamide gel electrophoresis (PAGE) of protein and 
heavy atom mixtures was used to search for gel shifts upon derivatization. This technique 
(Boggon & Shapiro, 2000) can show which reagents cause protein denaturation and are 
therefore less likely to be useful as heavy atom derivatives. There was a band shift observed 
for phenyl mercuric acetate, K2Pt(CN)4, and cis-platine II (Fig. 3.3). The band shift observed 
in these cases resulted from retardation of mobility, but the analysis of the diffraction data 
showed that even these compounds were bound only partially. Additionally, there was a 
significant non-isomorphism between different crystals. All the native and heavy-atom-
derivatized crystals were measured at similar temperature, i.e. 100 K. It was not possible to 
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scale data sets from different crystals together. Consequently, multiwavelength anomalous 
diffraction (MAD) experiments seemed most suitable for solving the phase problem. 
 
 
 
 
 
Fig. 3.3 Native gel showing band shifting 
when heavy-atom compound bound to 
the TGEV Mpro. 
 
 
Consequently the next recourse was expression and purification of SeMet-derivatized 
Mpros, which was done by Dr. Ziebuhr (Würzburg). First, the crystals of SeMet-HCoV Mpro 
were tried, but both the peaks for the mass of SeMet-derivatized protein in the MALD-TOF 
spectra (Fig.3.5) and the fluorescence peak of the SeMet-HCoV Mpro crystal were rather 
bleak. Additionally, the crystals and the data set were not of good quality, which persuaded to 
determine the TGEV Mpro structure first and the related structure of HCoV Mpro by molecular 
replacement later. The comparative details of the two derivatized proteins is described in the 
next section. 
 
3.2.4 Characterization of coronavirus SeMet-derivatized Mpros 
TGEV Mpro: Ziebuhr et al (1997a) found the molecule to be in the monomeric state in 
solution by gel filtration experiments. Figure 3.4 shows a typical spectrum of the protein as 
obtained by MALDI mass spectrometry (Section 2.2.4.1). The apparent mass was detected as 
33.17 kDa. The calculated molecular mass derived from the predicted wild-type amino acid 
sequence is 33.09 kDa. Comparison of predicted mass to the mass measured by MALDI mass 
spectrometry indicates an error of 0.2%, which is within the error margin of the instrument.  
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Fig. 3.4 Spectra obtained by MALDI-TOF for the native (upper) and SeMet-derivatized 
protein (lower) of TGEV Mpro. 
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Fig. 3.5 Spectra showing the accurate molecular mass of the native (upper) and SeMet-
derivatized protein (lower) of HCoV Mpro, obtained from MALDI-TOF. 
 
The mass spectra for SeMet-derivatized TGEV Mpro showed a peak at 33.51 kDa. The 
difference of mass shown by MALD-TOF between the wild-type TGEV Mpro and SeMet-
derivatized TGEV Mpro indicated about 70% of selenium incorporation in the protein, when 
calculated for 10 methionines. This was a good encouragement to crystallize this protein.  
 47
  Results and Discussion 
 
Preliminary dynamic light scattering experiments (Section 2.2.4.2) showed about 35% of the 
protein mass in the dimeric form. TGEV Mpro is a mixture of monomer (29.8 kDA) and dimer 
(67.5 kDa) in protein storage solution (11mM Tris.HCl pH 7.4, 120mM NaCl, 0.1mM EDTA, 
1mM DTT – buffer A, Section 2.2.4.2). When repeated under crystallization condition, 
mixing buffer A and buffer B (1.8 M ammonium sulfate, 6% MPD, 100 mM HEPES pH 8.8), 
the experiment showed the dimer as by far dominant species. Under crystallization conditions, 
the higher order aggregates (~200 kDa) were seen (buffer B), which was a clear indication 
that protein is not monomeric under crystallization conditions. The results were consistent 
when repeated a number of times (Table 3.3). A dimeric arrangement with approximate C2 
symmetry is also found in the crystal. Like TGEV Mpro, the HCoV proteinase is also a 
homodimer in the crystal, though it was crystallized under completely different conditions 
and in a different unit cell. 
 
Table 3.3 Dynamic light scattering data fot TGEV Mpro
Expt. 
No. 
Protein buffer Hydrodynamic 
radius (nm) 
Polydispersity
Intensity (%) 
Estimated mass (kDa) 
1. Buffer A 2.54 32.9 29.8 
2. Buffer A 3.54 37.5 67.5 
3. Buffer B 4.17 02.2 206.7 
 
HCoV Mpro: The proteinase was found as monomer in solution by gel filtration experiments 
(Ziebuhr et al., 1997). MALDI-TOF spectra showed the mass of the C-terminal deletion 
mutant (∆301-302) of HCoV Mpro determined by mass spectroscopy was 32.85 kDa, is within 
the error margin of the instrument (the calculated mass is 32.81 kDa) (Fig 3.5) and the mass 
of SeMet-derivatized Mpro was 33.2 kDa. The difference between both masses indicates about 
70% selenium incorporation for 10 methionines. But the reliability of the calculations was 
diminished due to the weak signal for the derivatized protein (Fig 3.5, lower panel).  
 
3.2.5 Data collection for SeMet-derivatized  TGEV Mpro crystals
3.2.5.1 Multiwavelength anomalous dispersion (MAD)  
MAD data sets for TGEV Mpro were collected around the Se K-edge using a Mar165 CCD 
detector at beamline BW7A of the EMBL Outstation at DESY (Hamburg, Germany) (Fig. 
3.6). A sharp 'white line' feature was observed (Fig. 3.7). The number and position of points 
of measurement were chosen so as to optimize the strength of the signals in the experiment. 
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At the minimum, two wavelengths are needed for a definitive evaluation of the unknown 
heavy- 
 
 
 
 
Fig. 3.6 Diffraction image of a 
SeMet-TGEV Mpro crystal (resolution 
2.8 Å), measured at the BW7A 
beamline at EMBL, DESY, 
Hamburg. Although not apparent 
from the picture, diffraction spots of 
low intensity are present in the 
outermost rings. Crystal to detector 
distance is 205 mm. 
 
 
 
atom position, but at least three are required to allow both the dispersive and Bijvoet 
differences to be optimized. Appropriate choices can be made from the experimental 
absorption spectrum. Clearly, diffraction data must be collected at an energy corresponding to 
the peak of absorption (f ") (Fig. 3.8). The second series of diffraction data must be collected 
at the edge inflection point f ' these are needed to maximize dispersive differences. When 
choosing the position for the high- and low-energy remote, it is important to note that 
systematic errors increase, as one gets further away from the edge. Most successful 
experiments (Table 3.4, 3.5) are carried out with the remote energies restricted to within 100 
to 300 eV of the edge. Data were measured at 100 K from crystals that were flash-cooled with 
liquid nitrogen using mustard oil as a cryo-protectant.  
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Fig. 3.7 Plot of f ' and f " calculated from a fluorescence scan on a SeMet-TGEV Mpro crystal, 
showing the data measured at low energy remote, f " maximum, f ' minimum and high energy 
remote. 
 
The minimum values for f ', obtained from the inflection points (E1, E2) of the fluorescence 
spectrum, were determined to be 12.6678 keV (0.97874 Å) and 12.6690 keV (0.97864 Å). 
The peak (P1, P2, P3) wavelengths from two crystals were determined to be 12.6714 (0.97846 
Å), 12.6715 (0.97845 Å) and 12.6712 (0.97848 Å). 
 
A reasonable Matthews coefficient (Matthews 1968) of 2.3 Å3/Da and a solvent 
content of 51% was obtained assuming six molecules in the asymmetric unit. The SeMet-
TGEV Mpro data were consistent with the monoclinic crystal system (P21), with unit cell 
parameters a = 72.81, b = 160.12, c = 88.95 Å and β = 94.3o. Additionally, self-rotation 
function calculations (CCP4 suite) suggested the presence of noncrystallographic twofold 
rotation axes.  
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Fig. 3.8 Theoretical plots for f ' and f " over the K absorption edge of selenium. Data for this 
plot were obtained from Merritt (1998) 
(http://www.bmsc.washington.edu/scatter/As_form.html). The theoretical absorption edges 
occur at 12.6580 keV (K-II /E/edge).  
 
Therefore, 60 crystallographically independent selenium sites had to be located as major part 
of the MAD phasing process. 
 
The majority of the crystals of the SeMet-derivatized TGEV Mpro were isomorphous to the 
native ones except one (therefore, the data from this crystal could not be merged with those 
obtained from the other crystals). Data were collected including an inverse beam sweep (ie. a 
sweep of data collected with the crystal rotated by 180º with respect to the initial sweep) for 
the ∆f " maximum and ∆f ' minimum wavelengths, in order to guarantee the collection of all 
possible anomalous pairs. A four-wavelength experiment was conducted for one crystal, 
whereas three-wavelengths data were collected on other isomorphous crystals. A data set 
collected from a native crystal was used as low-energy remote for the second crystal. All the 
data from SeMet-crystals were used up to 2.8 – 2.9 Å resolution. A diffraction image taken of 
a SeMet-TGEV Mpro crystal is shown in Figure 3.6. Three different MAD data sets were 
collected using three different SeMet-substituted crystals. With one of the crystals, the peak 
wavelength was measured twice. A summary of the MAD experiment data is given in 
Table 3.4. 
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Table 3.4 Summary of X-ray diffraction data  (SeMet substituted TGEV Mpro) 
Beamline BW7Aa
Data setb      P1      P2 P3 E1 E2 H1 H2 L1 
Wavelength (Å)c 0.97487 0.97845 0.97848 0.97864 0.97874 0.95583 0.9080 1.0022 
Resolution (Å)  30-2.8  30-2.8 30-2.8 30-2.8 30-2.8 30-2.8 30-2.8 30-2.8 
Completeness (%) 99.9  98.1  99.7  99.9  99.7  99.7  98.8  97.3  
Mosaicity (°) 0.4 0.6 0.7 0.4 0.6 0.4 0.6 0.4 
Rmerge (%)d 10.5 11.4 10.6 8.1 8.2 8.6 7.2 8.0 
Rrim (%)e 12.1 13.0 12.3 9.2 8.9 10.2 7.5 10.3 
Rpim  (%)f 6.1 6.6 6.4 4.7 4.5 5.2 3 .2 5.4 
Redundancy 3.8 3.8 3.9 3.8 3.9 3.7 3.6 2.9 
I/σ(I) 5.4  4.7  4.8  6.1 4.1 4.1   4.9 2.5 
a Wiggler beamline of EMBL at DESY, Hamburg, equipped with a Mar CCD detector
 b P1, P2, P3 = Peak wavelengths 1, 2 and 3 
   E1, E2 =  Edge wavelengths 1 and 2 (point of inflection) 
   H1, H2 = High-energy remote wavelengths 1 and 2 
   L1 = Low-energy remote wavelength 
c The inflection point and peak wavelengths were collected in inverse beam mode, whereas  
   the remote wavelengths were collected at the low energy side of the Se edge where there is 
little anomalous signal and, therefore, no inverse beam data were collected 
 d Rmerge, e Rrim, f Rpim: for details see Section 2.2.12 
 
3.2.5.2 Structure determination by MAD phasing  
TGEV Mpro: Crystals grown from the SeMet-derivatized protein formed the basis for solving 
the phase problem by multiwavelength anomalous diffraction (Hendrickson et al., 1990). 
Each of the ten sulfur atoms replaced by selenium in the SeMet protein of 302 amino-acid 
residues was expected to diffract anomalously at multiple wavelengths (Section 2.2.10). 
Crystals from the SeMet-substituted protein proved to be isomorphous to the native ones. 
Locating the selenium positions was first tried by taking one peak wavelength, but probably 
due to the low redundancy (3.8) (Table 3.5), this did not succeed. Therefore, many data sets in 
different combinations were merged, so that high data redundancy was achieved in order to 
improve the signal-to-noise ratio. By increasing the redundancy through merging of various 
data sets, the precision of the averaged intensities (as described by Rpim) was increased 
sufficiently. The average anomalous signal from all the measured peaks and edge 
wavelengths were calculated yielding more accurate diffraction data (Table 3.5). 
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Table 3.5 Solutions from Shake & Bake (TGEV Mpro) 
Data sets  No.of 
Sol/trials 
Rmin 
(%) 
CCa No.of 
sites 
  I/σ Rpim (%) Ranom. (%) Redundb
. 
P1 0/1000 81 0.19 60   5.4 6.2 10.5             3.8 
P1 + P2 6/3000 60 0.19 60   4.7 4.8 12.5             7.5 
P1 + P2 + P3c 77/2300 52 0.47 60   9.5 4.3 14.0          11.5 
H1 + H2d 1/4000 62 0.35 60 11.8 4.1   9.8             6.5 
P1 + P2 + P3 +
E1 + E2c,e 
 105/5000 49 0.51 60 13.6 3.9 12.8          18.7 
a Correlation coefficient (The correlation coefficient is a number between 0 and 1. It is a measure of how well 
the predicted values from a forecast model "fit" with the real data). 
b Average redundancy 
c P1, P2, P3 = Peak wavelengths one, two and three 
d H1, H2 = High energy remote wavelengths one and two 
e E1, E2 =  Edge wavelengths one and two (point of inflection) 
 
The direct methods program SnB v2.0 (Weeks & Miller, 1999) was chosen to solve 
the phase problem. SnB is a multi-trial direct methods program. The program is based around 
the dual-space Shake & Bake algorithm, which alternates reciprocal space phase refinement 
with peak picking in real space. Many attempts at solving the structure were carried out. Each 
attempt (or trial) was started from a random set of atoms, which were then subjected to a 
number of cycles of phase refinement. A criterion, known as the minimal function, is then 
used to assess each trial and identify possible solutions. The algorithm is computer-intensive, 
because of the Fourier transforms that are required to continually switch between real and 
reciprocal space. Later each trial in SnB v 2.0 was processed for 120 cycles of dual-space 
refinement. After 1913 trials had been processed, one trial was identified that had a lower 
minimal function value (Guo et al., 1991) (Rmin=0.491, CC=0.51) compared to the other 1912 
trials (Rmin = 0.76-0.495, CC = 0.48). This indicated that a solution for the selenium 
substructure could be clearly determined. All of these initial trials were carried out using an 
electron-density grid size of 0.9 Å and minimum E/σ(E) = 2.55 (minimum E/σ(E) is the 
minimum signal-to-noise ratio for reflections to be used for phasing). Out of the 105 
solutions, the first five were the top peaks from the initial solution. Although the three merged 
data sets collected at three peak wavelengths gave a better structure solution, the solution 
from five merged data sets on an average was better than the ones from three data sets 
because of superior quality of the data, resulting in a better Rmin. The higher the redundancy 
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(or the lower Rpim), the higher will be the correlation coefficient and the lower the Rmin of the 
correct solution (Weiss, 2001). Therefore, it is not number of trials used in SnB, but more 
importantly, the quality of data used for solutions. The positions of the best 60-atom solution 
from SnB were examined for NCS. In total, 37 positions were found to obey a 6-fold NCS. 
This symmetry predicted a further 11 positions (Fig. 3.9), which were not found initially from 
SnB. All 48 positions were used in MLPHARE (Otwinowski, 1991) for phasing, followed by 
solvent flattening and 2-fold NCS averaging in DM (Cowtan & Main, 1996), according to the 
standard protocols. The resulting electron density maps were of sufficient quality for chain 
tracing (Fig. 3.10). 
 
Parts of the first monomer were built manually into the experimental electron density 
map. The other monomers were generated by NCS. The preliminary model was used as input 
to Arp/warp (Perrakis et. al., 1999) but manual intervention was still mandatory. 
 
Therefore, initial rounds of refinement involved a combination of CNS and Arp/wArp. 
At some places (mostly loop and helix regions), the electron density was not good enough to 
build the side chains. After refining about 1000 residues out of 1800 using CNS, Arp/wArp 
was used for automatic building of molecules. All the bits and pieces resulting from 
Arp/wArp were joined together utilizing the known NCS and were put back into CNS. This 
was repeated for several cycles and it helped to automatically build of 200 more residues. The 
procedure also gave clearer electron density for the side chains. All the following refinement 
cycles involved only CNS. Non-crystallographic symmetry restraints were applied during the 
initial stages of refinement at low resolution and later gradually released as the resolution 
limit was extended to 1.96 Å. 
 
All six copies (designated A - F) of the TGEV proteinase in the asymmetric unit of the 
crystal could be built into well-defined electron density, which covered 301 amino acid 
residues of each monomer, except monomer A, E, and F that lacked electron density for 
residue 300 as well. The final model comprises 1798 amino acid residues, 27 sulfate ions, 6 
MPD molecules, 9 dioxane molecules and 1006 water molecules. 
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Fig. 3.9 Selenium substructure as determined by 
SnB and NCS. Brown spheres: wrong positions 
found by SnB. Dark brown spheres: correct 
positions found by SnB. Colored spheres (yellow, 
purple and green): additional positions determined 
by NCS. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.10 Stereo view of a representative part of the electron density map. The ||2Fo|-|Fc|| 
electron density map (1.96 Å resolution, contoured at 1σ above the mean) corresponds to 
TGEV Mpro residues 160-162 (Tyr-Met-His), a conserved motif in coronavirus main 
proteinases. The strong H-bond (2.93 ± 0.096 Å) (average over all monomers) between the 
Tyr160 hydroxyl group and His 162 Nδ1 is indicated. 
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3.2.5.3 Molecular replacement method for the HCoV Mpro structure 
60% sequence identity between TGEV Mpro and HCoV main proteinase made TGEV Mpro a 
good model to solve the HCoV Mpro structure. The structure was determined by the method of 
molecular replacement (Rossmann, 1990) using the AMoRe software package (Navaza, 
1994). The data from the native ∆301-302 protein crystal were not good enough to solve the 
structure therefore, four data sets collected from different wavelengths were merged together 
of the SeMet-derivatized crystals of ∆301-302 HCoV Mpro.  These data had not proved useful, 
as the selenium signal was weak. The four merged data sets gave highly redundant data to 
solve the ∆301-302 HCoV Mpro crystal structure by molecular replacement method (AMoRe). 
Since from packing consideration (Matthews, 1968), the content of one asymmetric unit of 
HCoV Mpro crystals was assumed to be two molecules, one monomer of the TGEV Mpro was 
used as a search model. For this, the TGEV monomer model was mutated to the HCoV 
sequence and then refined using program CNS (Brünger 1998a) to remove bad contacts. 
Diffraction data in the resolution range of 10 – 4 Å and 8 – 4 Å were used for rotation and 
translation function searches, respectively. Using a Patterson cut-off of 30 Å, a list of 10 
rotation function peaks was obtained, with the top peak having a correlation coefficient of 
0.116. The translation function search yielded a solution with a correlation coefficient of 
0.212, fixed on the first solution from the rotation function search. After performing rigid-
body refinement using the program AMoRe (Navaza, 1994) for two solutions, the correlation 
coefficient increased to 0.30. A summary of the molecular replacement solution for the HCoV 
Mpro structure is given in Table 3.6. 
 
 
 
 
 
 
 
 
 
 
 
 56
  Results and Discussion 
 
Table 3.6 Structure solution by molecular replacement: HCoV Mpro 
Resolution range 10.0 - 4.0 Å 
Rotation and translation function (1st monomer) (fractional) 
Best solution α =21.64o, β = 59.58o, γ =  256.95o 
tx = 0.483, ty = 0.000, tz = 0.250 Å 
Correlation coefficient  0.217 
R-factor 51.9% 
Rotation and translation function (2nd monomer ) (fractional) 
Best solution α = 319.92o, β = 79.38o, γ = 5.39o 
tx = 0.054, ty = 0.481, tz = 0.785 Å 
Correlation coefficient 0.213 
R-factor 52.1% 
Refinement of combined solution 
Monomer 1 α = 21.80o, β = 60.40o, γ =  257.02o 
tx =0.478, ty = -0.002, tz = 0.250 Å 
Monomer 2 α = 320.45o, β = 79.89o, γ =  5.89o 
tx = 0.057, ty = 0.482,   tz = 0.784 Å 
Correlation coefficient 0.30 
R-factor 48.8% 
 
 
3.2.6 Refinement and model building of the HCoV Mpro structure 
The output model from AMoRe was subjected to rigid-body refinement using CNS (Brünger 
et al., 1998b) and interspersed with cycles of manual inspection and rebuilding in the 
resolution range of 25-2.6 Å. A random set containing 4% of the total data was excluded from 
the refinement, and the agreement between calculated and observed structure factors 
corresponding to these reflections was used to monitor the course of the refinement (Rfree, 
Brünger, 1992a). The model fit against the electron density, was visually checked using the 
program 'O' (Jones et al., 1991). The refinement cycles consisted of simulated annealing 
(Brünger et. al., 1990), followed by conjugate-gradient minimization of atomic coordinates 
and isotropic temperature factors. The first round of positional and temperature factor 
refinement lowered the R-factor to 36.3% and the Rfree to 44.7%. At this stage, SigmaA-
weighted maps were calculated using program SIGMAA (Read, 1986) and careful 
examination of the maps allowed corrections to be incorporated into the model. There was no 
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density for residues 212-228, 251-260, and 269-276 in each monomer in the initial maps. 
Therefore, these residues were removed from the model.  
 
Alternating cycles of manual rebuilding, conventional positional refinement and 
simulated annealing, using the slow-cool protocol as implemented in CNS (Brünger et al., 
1998b), allowed some of the missing residues to be placed in the density. For more accurate 
main-chain and side-chain tracing the crystallographic refinement was continued in a 
combination with OMITMAP. So, first the omitmap cycles were executed followed by 
refinement cycle. After each round of refinement, the 2Fo-Fc and Fo-Fc maps were calculated 
and the model was visually checked using 'O' (Jones et al., 1991). Many cycles of OMITMAP 
were executed, each time building an appended segment of polyalanine model and side chains 
into the electron density maps. The OMITMAP is calculated in order to reduce the effects of 
model bias. In the case of unclear density of the model, an omit map that covers the entire 
molecule is most useful. It is not possible to exclude the entire model (at most 10% can be 
omitted), instead small regions of the model are systematically excluded. A small map is 
made covering the omitted region. These small maps are accumulated and written out as a 
continuous map covering the whole molecule (or the defined region) (see Section 2.2.13).  
 
Finally all 300 amino acid residues for each monomer in the asymmetric unit of the 
crystal could be built into electron density. The structure of the HCoV Mpro contains two 
copies (designated A, B) in the asymmetric unit of the crystal. There were no residues lacking 
electron density. The final model comprises 600 amino acid residues, 2 dioxane molecules 
and 221 water molecules.The refinement statistics are summarized in the Table 3.7.  
 
3.2.7 Quality of the model 
TGEV Mpro: All the monomers are essentially complete, except for a few disordered residues 
at the carboxy terminal segment (residues 300-302 missing for monomers A, E and F, 
residues 301-302 in B and C, and residue 302 in D). The refinement converged to a final R 
factor of 0.210 and a free R factor of 0.256. The final model exhibited good stereochemical 
geometry. A Ramachandran plot (Fig. 3.11A) calculated with PROCHECK (Laskowski et al., 
1993) showed that 89.1% of the residues are located in the most favored regions and 10.3% in 
the additionally allowed region; Asn70, Asn71, and Ser279 are in generously allowed regions 
(0.6%) but have good electron density, and there are no residues in the disallowed region. For 
evaluating the quality of structure-factor data and their agreement with the atomic  
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Fig.3.11A  Ramachandran plot for the final model of TGEV Mpro. Regions are delineated as 
follows: red – most favored; regions a, b, p and l – additionally allowed (yellow); ~a, ~b, ~p 
and ~l –generously allowed (light green); white – disallowed. Glycine residues are 
represented as triangles; non-glycine residues as squares. 
 
model, the program SFCHECK (Vaguine et al., 1999) was used, which yielded a correlation 
factor of 0.942 between the model generated and the experimental structure factors. 
 
HCoV Mpro: The final model consists of one dimer in each asymmetric unit of HCoV Mpro. 
There is a crystallographic symmetry between the monomers and both the monomers are 
essentially complete. The refinement converged to a final R factor of 0.219 and a free R factor 
(Brünger et al., 1992) of 0.283, with good stereochemistry. A Ramachandran plot (Fig. 
3.11B) calculated by PROCHECK (Laskowski et al., 1993) showed 85.1% of the non-glycine 
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amino acid to be in the most favored regions of the Ramachandran plot, and 15.5% are in 
additionally allowed regions. The experimental structure factor data and their agreement with 
the calculated atomic model showed a correlation factor of 0.868, computed using the 
program SFCHECK (Vaguine et al., 1999). 
 
Fig. 3.11B Ramachandran plot for the final model of  HCoV Mpro. a, b, p and l – additionally 
allowed (yellow); ~a, ~b, ~p and ~l –generously allowed (light green); white – disallowed. 
Glycine residues are represented as triangles; non-glycine residues as squares. 
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Table 3.7 Phasing statistics, refinement statistics and model quality 
Phasing TGEV Mpro  HCoV Mpro 
FOMa before solvent flattening 0.48  
FOMa after solvent flattening (no averaging) 0.72  
FOMa after solvent flattening (with averaging) 0.79  
 
Refinement 
  
Resolution range (Å) 50 – 1.96 25 – 2.6 
R factorb 0.210 0.219 
Rfree  0.256 0.283 
 
No. of non-hydrogen atoms (average B value (Å2)) 
  
Protein (main chain) 7198 (46.1) 2402 (27.0) 
Protein (side chain) 6613 (47.2) 2192 (27.7) 
Water 1006 (50.3) 221 (24.9) 
MPD 48 (67.6)  - 
Sulfate 135 (57.1)  - 
Dioxane 54 (71.7) 12 (58.39) 
 
Rms deviation from ideal geometry 
  
Bonds (Å) 0.017 0.012 
Angles (o) 1.9 1.5 
Improper dihedral angles (o) 1.16 0.74 
a FOM = figure of merit (the overall probability to determine the phase is represented by 
figure of merit). 
bR-factor = Σ (|Fo| - k|Fc|) / Σ |Fo|, where k is the scale factor 
 
3.3 Structures of the Mpro 
3.3.1 Quaternary structure 
Coronavirus proteinase is found to be a monomer in solution by the gel filtration method 
(Ziebuhr et al., 1997a). However, the quaternary arrangement of TGEV and HCoV 
proteinases in the crystal is a homodimer. Three dimers are found in the asymmetric unit 
(monomers A and B, C and D, E and F) of TGEV Mpro, whereas there is only one dimer in the 
asymmetric  
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Fig. 3.12 Stereo depiction of the six molecules (three dimers) of TGEV Mpro in the 
asymmetric unit. The monomers A to F are shown in different colors; A – red, B – black, C – 
green, D – orange-red, E – yellow and F – cyan. Note the twofold symmetry axes between the 
monomers in each of the dimers, and between the two lower dimers in the figure (AB and 
EF). Each of the monomers measures approximately 40 Å x 22 Å x 70 Å. 
 
unit of HCoV Mpro (monomer A and B). All dimers have approximate C2 symmetry (non-
crystallographic proper twofold axes) and about 1580 (±199) Å2 of each monomer, i.e. 11 – 
12% of its solvent-accessible surface, are buried upon dimerization. Figure 3.12 shows the 
arrangement of the dimers in the asymmetric unit of TGEV Mpro. The dimers AB and EF are 
most similar (rmsd for 598 Cα pairs = 0.49 Å), whereas dimer CD deviates somewhat more 
from dimers AB and EF (rmsd for 598 Cα pairs = 0.79 and 0.81 Å, respectively). The 
occurrence of three independent dimers in the asymmetric unit of the TGEV Mpro crystals 
and of one dimer in the HCoV Mpro structure demonstrates the relevance of the dimeric state 
of these proteinases. Interestingly, with chymotrypsin and picornavirus proteinases no dimer 
formation was observed, with the exception of poliovirus 3C proteinase (Mosimann et al., 
1997). In the latter case, the dimer is created by formation of a large β-sheet via β-strands e2I 
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of both monomers. In TGEV and HCoV proteinases, however, other regions are involved (see 
below) and no contiguous β-sheet is formed. Moreover, the C-terminal domain contributes to 
the dimer interface and might be the driving force for dimerization.  
 
3.3.2 Tertiary structure 
TGEV Mpro: Each monomer has approximate dimensions of 40 Å x 22 Å x 70 Å, and is 
folded into three domains, the first two of which are antiparallel β-barrels reminiscent of those 
found in serine proteinases of the chymotrypsin family (Fig. 3.43). Residues 8 to 102 form 
domain I, and residues 103 to 182 make up domain II. The connection to the C-terminal 
domain III is formed by a long loop comprising residues 183 to 198. Domain III (residues 199 
to 302) contains a novel arrangement of five α-helices (see below). A cleft between domains I 
and II, lined by hydrophobic residues, constitutes the substrate-binding site. The catalytic site 
is situated at the center of the cleft.  
 
 
Fig. 3.13 Diagram showing the overall fold of TGEV Mpro with the two β-barrel domains and 
the α-helical C-terminal domain. The β-barrels of each domain I and II are composed of six-
stranded β-sheets (green). Domain III is mainly composed of α-helices (red). Active-site 
residues Cys144 and His41 are depicted in a ball-and-stick mode. 
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The interior of the β-barrel of domain I consists entirely of hydrophobic residues. A 
short α helix (helix A; Tyr53 – Ser59) closes the barrel like a lid (Fig. 3.14). Domain II is 
smaller than domain I and also smaller than the homologous domain II of chymotrypsin and 
hepatitis A virus (HAV) 3Cpro (Tsukada & Blow, 1985; Bergmann et al., 1997). Several 
secondary structure elements of HAV 3Cpro (strands bII and cII and the intervening loop) are 
missing in TGEV Mpro (see Section 3.5; Fig. 3.42 and 3.43). 
 
Also, the domain-II barrel of the TGEV Mpro is far from perfect (Fig. 3.13). The 
segment from Gly135 to Ser146 forms a part of the barrel, even though it consists mostly of 
consecutive loops and turns. In contrast to domain I, a structural alignment of domain II has 
proven difficult. The superposition of domains I and II of the TGEV Mpro onto those of the 
HAV 3Cpro yields an rmsd of 1.85 ± 0.05 Å for 114 equivalent (out of 184 compared) Cα 
pairs, while domain II alone displays an rmsd of 3.25 ± 0.28 Å for 57 (out of 85) Cα pairs.  
 
Domain III is composed of five, mostly antiparallel, α-helices and the loops 
connecting them. The crossover angles are ~90° between helices B and E, ~30° between B 
and D, ~20° between C and E, and ~80° between E and F, whereas C B and B F are parallel to 
each other (Fig. 3.20). Hydrophobic side chains mediate interhelical contacts. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.14 Stereo diagram showing the hydrophobic environment of Tyr53 in TGEV Mpro, 
which forms a part of helix A that closes the domain I β-barrel like a lid. 
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The loops between the helices are quite long and fill up most of the interstitial space of 
domain III. The N-terminal segment (residues 1 –7) of the polypeptide chain folds onto 
domain III, placing the amino terminus of the protein within 17.0 (±2.7) Å of the C-terminus. 
Database searches (Holm & Sander, 1993; Gilbert et al., 1999) did not reveal other proteins or 
protein domains with the same topology as TGEV Mpro domain III (Section 2.2.15).  
 
The C-terminal domain of the TGEV Mpro has been shown to be, directly or indirectly, 
involved in the proteolysis reaction, since deletion of the entire domain leads to a nearly 
complete loss of proteolytic activity in a peptide cleavage assay (Anand et al., 2002a). The 
formation of the TGEV Mpro dimer involves, among others, interactions between domains III 
of the monomers across the non-crystallographic twofold axis. This interface is anchored by 
only two hydrogen bonds, between the amide group of Gly281 (molecule A) and the main-
chain oxygen of Ser279 (molecule B), as well as its symmetry mate, Gly281B...Ser279A 
(3.22 ± 0.37 Å, averaged over all six monomers). Involving an area of only 337 ± 45 Å2, the 
domain III – domain III interface appears to be the consequence rather than the cause of other 
intermolecular interactions described below (Section 3.4.7), in particular between domains II 
and III of one monomer and the N-terminal residues of the other. 
 
HCoV Mpro: The HCoV Mpro structure has a fold similar to that of TGEV Mpro; it is divided 
into three domains as well. The monomer measures ~36 Å x 26 Å x 69 Å. The two monomers 
(designated A and B) in the asymmetric unit have the same mutual arrangement as in TGEV 
Mpro. The monomers are oriented at an angle of 90o to each other (Fig. 3.15). Domain I 
consists of residues 8 to 99, and domain II of residues 100 to 183. They comprise six β 
strands each, folded into β-barrels as in chymotrypsin-like proteases. As in TGEV Mpro, these 
two domains provide the residues that define the specificity for the substrate that binds in a 
cleft between them. There is a long loop from residue 184 to 199 connecting domain II to the 
C-terminal domain. The C-terminal domain is a globular cluster of five helices. Domain III of 
monomer B is rather flexible, with a higher overall average B factor compared to domain III 
of monomer A (see also Fig. 3.26). The C-terminal domain has been implicated in the activity 
of the protease. Deletion of 81 residues from the C-terminus of HCoV Mpro has been reported 
to lead to total loss of proteolytic activity (Ziebuhr et al., 1997b) in the standard peptide 
cleavage assay. Similar but more detailed results have been obtained for TGEV Mpro in more 
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sophisticated experiments designed on the basis of the crystal structure described in this work 
(Anand et al., 2002a; see below). 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.15 Arrangement of monomers in the asymmetric unit of HCoV Mpro. Both monomers 
are lying perpendicular to each other (~90o). A similar arrangement of monomers is seen in 
the dimer of TGEV Mpro. 
 
3.3.2.1 Comparison between the monomers 
TGEV Mpro: Figure 3.16 shows the Cα backbones of all six molecules superposed on each 
other using monomer A as a reference. As can be seen from the figure, the backbone trace is 
very similar. A superimposition of any two monomers in the asymmetric unit gives rmsd 
values from 0.28 to 0.43 Å on the basis of 299 Cα pairs. The molecules superimpose very 
closely near the active site and larger deviations occur for residues that are radially further 
out. The surface near the active site, presumably involved in molecular recognition, is 
retained in all the molecules in spite of non-identical environments in the crystal. 
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Fig. 3.16 Monomers B to F of TGEV Mpro superimposed on monomer A. The core part has an 
rmsd of 0.29 (± 0.09) Å for 130 equivalent Cα atoms. The largest deviation occurs at the N-
terminal segment (residues 1-4) and at the C-terminal segment (residues 294-300). The 
active-site region is approximately indicated by a light orange circle. N- and C-terminals are 
labeled. 
 
The core of domains I and II (defined as the region around the active-site cleft between the 
two domains) displays an rmsd of 0.29 (± 0.09) Å for 130 equivalent Cα atoms. If all 299 
well-determined Cα positions are included, the average rmsd for all monomers is 0.57 (± 0.18) 
Å (monomer A as reference). Among all monomers, the pairs A-E and B-F are most similar to 
one another (rmsd 0.24 Å and 0.28 Å, respectively), while B-C displays the largest difference 
(rmsd 0.43 Å). The difference in the rmsd values indicates that there is some variation in the 
loop regions, which is probably due to crystal packing effects. The largest deviations of the 
main-chain trace are in: i) the N-terminal segment from residues 1 to 4 (average rmsd: 1.69 ± 
0.91 Å), ii) the flexible surface loop from residues 216 to 225 (average rmsd: 0.99 ± 0.51 Å); 
iii) the C-terminus of helix E and the loop region between residues 267 and 276 (average 
rmsd: 0.99 ± 0.42 Å); and iv) the segment 294-300 following the C-terminal F helix (average 
rmsd: 1.55 ± 0.44 Å). In addition to being flexible and at the surface of the molecules, 
segments ii) and iii) are involved in inter-dimer crystal contacts in some but not all of the six 
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protomers. Surprisingly, the regions with the highest rmsd are not the regions with the highest 
temperature factors except for the C-terminal domain of monomer F that does have high 
temperature factors (~70 Å2, whole model 47 Å2, including all 1006 water molecules; also see 
Fig. 3.25). The inter-dimer interface (Fig 3.12) between monomers A and C involves mainly 
loops, turns and 310 helices, whereas it contains mostly loop regions for the mutual packing of 
monomers B and E. Between monomers D and B, it is mostly helices that are involved in the 
interface (see Section 3.3.3.1). There are also limited contacts between monomers A and B, 
on the one hand, with monomers E and F, on the other. Similarly, monomer C (domain III) 
also has contacts with monomer F (domain I).  
 
 A domain-wise comparison of monomers of the TGEV Mpro reveals that domain II has 
the best superimposition (~0.39 Å) followed by domain I (0.48 Å) and domain III (0.79 Å). 
The helical domain III is quite flexible. It has many long loop regions and high thermal 
factors in both proteinases. Comparison along the secondary structure elements reveals the 
loop regions of the domain to be deviating most. 
 
 
Fig. 3.17 Average rms deviation between TGEV Mpro monomer A and the other monomers 
(B-F) (black), and HCoV Mpro monomers A and B (monomer B on A, magenta). The standard 
deviation for TGEV monomers (B-F) superimposed on molecule A is shown in green. The 
first helix indicated in the secondary structure legend is absent in TGEV Mpro. 
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HCoV Mpro: In the HCoV proteinase dimer, the rmsd deviation between monomer A and B is 
0.28 Å for 300 pairs of Cα atoms. The two monomers are related by two-fold non-
crystallographic symmetry. The arrangement of the monomers in the dimeric HCoV Mpro is 
similar to that seen in TGEV Mpro. The most different regions are the N- and C-terminal 
segments, the loop region 46–49 and the loop-helix region 242–256. These are also the 
regions of comparatively high temperature factors. The domain-wise rms deviation between 
the monomers are 0.27 Å, 0.19 Å, and 0.40 Å for the domains I, II and III, respectively. The 
average solvent-accessible area for the HCoV Mpro monomers is 14231 (±64) Å2 and around 
9% of this surface is buried on dimer formation.  
 
3.3.2.2 Comparison between TGEV Mpro dimers 
The general arrangement of the monomers is such that the AB pair, the CD pair and the EF 
pair share maximum contacts. Molecule A residues from β-strand cII, N-terminal residues, 
and loop regions of domain III pack against the equivalent regions of molecule B. Similar 
arrangements are present in all the remaining dimers. At least four inter-subunit salt bridges 
stabilize each of the TGEV Mpro dimers. Among these, two link domain III of one monomer 
to the N-terminus of the other: Glu286A Oε2-Arg4B Nη2 and its symmetry mate, Glu286B 
Oχ2-Arg4A Nη2 (average distance between the Oε1 and NH1 atoms: 5.31 ± 1.02 Å). The third 
one is N-terminal Ser1A N-Glu165B Oε2 and its symmetry mate, Ser1B N-Glu165A Oε2 
(average distance between N and OE2 atoms: 4.72 ± 2.17 Å) (see appendix, Table 6.2.1 - 6.4). 
The protein has a tightly packed structure devoid of many water molecules in the interior 
(only 78 out 1006 for all three dimers) (see appendix, Table 6.3A, B). The average accessible-
surface area of the isolated monomers is 14136 (± 112) Å2. There is an average burial of 11% 
upon formation of the dimer(s). 
 
3.3.3 Structural relationship between the TGEV and HCoV Mpro 
There is a high sequence identity (60%) between the two coronavirus proteinases. Both 
proteins crystallize as dimers and the crystals belong to space group P21. The difference is in 
the number of dimers in the asymmetric unit, TGEV Mpro contains three dimers, whereas 
HCoV Mpro has only one. The fold of the polypeptide chain is similar in both cases. When 
300 Cα atoms of HCoV Mpro monomer A, including all those which are involved in regular 
secondary structure elements, are superimposed onto monomer A of TGEV Mpro, a high 
overall rmsd value of 1.5 Å is obtained (Fig. 3.18). This high value is due to the most 
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deviating region, i.e. domain III (~2.55 Å). Domains I and II fit much better, with rmsd values 
of 1.05 Å and 0.90 Å, respectively. When domain III is excluded from the alignment, the 
rmsd value improves to 0.68 Å for 162 target pairs (out of 184 residues). The isolated domain 
III structures of the two Mpros superimpose rather well (0.79 Å for 94 target Cα pairs), 
indicating that the relative orientation of this domain differs in the HCoV and TGEV Mpro 
structures.  
 
3.3.3.1 Interface 
 The interface between the respective monomers of both TGEV Mpro and HCoV Mpro dimers 
is rather large (~2500Å2). All three domains are involved in the monomer-monomer interface. 
The major portion of the interface area is however contributed by domain II, the long loop 
184-199 and some smaller loops, the β-strand cII as well as two residues, Glu165 and His171, 
from β-strands eII and fII, respectively. Also, the N-terminal segment 1-14 from domain I and 
some residues from the C-terminal segment (helix F, 281 - 300) participate in the interface. 
Mostly main-chain amides and carbonyl oxygen atoms are making hydrogen bonds in the 
interface in both TGEV Mpro and HCoV Mpro. 
 
Fig. 3.18 Three-dimensional superposition of the Cα traces of TGEV (red) and HCoV Mpro 
(blue). 
 
Domain III is the most divergent region between the HCoV and TGEV Mpro. Most of 
the mutations between the Mpros, are also located in domain III. Domain II has the most 
identical residues in the structures. There is a significant difference in the number of charged 
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residues. Glu is in large excess in TGEV Mpro, as a result of which the theoretical estimate of 
charge is double that of HCoV Mpro. A look at figure 3.19 suggests that most amino acid 
exchanges are contiguous in three-dimensional space. 
 
 
 
 
 
 
 
 
 
Fig.3.19 Three-dimensional locations in the polypeptide chain (red) where amino acids are 
exchanged (in blue) in TGEV Mpro to yield the HCoV Mpro structure. N- and C-termini are 
also shown. 
 
3.3.4 Secondary structure: TGEV and HCoV Mpro 
3.3.4.1 α-Helices 
TGEV and HCoV Mpros contain six α-helices and 16 short 310 helices each. HCoV Mpro has 
an extra short helix at the N-terminus. The α-helices are stabilized by recurring hydrogen 
bonds between NH and CO groups at positions i+4 and i in the sequence. The α-helices of 
TGEV Mpro are labeled as A from residue 53 to 58 in domain I, B from residue 200 to 212, C 
from residue 226 to 235, D from residue 248 to 254, E from residue 258 to 266 and F from 
residue 289 to 295 (Fig.3.20). The α-helices in HCoV Mpro are A' from residue 11-14 and A 
from residue 53 to 58 in domain I, B from residue 200 to 212, C from residue 226 to 234, D 
from residue 249 to 252, E from residue 258 to 268 and F from residue 289 to 297. The 
lengths of the helices are identical in the two structures except for helix C, D and F. In HCoV 
Mpro, the C helix is shorter by one residue at the C-terminus. Helix D in HCoV Mpro is shorter 
than in TGEV Mpro by three residues, one at the N-terminus and two at the other end; helix F 
is longer by two at the C-terminal end. The extra N-terminal helix A' in HCoV Mpro is 
replaced by a stretch of turn and 310-helical residues in TGEV Mpro. 
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Fig. 3.20 Topological representation of the secondary structure elements of a TGEV Mpro 
(left) and HCoV Mpro (right) monomer. α-helices and β-strands are represented as cylinders 
and arrows, respectively. The N- and C-terminal residue positions of the secondary structure 
elements are indicated. Strands bI and cI are adjacent. The active-site residues Cys144 
(yellow) and His41 (blue) are shown by circles. The positions of the N- and C-termini of the 
Mpro are indicated. Also, the presumed localization of the P5-P1 region of a model substrate is 
shown (blue) (for details see Section 3.4.4 and Fig. 3.31). 
 
 72
  Results and Discussion 
 
 
3.3.4.2 β-Sheets 
About 1/4th of the polypeptide sequence of TGEV and HCoV Mpro is made up of almost fully 
extended strands, with φ,ψ angles within the wide, shallow energy minimum in the upper left 
quadrant of the Ramachandran plot (Fig. 3.11A). There are twelve strands in TGEV Mpro, six 
each in domains I and II. Strand aI in domain I from residue 17-22, bI from 25 to 32, cI from 
35 to 39, dI from 66 to 69, eI comprises residue from 72 to 82 and fI from 85 to 90.  The six 
β-strands in domain II are aII from residue 101 to 102, bII from 110 to 117, cII from 120 to 
128, dII contains 147 to 152, eII consists of 155 to 165, fII contains 171 to 174 (Fig. 3.20). In 
HCoV Mpro, the situation is identical except for strands dI, aII, bII and cII. In dI and aII, the β-
strands are longer by one residue at the N-terminus. The β-strands bII and cII are shorter by 
one residue at C- and N- terminus, respectively. All the strands are antiparallel except the 
shortest strand aII, which is parallel to the longest strand eII. The antiparallel sheets have one 
side exposed to solvent and the other side buried. They show an alternation of side-chain 
hydrophobicity in the amino acid sequence. There is a tendency toward greater 
hydrophobicity for the central than for the edge strands of the sheet (Sternberg & Thornton, 
1977). In the TGEV and HCoV Mpro structures, the large antiparallel sheets roll up either 
partially or completely around to join the edges into a cylinder or 'barrel'. The barrels in 
domains I and II of TGEV and HCoV Mpro measure  ~24 Å in length, ~15 Å in width, and 
~17.3 Å in length, ~12.7 Å in width, respectively. The barrels are not uniformly cylindrical, 
especially that of domain II. The diameter of the barrel is dependent on the number of 
constituting strands and their twist – the twist being one of the most conspicuous features of 
the β sheet (Chothia, 1973). Residues 147 to 152 (dII) form an antiparallel sheet with strand 
eII; however, the strand beyond residue 159 in eII is twisted and is almost perpendicular to 
the adjacent dII strand. Due to this, there is no hydrogen bond from residue 159 to the 
neighboring dII strand. The twist can be measured by the angle at which strands on opposite 
sides of the barrel cross one another; that angle averages 40o for 7- and 8-stranded, 30o for 9-
13-stranded barrels and 95o for 6-stranded antiparallel barrels (Chothia, 1973), as in the case 
of TGEV and HCoV Mpros, Strands cI, dI, eI and fI form a Greek key motif. The 
nomenclature of the β-strands used here is based on picornavirus 3C proteinase structures. 
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3.3.4.3 Reverse turns 
Reverse turns are a common feature of protein structure. These conformational elements 
enable proteins to adopt their globular structure by significantly changing the polypeptide 
chain direction. Reverse turns are of many types, among which β-turns are most frequent and 
are composed of four residues forming a bend involving a hydrogen bond between the CO(i) 
and NH(i+3) group. The presence of the i←i+3 hydrogen bond constrains the backbone 
torsion angles (φ,ψ) of residues in the i+1 and i+2 position to a limited number of 
combinations (Venkatachalam, 1968), giving rise to turn types of different denominations ─ I, 
I', II, II', III, III', etc. In some cases, however, in spite of proper (φ,ψ) angle combinations at 
i+1, i+2 positions, the hydrogen bond is not always in a proper geometry, and a 
Cα(i)...Cα(i+3) distance of less than 7.0 Å is also considered a limit for β turns in such a case 
(Richardson, 1981).  
 
There are numerous β-turns in TGEV Mpro, mostly of the type I, I´, II and II´. Type I’ 
and II’ are mirror images of I and II, respectively.  Normally, type I and II turns are far more 
frequent in proteins than I' and II' (Creighton, 1993). But the situation is different in TGEV 
Mpro. The conformational details are listed in Table 3.8. In turns, the side chains are usually 
solvent-accessible and are often hydrophilic. Additionally, they can form side chain-to-main 
chain hydrogen bonds, which presumably stabilize the turn. However, the β-turns rarely 
contain side chains that locally stabilize the turn at all four positions. In fact, many side-
chains are involved in long-range interactions that help stabilize the tertiary structure. This is 
broadly found in TGEV/HCoV Mpro with some exceptions. A particularly interesting example 
is a type I turn that is rather hydrophobic (R216-W217-F218-V219), and present adjacent to 
the helix-capping Schellman motif (Schellman, 1980) in position 210-215 in TGEV Mpro. 
Although the phenyl group of F218 is buried inside the core, the Trp group is exposed to the 
surface and is partly covered by the side chain of Arg 275. The remaining part of the indole 
ring is involved in an intersubunit contact stabilizing the subunit association. 
 
Almost half of the β turns in TGEV/HCoV Mpro are involved in reversing the direction 
of the polypeptide so that two adjacent stretches can form antiparallel strands. Strand pairs 
aI,bI;  bI,cI; dI,eI; eI,fI; bII,cII; dII,eII; eII,fII form a strand-turn-strand segment. Of these eII, 
fII are connected by type I, bII,cII; and dII,eII by type I' and the rest by type II' turns. 
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Table 3.8 Torsion angles and distances of β-turns of monomer A in TGEV Mpro 
Residue  CO(i)...
NH(i+3) 
(Å) 
Cα(i)... 
α(i+3) 
(Å) 
φi+1 
(o) 
ψi+1 
(o) 
φi+2 
(o) 
ψi+2 
(o) 
Turn 
type 
D46-T47-T48-R49 3.49 6.08 -86.16  5.83 -97.00 -5.97 I 
N94-P95-N96-T97 3.32 5.36 -71.38 -11.16 -105.40 23.66 I 
R130-S131-Q132-G133 2.79 5.36 -52.44  -35.86 -83.76   3.26 I 
L166-G167-N168-G169 2.65 5.42 -49.10 -34.91 -80.18 11.36 I 
N175-F176-E177-G178 3.12 5.54 -85.66 7.32 -93.58 -5.05 I 
R216-W217-F218-V219 2.70 5.52 -40.83 -31.38 -83.38 -6.67 I 
L268-N269-K270-G271 2.68 5.26 -44.48 -34.33 -80.36 -0.69 I 
Y117-E118-G119-C120 2.78 5.13 34.37 57.60 93.75 -9.16 I' 
E152-N153-G154-I155 2.81 5.21 51.28 43.27  80.34 -6.46 I' 
F272-G273-G274-R275 3.15 5.22 61.83 31.75  92.14 -9.26 I' 
I277-L278-S279-Y280 2.92 5.24 44.97 45.75 78.45  -13.01 I' 
K106-A107-G108-E109 2.92 5.54 -52.37 142.30 80.39 -6.04 II 
I140-A141-G142-T143 3.07 5.94 -46.36 132.74 103.97  -13.00 II 
T143-C144-G145-S146 2.95 5.64 -57.28 145.51 88.98  -10.57 II 
Y22-G23-N24-N25 3.08 5.45 71.47 -133.74  -95.85 4.73 II' 
L32-G33-D34-E35 2.96 5.50 58.93 -132.25  -106.16   26.14 II' 
K69-N70-N71-V72 2.84 5.26 58.48 -133.24 -105.36 13.02 II' 
K82-G83-V84-N85 3.05 5.18 67.15 -134.05 -87.50 3.98 II' 
S10-G11-L12-V13 2.95 5.41 -50.85 -37.60  -71.45 -31.25 III 
 
The presence of a large number of strand-turn-strand segments is also a requirement for the 
formation of the β-barrel topology. Sibanda and Thornton (1985) have observed that type I' is 
predominant for antiparallel hairpin bends, which is not the case in TGEV Mpro. Gly is present 
in all these turns and its preference at the i+1 and i+2 positions (type I'/II') is consistent with 
the presence of a positive φ angle in one (or both) of these positions. Only a single case of 
type II turn is present, where the two-residue β strand (aII) is in contact with the adjacent 
parallel strand eII. 
 
The presence of the all-α-helical domain III requires the presence of helix-loop-helix 
segments to ensure proper packing of the helices. However, in TGEV Mpro, there are no short 
loops that forms helix-turn-helix segments. In fact, all the turns that have not been discussed 
so far are part of a much longer loop connecting two regular secondary structural elements. A 
majority of these are type I turns, consistent with the previous observation of their high 
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frequency in globular proteins (Creighton, 1993). Interestingly, however, the two adjacent 
turns (residues 140-143, 143-146) that involve the active site residue Cys144, are of type II 
category. They have Gly at the i+2 position, as observed earlier (Wilmot & Thornton, 1988). 
There are no cis peptide bonds in both TGEV Mpro and HCoV allowing for any possibility of 
type VI β turn formation.  
 
All turns observed in TGEV Mpro are observed in HCoV Mpro, with four exceptions. 
The turn segment from residue 10 to 13 in TGEV Mpro is replaced by an α-helix, and the 
immediate neighbouring 310-helical segment is replaced by a type I turn (middle residues 15 
and 16 (φ,ψ;  -65.26, -11.95 and -97.74, -10.39 respectively) connected to strand aI in HCoV 
Mpro. The residue segment 117-120 (type I' turn) and 210 to 219 (consisting of a Schellman 
motif followed by a type I turn) of TGEV Mpro are found as simple non-hydrogen-bonded 
bends in HCoV Mpro. Residues 253 - 255 are in the type III conformation (φ, ψ; -52.21, -
32.88; -72.94, -53.08; -50.65, -31.43) at the C-terminus of helix D in HCoV Mpro; the 
corresponding region in TGEV Mpro has an α-helical structure. Two examples of β turn are 
shown in Fig 3.21. 
 
 
Fig. 3.21 Example for  type I (left) and type II (right) β-turns in the TGEV Mpro and 
HCoV Mpro crystal structures superimposed on each other. Side chains are omitted for clarity. 
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3.3.4.4 α−Turns 
Five consecutive residues in the two sequence segments A233-K234-T235-N236-S237-F238 
and A251-A252-K253-T254-G255-Q256A make an intra-turn hydrogen bond between the 
backbone Oi and backbone NHi+4 and their Cαi−Cαi+4 distances are all less than 7 Å.  The 
former is at the C-terminus of the C-helix and the latter is connecting the D- and E-helices 
(Fig. 3.22).  Specific backbone torsion-angle combinations are possible for α turns, which 
have been previously classified into I-αRS, I-αLS, II-αRS, I-αRU, I-αLU, II-αRU, II-αLU, and I-αC 
based on particular combinations of backbone dihedral angles (Nataraj et al., 1995; Pavone et 
al., 1996; Chou, 1997). Using the torsion angle criteria, the above two examples can be 
classified as I-αRS, although the backbone angles of N236 in the first example have highly 
deviant torsional values. It appears that the loop segment beyond F238 is responsible for such 
discrepancy. Both the turns have a Lys each, indicating their highly hydrophilic nature. Gly in 
the helix termini as in G255 is known to form α-turn Gly motifs (Aurora et al., 1994). In 
HCoV Mpro, both the α-turns are also detected. Below is the table showing the residues 
involved and their conformation. 
 
Table 3.9  α-Turn examples from TGEV Mpro subunit A 
 
Residue CO(i)...
NH(i+4) 
(Å) 
Cα(i)..Cα
(i+4) 
(Å) 
φi+1 
(o) 
ψi+1 
(o) 
φi+2 
(o) 
ψi+2 
(o) 
φi+3 
(o) 
ψi+3 
(o) 
φi+4 
(o) 
ψi+4 
(o) 
A233-K234-
T235-N236-
S237-F238 
3.78 6.46 -54.31 -28.82 -108.51 10.77 -130.26 12.78 70.7 40.40 
A251-A252-
K253-T254-
G255-Q256 
2.93 5.48 -58.86 -49.21 -66.11 -36.19 -90.05 -20-75 84.59 -5.82 
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Fig. 3.22 Superimposed α-
turn motif from TGEV 
and HCoV Mpro. Side 
chains are omitted for 
clarity. 
 
 
3.3.4.5 Schellman motif 
Capping the unsatisfied hydrogen-bonding potential of the carbonyl groups at the C-terminus 
of an α-helix is an important requirement for its stability. Schellman (1980) reported that 
about one-third of helices in proteins end in a residue with left-handed (αL) conformation 
having a residue with positive angles (φ, ψ) at position C' and two main-chain/main-chain 
hydrogen bonds between residues C3 with C" and C2 with C'. This has been called the 
‘Schellman motif’. It was first seen by Watson (1969) at the C-terminus of the H-helix of 
myoglobin. It is usually favored by glycine residues that have extended freedom of backbone 
allowing for positive φ angles and αL conformation. It satisfies two successive backbone CO 
groups while turning the axis of the chain in a direction that terminates the helix – permitting 
a large exposure of the main chain CO group (Richardson & Richardson, 1988). In TGEV 
Mpro, the B-helix is terminated by such a motif: A210 (C3)-L211 (C2)-I212 (C1)-N213 (Ccap)-
G214 (C')-E215 (C'') (Fig. 3.23). The conformational details of the motif are given below 
(Table 3.10). According to Aurora et al. (1994), the helix capping motifs  (Schellman motifs 
and the α-turns as found involving G255, Section 3.3.4.4) have two ‘facets’ – one helical and 
the other not. The helical facet rigidifies the final helical turn, by hydrogen bonding back to 
the main-chain CO, whereas the other facet terminates the helix and directs the polypeptide 
chain along a new trajectory. It is likely that such a motif substantially adds to the stability of 
the overall structure. 
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The residues in the equivalent position (210-215) in HCoV Mpro do not display a 
Schellman motif. A detailed look at the electron density revealed that its poor quality 
disallowed any definitive model building. The general direction of the polypeptide chain 
starting from 210 to 216 is similar in both TGEV Mpro and HCoV Mpro, except that residues 
N213 and G214 had particularly ill-defined density in HCoV Mpro indicating that presence of 
this motif cannot be totally ruled out. 
 
Table 3.10 Example for Schellman motif from TGEV Mpro chain A 
Residue CO(i)...NH
(i+5) (Å) 
CO(i+1)...
NH(i+4) 
(Å) 
φi+1
(o) 
ψi+1 
(o) 
φi+2 
(o) 
ψi+2 
(o) 
φi+3 
(o) 
ψi+3 
(o) 
φi+4 
(o) 
ψi+4 
(o) 
A210-L211-
I212-N213-
G214-E215 
3.03 2.88 -59.04 -58.29 -55.91 -38.22 -90.73 11.19 105.06 -2.60
 
 
 
 
 
 
 
 Fig. 3.23 A Schellman motif 
found in the TGEV Mpro 
crystal structure. For clarity, 
the side chains are omitted. 
 
 
 
 
 
3.3.4.6 β-Bulges  
Like tight turns, bulges can affect the directionality of the polypeptide chain, but in a much 
less drastic manner (Richardson et al., 1978). Compared to regular β structures, a β-bulge 
puts the usual alternation of side-chain direction out of register in one of the strands, thereby 
introducing a slight bend in the β-sheet. β-bulges can be classified into several different types, 
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the most common of which is the  'classic' β-bulge. It is a region between two consecutive β-
type hydrogen bonds which includes two residues (position 1 and 2) on one strand opposite a 
single residue (position x) on the other strand. Residue 1 is in approximately α-helical 
conformation (averaging φ1 = -100°, ψ1 = -45°) and residue 2 and x are in approximately 
normal β conformation (averaging φ2 = -140°, ψ2 =160°, and φx = -100°, ψx = 130°). There 
are three classic β-bulges each in the TGEV and HCoV Mpro structures conforming to these 
features (Table 3.11). In TGEV Mpro, strand eI involving residues V77 and S78 makes a bulge 
with K89 (position x) in strand fI. The second bulge is found at G122-S123 in strand cII, and 
its opposite strand is bII with A115 as the hydrogen-bonding partner. The third β-bulge is at 
H163-L164 of strand eII, which is antiparallel to the fII strand and involved in hydrogen 
bonding with G172.  In HCoV Mpro, the β-bulges are observed at the same position as in 
TGEV Mpro (Fig.3.24; Table 3.11). 
 
       Table 3.11 Classic β-bulges found in the A subunit of TGEV and in HCoV Mpros 
Residues φ1 (ο) ψ1 (ο) φ2 (ο) ψ2 (ο) φx(ο) ψx (ο) 
TGEV Mpro 
V77-S78; K89 -92.79 -25.53 -165.14 162.92 -80.07 131.85 
G122-S123; A115 -116.27 -40.02 -156.51 160.01 -77.31 124.41 
H163-L164; G172 -117.71 -50.00 -159.90 174.57 -122.44 134.65 
HCoV Mpro 
V77-G78; K89 -112.92 -18.03 -172.83 161.56 -90.07 117.71 
Q122-G123; A115 -117.24 -20-09 -171.86 162.18 -73.18 117.90 
Q163-I164; V172 -124.87 -49.23 -144.91 163.96 -134.76 136.36 
 
β-bulges are suited to fill in a protein structure. The β-bulges at 77-78 and 122-123 are 
located at a junction where the strand leaves the β-sheet in a different direction. His162-
His163 are involved in substrate binding and the bulge at this position provides a bend in the 
β sheet which helps the overall structure to fit together better and orient side chains in the 
needed direction such that they are appropriately placed at the binding site. The bulges can 
also provide a mechanism for accommodating a single-residue insertion or deletion mutation 
without totally disrupting the β sheet.  
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Fig. 3.24 Three β-bulge examples from the TGEV Mpro structure. Positions 77 (left), 122 
(middle) and 163 (right) also embed the bulge conformation in HCoV Mpro. Side chains are 
omitted for clarity. Thick sticks through the Cα positions of the bulge residues indicate the 
bulge region.  
 
3.3.4.7 Hydrogen bonding 
TGEV Mpro: Regular secondary structure accounts for about ~70% of the polypeptide chain. 
These structural elements are stabilized mainly through hydrogen bonds between backbone N 
and O atoms. Main-chain-side-chain interactions are fewer in number compared to main-
chain-main-chain interactions, as in most other proteins. This observation is consistent with 
the fact that most polar side chains are distributed on the outer surface of the protein 
molecule, while a considerable fraction of the main-chain atoms are buried in the interior. 
Most of the main-chain-side-chain hydrogen bonds are short-range interactions occurring 
within four residues along the polypeptide chain. The 717 hydrogen bonds were counted for 
the calculation of mean value distances in α-helices is 3.10 (± 0.14) Å in all six molecules. 
The short 310 helices gave the value 3.11 (± 0.139) Å for 85 H-bonds. The H-bonds counted 
for 786 β-sheets, gave mean value of 3.04 (± 0.09) Å for all molecules. The 244 hydrogen 
bonds in β-turns, on an average, are 3.07 (±0.11) Å long.  
 
 
 
 
 81
  Results and Discussion 
 
HCoV Mpro: The secondary structure distribution is similar to that of TGEV Mpro. The mean 
value of 223 calculated hydrogen-bond distances in α-helices is 3.08 (± 0.14) Å for the dimer 
of HCoV Mpro. For the short 310 helices the value is 3.15 (± 0.17) Å out of 12 H-bonds. The 
260 β-sheet-hydrogen bonds gave the mean value of 3.04 (± 0.09) Å for both molecules, and 
66 hydrogen bonds in β-turns, on an average, are 3.14 (± 0.17) Å long. 
 
3.3.5 Dynamic aspects 
3.3.5.1 Thermal parameters 
Electron density maps provide direct evidence for flexibility in protein molecules. The B-
factor indicates the true static or dynamic mobility of an atom, it can also indicate where there 
are errors in model building. The B-factor is given by Bi = 8π2Ui2, where Ui2 is the mean 
square displacement of atom i.  
 
This produces a weighting factor on the contribution of atom i to the Fourier transform 
by: exp(–Bi sin2θ/λ2). As U increases, B increases and the contribution of the atom to the 
scattering is decreased. If atoms are incorrectly built, their B-factors will tend to be higher 
than those for correctly built atoms nearby.  
 
The value of the temperature factor is affected not only by the flexibility of the protein 
molecule but also by errors in the crystallographic phases and by disorder in the crystal 
lattice. Thus an interpretation of B values is not straightforward. Lattice disorder and internal 
flexibility can be distinguished by comparing different parts of the electron density map to 
determine which variation can be explained by a slightly different packing of rigid molecules 
in the unit cell, by comparing maps of the same molecules in different crystal lattices or in 
different environments in the same lattice (e.g. when there is noncrystallographic symmetry), 
or by varying the temperatures of data measurement. 
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TGEV Mpro: Figure 3.25A shows the plot of average B values for main-chain atoms 
(N,Cα,C,O) as a function of the residue number. The average temperature factor is 46.1 Å2 for 
the main-chain atoms, 47.2 Å2 for side-chain atoms and 47.0 Å2 for all protein atoms. The 
domain III of monomer F shows large differences in B values (~70 Å2), compared to the other 
monomers A-E.  
 
As evident from the three-dimensional distribution of B-factors (Fig. 3.25B), 
monomers A, B, and E have relatively large areas with lower thermal parameters (indicated 
by blue). The inter-monomer loop regions also have lower temperature factor values 
compared to other exposed regions. Monomer F, especially its third domain, has high 
temperature factors, albeit with limited influence on other protein regions in the contiguous 
space. In both TGEV and HCoV proteinases, it is found that the buried residues (ASA < 0.07 
Å2) have lower temperature (~39 and ~19 Å2, respectively) factors than the exposed ones 
(~43 and 28 Å2, respectively). 
 
HCoV Mpro: Figure 3.26A shows the B-factor plot of the HCoV Mpro structure. Except for the 
residues near the two termini and in irregular secondary structure elements (loops, bends, 310-
helices, turns, β-ladder, etc), all residues have comparable B values in the two molecules and 
show the same pattern of variation along the chain. The B values peak at the turns and loops 
exposed to solvent, while making troughs at the ends of the strands that form the core of the 
protein molecule (Fig. 3.26B). The average temperature factors are 27.03 Å2 for the main-
chain atoms, 27.8 Å2 for side-chain atoms and 27.08 Å2 for all protein atoms.  The loop-helix 
segments 213-231 and 240-260 are the regions with significantly increased B-factor values, 
although these regions have well defined electron density. 
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      A  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.25 A. Average temperature factor for each of the six monomers of TGEV Mpro. The 
average B-factor of the C-terminal domain of monomer F is distinctively higher than that of 
the other monomers. The B-factor limit (program CNS) here is 100 Å2. B. Variation of the 
temperature factors in the three-dimensional structure. The color code ranges from blue to red 
indicating lower to higher temperature factors. Monomers A–F are labeled. 
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A 
B 
 
Fig. 3.26 A. B-factor plots for the HCoV Mpro crystal structure showing the flexible C-
terminal domain with relatively higher thermal factors than for the other two domains.  
B. Variation of the temperature factor in monomer A. Color codes are as in Figure 3.23. 
Monomer B has a similar B-factor distribution (see panel A). 
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3.3.5.2 Solvent Structure 
Water molecules contribute to the overall stability of proteins and to the characteristics of the 
surface (Caspar & Badger, 1991; Herron et al., 1994; Karplus & Faerman 1994; Zhang & 
Matthews, 1994). They influence protein folding, maintain the native structure and can be 
critical for the function, e.g. enzyme activity (Rupley et. al., 1980). In the TGEV Mpro 
asymmetric unit, there is clear electron density for at least 1006 water molecules while 221 
sites were located for the HCoV Mpro structure for water molecules. Most of these water 
molecules interact with polar portions of the amino-acid residues on the surface of the protein, 
whereas only a few are buried within the protein core (see appendix, Table 6.3A) (Lee & 
Richards, 1971; Rashin et al., 1986; Tilton et al., 1986). The water molecules form an 
extensive network of hydrogen-bonding interactions in both crystals. In TGEV Mpro, the 
buried water molecules, W11, W14, W15, W28, W204, W258 and W321 are related by NCS. 
They superpose on each other and are located in the active-site cavity  (Fig. 3.31) of each of 
the six monomers. Many of the water molecules are well ordered, bind firmly through three or 
four hydrogen bonds and are located in surface pockets and crevices. The water molecules 
related by non-crystallographic symmetry have comparable temperature factors and 
occupancies. 
 
All the water molecules except W10, W291, W499, W800, W884, W909, W955, 
W983, W984, and W1002 form at least one hydrogen bond to a protein atom directly, and 
thus occur in the first hydration shell. The water molecules that are further than 3.3 Å from 
the protein have higher B values and form hydrogen bonds to the protein surface through 
other water molecules.  
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3.3.5.3 Electrostatic surface 
Surface representations are an important tool for representing molecules and for computing 
inter-molecular interactions. Various molecular properties, such as atomic charge, 
electrostatic potential, hydrophobicity, polarizability, etc. strongly influence the way in which 
molecules interact with one another. In order to represent this, the information is displayed 
onto the molecular surface color codes, e.g., in the surface color-coded by electrostatic 
potential, the red areas (where the surface is negative) are interpreted as areas, which will 
most favorably interact with another molecular surface, which is blue (where the surface is 
positive). These kinds of representations are used to understand and predict how molecules 
will interact with one another, dock with one another and even to design molecules that will 
optimally bind to another molecule.  
The overall surface charge for both TGEV Mpro and HCoV Mpro is largely neutral 
(Fig.3.27A and 3.27B); however, HCoV Mpro has even fewer charged patches than TGEV 
Mpro. Even the active site groove bears only some negative potential.  
 
 The Mpro molecules were rotated to compare and align with the KFDRI region of the 
HAV 3C proteinase. The interdomain connection between I and II, is a surface that has been 
demonstrated to be involved in RNA recognition in picornavirus 3C proteinases (Bergmann et 
al., 1997). In contrast to the latter proteinases, very few charged residues contribute to the 
corresponding surface of Mpro. Further investigations for RNA-binding site continued with 
domain III. In domain III, there is no RNA binding site detectable, as the surface does not 
contain any particular patches of the basic residues. Domain III was individually checked for 
the overall charge pattern, which is again the same as that of the domain I and II. No distinct 
patches of basic amino acid residues were found.  
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Fig. 3.27  Surface 
representation (GRASP, 
Nicholls et al., 1991) of 
A., TGEV Mpro and B., 
HCoV Mpro. 1. Surface 
containing the active-
site cleft; the catalytic 
residues Cys144 and 
His41 are indicated. 2. 
The Mpro molecule is 
rotated by approx. -90° 
relative to the view 
shown in 1 to compare 
and align with the 
KFDRI region of the 
HAV 3C proteinase. 
Positive and negative 
surface charges are 
colored blue and red, 
respectively.  
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3.3.6 Crystal Packing 
The area of the protein surface involved in packing contacts is generally small and its amino 
acid composition is indistinguishable from that of the protein surface accessible to the solvent. 
Crystal packing provides examples of nonspecific protein-protein interactions, which can be 
compared to biologically relevant ones. The number of protein chains and protein segments 
involved in a crystal-packing contact is variable. The fraction of the protein surface involved 
in crystal contacts is very variable and independent of the number of packing contacts. A 
study by Janin & Rodier (1995) mainly focused on the geometrical features of the thermal 
motion at the crystal-packing interface and on the relation between surface burial and 
symmetry of the crystal. The number of crystal contacts and the percentage of the protein 
surface buried by them, decreases as the percentage of the solvent content increases 
(Matthews, 1968). Similarly, the temperature factors at the crystal packing contacts decreases 
as the area of the surface involved in the contact increases (Carugo & Argos, 1997). These 
general points have been confirmed during the analysis of the TGEV/HCoV Mpro structures. 
  
The lattice arrangement of the six TGEV Mpro monomers is shown in Figure 3.28 A, B 
and HCoV Mpro dimer in Figure 3.28 C, D. Analysis of contacts between symmetry-related 
TGEV Mpro molecules shows that the molecules F-C and E-B have more number of contacts 
as compared to the other monomers. The A and D monomers are less involved in the crystal 
contacts. Most of the regions involved in subunit association have irregular secondary 
structure, namely loop regions, bends, turns and 310 helices. Helix D and E of TGEV Mpro 
monomers pack against each other in the dimer, and so do β-strands aI and fI. The lattice is 
stabilized by quite a few strong electrostatic interactions (see appendix, Table 6.2.1-6.2.4). An 
elaborate web of hydrogen bonds supplements these interactions. There are at least 80 strong 
hydrogen bonds involved in crystal packing among the symmetry-related molecules. The 
interfaces between the molecules are essentially hydrophilic in nature with no residues being 
disordered.  
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Fig 3.28 Crystal packing. TGEV Mpro: A. View along the crystallographic y-axis B.  view 
along the z-axis, whereas HCoV Mpro: C. view along the y-axis and D. along the z-axis. All 
copies of the TGEV Mpro and HCoV  Mpro are shown in individual colors. 
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3.3.7 Bound crystallization additives 
Additional electron density was found in both the TGEV and HCoV Mpro structures, on the 
surface and in the active sites. In TGEV Mpro, nearly spherical densities close to arginines 19, 
61, 130, 216, 275, and 294 were interpreted as sulfate ions. They make reasonable hydrogen 
bonds with the guanidinium groups of these arginines and with adjacent main-chain nitrogens. 
Some of the sulfates are half, some are fully occupied.  
 
In our electron density maps, part of the S2 subsite (of all six copies of the monomer) 
harbours extra electron density that is interpreted as an MPD molecule from the 
crystallization medium (Fig. 3.30), (the crystallization precipitant contained additives such as 
MPD and dioxane). 6 MPD and nine dioxane molecules were modeled into difference density 
in the TGEV Mpro crystal structures. In the case of both HCoV Mpro monomers, a dioxane 
molecule was built into the S2 subsite (Fig. 3.29) (see appendix 6.5). 
 
Fig. 3.29 Stereo figure showing the environment of a dioxane molecule bound in the 
substrate-binding site of HCoV Mpro. Active site residues are labeled; the distance between 
the oxygen atom of dioxane and the water molecule is 2.17 Å. Extreme right: electron density 
map (2|Fo|-|Fc|) for the dioxane molecule (2.7σ above the mean). 
 
The MPD molecule binds near the presumed S2 and S3 subsites of the substrate-
binding site, between the two β-barrel core domains. This MPD molecule is also interacting 
with the long loop (residues 184 to 199) connecting domains II and III; this loop is involved 
in substrate binding (Fig. 3.20 & 3.30). 
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Fig. 3.30 The first two domains of TGEV Mpro where an R-MPD molecule binds to the 
substrate-binding site and interacts with two additional residues from the loop connecting 
domains II and III. (The loop is shown in figure 3.13, 3.20). Extreme right: an MPD molecule 
bound in electron density (2|Fo|-|Fc|), at 2.7σ above the mean.  
 
The C1 atom of the MPD contacts the Cβ of Leu164; O2 forms a hydrogen bond with the 
main-chain oxygen of Thr47 and C5 stacks with the peptide bond connecting Asp186 and 
Gln187. The protons attached to C4 can possibly interact with the imidazole π electrons of 
His41.  
 
The physicochemical properties of the substrate recognition sites of many proteinases 
suggest that, although they are not always hydrophobic, they may have hydrophobic subsites, 
which can be potential binding sites for MPD and other solvent molecule(s). The role of MPD 
in protein crystallization is stabilization of proteins by filling up voids and cavities on the 
protein surface rather than glue for binding proteins together in a crystal lattice (Anand et al., 
2002b). This is seen in the TGEV Mpro crystal structure where MPD does not take part in 
crystal contacts, but lies freely in the active-site groove.  
 
3.4 Functional implications of the structures  
3.4.1 Catalytic system of Mpro 
The active site of the coronavirus Mpro (Fig. 3.31) is similar to those of the picornavirus 3C 
proteinases, as had been predicted earlier (Gorbalenya et al., 1989b). The mutual arrangement 
of the nucleophilic Cys144 and the general acid-base catalyst His41 of TGEV Mpro is identical 
to that of the HAV 3Cpro residues Cys172 and His44 and to the residues Ser195 and His57 of 
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chymotrypsin. In TGEV Mpro, the average distance between the sulfur atom of Cys144 and 
the Nε2 of His41 is 4.05 (± 0.04) Å, i.e. longer than the corresponding Cys-to-His distances in 
HAV 3Cpro (3.92 Å; Bergmann et al., 1997), poliovirus (PV) 3Cpro (3.4 Å; Mosimann et al., 
1997), and papain (3.65 Å; Kamphuis et al., 1984) (Fig. 3.31A and 3.32B). In contrast to 
papain, but in agreement with the picornavirus 3C proteinases, the sulfur atom is in the plane 
of the histidine imidazole. There are clear indications from the difference Fourier synthesis 
that Cys144 is oxidized (Fig. 3.32A), at least to the stage of the sulfinic acid, -SO2¯, and 
probably to the sulfonic acid, -SO3¯, in all six copies of TGEV Mpro in the crystal. Such 
oxidation could occur during the time required for crystallization or during X-ray data 
collection and would lead to inactivation of the enzyme.  
 
The active-site residues are conserved between TGEV and HCoV Mpro (Fig. 3.31A & 
B); in HCoV Mpro, the distance between the active-site Cys144 and His41 (3.75 ± 0.04) Å is 
shorter than found in the TGEV Mpro. The active-site cysteine residues in both Mpros are 
oxidized. In HCoV Mpro, the difference electron density at the active-site cysteine of both the 
molecules in the asymmetric unit could be interpreted as a sulfenic acid (-SO¯). Refinement of 
the oxidized Cys derivatives was not successful. 
  
It is generally assumed that the native state of the active site of papain-like cysteine 
proteinases is a thiolate-imidazolium ion pair formed by cysteine and histidine residues 
(Polgár, 1974). In proteinases of the papain family, an asparagine is the third member of the 
catalytic triad. Chymotrypsin and other members of this serine proteinase family have a 
catalytic triad consisting of Ser195...His57...Asp102. In HAV 3Cpro, Asp84 is present at the 
required position, although its side chain points away from His44, making its role disputable 
(Malcolm, 1995; Bergmann et al., 1997). PV 3Cpro, human rhinovirus (HRV) 3Cpro, and HRV 
2Apro have a glutamate or aspartate in the proper orientation to accept a hydrogen bond from 
the active-site histidine (Matthews et al., 1994; Mosimann et al., 1997; Petersen et al., 1999). 
In contrast, both TGEV and HCoV Mpros have Val84 in the corresponding position, with its 
side chain pointing away from the catalytic site (Fig. 3.31 A, B and 3.32B). In both structures, 
a buried water molecule is found in the place that would normally be occupied by the side 
chain of the third member of the catalytic triad. This water molecule makes hydrogen bonds 
to His41 Nδ1, His163 Nδ1, and Asp186 Oδ1 (Fig. 3.31). 
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Fig. 3.31 The active site of coronavirus Mpro. A. The catalytic Cys144 and His41 residues of 
TGEV Mpro are shown. The region forming the oxyanion hole (main-chain amides of Gly142, 
Thr143, Cys144) is highlighted in pink. The water molecule, which occupies a position 
equivalent to that of the catalytic Asp of serine proteinases, is shown together with its 
hydrogen-bonding partners His41, His163 and Asp186. B. Similar diagram for HCoV Mpro. 
There is Ala143 instead of Thr143 in the oxyanion hole. The main chain amide of Ile140 is 
strongly interacting with OH of Tyr117, thus stabilizing the oxyanion hole. There is Gln at 
position 163 instead of His. The active-site geometry is similar to that of TGEV Mpro. Asp186 
cannot take the position of the water molecule through rotation about its Cα-Cβ bond. It is 
making a strong salt-bridge with Arg40. 
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His163 is not conserved among coronavirus main proteinases and its substitution by 
Leu (Mpro-H163L) had no significant effect on the proteolytic activity in the standard peptide 
assay (see Section 3.4.8), as compared to the activity of the wild-type Mpro (Ziebuhr et al., 
2000) (Table 3.12). Asp186 makes a salt bridge to Arg40 that appears to be required to 
maintain the active site geometry – both residues are absolutely conserved among 
coronaviruses. Through this (and other) interaction(s), the polypeptide segment 184 – 199, 
which connects domains II and III and is probably involved in substrate binding, is held in the 
proper position. Taken together, the data contradict a direct involvement of His163 or Asp186 
in catalysis, making both the TGEV Mpro and HCoV Mpro clear case, of viral cysteine 
proteinases employing only a catalytic dyad.  
 
Fig. 3.32 A. The catalytic Cys144 in TGEV Mpro is shown along with the difference electron 
density (|Fo|-|Fc| at 3.0 σ above the mean; red) for the oxidized state – indicating three oxygen 
atoms bound to the sulfur.  
B. Superposition of the active-site residues, including the third catalytic residue (Asp102) of 
chymotrypsin (shown in red), amino-acid residue Asp84 of HAV 3Cpro (side chain oriented 
differently; green) and Val84 (blue) of TGEV Mpro are shown. 
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3.4.2 Transition state stabilization 
It is generally accepted that substrate hydrolysis by cysteine proteinases occurs through a 
covalent tetrahedral intermediate resulting from attack of the active-site nucleophile on the 
carbonyl carbon of the scissile bond. In all known cysteine and serine proteinases, distortion 
of the carbonyl of the substrate is stabilized by strong hydrogen bonds between the 
developing oxyanion and amide groups of the enzyme. This so-called 'oxyanion hole' is also 
found in both TGEV Mpro and HCoV Mpro. It is made up by the main-chain amides of Gly142, 
Thr143 (Ala143 in HCoV Mpro), and Cys144 (Fig. 3.31 A, B). The glycine is in the i+2 
position of a type II reverse turn, which immediately precedes a second type II turn carrying 
the nucleophile. In TGEV Mpro, Thr143 plays a pivotal role in stabilizing the two connected 
turns by properly orienting the main-chain amides that donate the hydrogen bonds to the 
oxyanion. The side-chain hydroxyl group of this residue accepts a 3.09 (±0.09) Å hydrogen 
bond from the main-chain amide of Ile140, and it donates a 2.94 (±0.19) Å H-bond to the 
main-chain carbonyl of the same residue. The threonine side-chain is absent in HCoV Mpro 
(Ala143). Here, the proximal Tyr117 OH stabilizes the two connected turns. This is similar in 
the picornavirus proteinases or chymotrypsin, where the architecture of the oxyanion hole is 
very similar to the coronaviruses but employs different stabilizing interactions. The distinct 
hydrogen-bonding pattern is similar to that in bacterial chymotrypsin-like proteinases such as 
α-lytic proteinase (αLP; Fujinaga et al., 1985) and Streptomyces griseus proteinase A 
(SGPA)  (James et. al., 1980).  
 
Chymotrypsin-like serine proteinases have the sequence Gly(193)-Asp(194)-Ser(195)-
Gly(196) around the nucleophile. Asp194 forms a hydrogen bond both to the main-chain N at 
position -3 from the nucleophile in its own reverse turn and to β strands topologically 
identical to aII and bII1 found in HRV2-2Apro (Fig. 3.33).  In contrast, a similar hydrogen-
bonding pattern is not found in the 3Cpros of PV and HAV. In the PV 3Cpro, the residue 
preceding the nucleophile is Gln, whereas in HAV 3Cpro it is Met. In both cases, there are no 
interactions with strands aII and bII1. Replacement of the active site Cys172 in HAV 3Cpro by 
Ala causes the oxyanion hole to collapse (Allaire et al., 1994). This suggests that the thiolate 
ion of the proposed imidazolium-thiolate ion pair stabilizes the oxyanion hole by electrostatic 
interaction, forcing the main-chain carbonyl oxygens from the two residues preceding the 
nucleophile away from the thiolate as seen in HRV2-2Apro (Petersen et. al., 1999). The 
structure of the oxyanion hole in monomer A of TGEV proteinase is shown in Figure 3.31A 
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and in HCoV Mpro in Figure 3.31B.  The active-site Cys144 is oxidized but nevertheless takes 
part in making the oxyanion hole.   
 
 
 
 
 
Fig. 3.33 Superposition of oxyanion 
holes of  TGEV Mpro (blue), HAV 
3Cpro (green) and chymotrypsin (red) 
is shown. Labels are colored 
accordingly.  
 
 
 
 
One of the oxygens bound to the sulfur atom makes a H-bond with the main-chain 
amide of Cys144. The cysteine could have been oxidized in solution as well as in the crystal. 
DTT was used during protein purification. Furthermore, 5mM DTT was used in 
crystallization, but still the Cys144 is oxidized. This could be due to a combination of various 
factors: (i) DTT degrades with time as the crystallization proceeds for longer period (~10 
days), (ii) DTT may not have been used in sufficient amounts, (iii) Cys144 is exposed to the 
solvent, (iv) radiation damage during data collection may also cause oxidation. 
 
3.4.3 TGEV Mpro - TLCK complex 
At present, the available experimental evidence for the catalytic mechanism of coronavirus 
Mpros points to a catalytic dyad (Anand et.al., 2002a). For a better insight into this, HCoV 
Mpro was tested for sensitivity towards common proteinase inhibitors by Dr. J. Ziebuhr. Six 
compounds effectively inhibited the Mpro-mediated peptide cleavage. These were 3,4-
dichloroisocoumarin, phenylmethyl-sulfonyl fluoride (PMSF), PefablocSC [4-(2-Aminoethyl) 
benzenesulfonly fluoride HCl (C8H10NSO2FHCl)], TLCK, antipain [(S)-I-carboxy-2-
Phenylethy-carbamoyl-L-Arg-L-Val-Arginal, (C27H44N10O6)] and ZnCl2. Inhibition was 
defined as a reduction in cleavage product formation to less than 15% of the inhibitor-free 
control reaction. In contrast, TPCK, leupeptin, elastatinal, chymostatin, E-64, pepstatin, and 
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EDTA had no significant inhibitory effect. Thus despite having a nucleophilic Cys residue 
which cannot be functionally replaced by Ser (Ziebuhr et. al., 1995), the HCoV Mpro enzyme 
can be effectively inhibited by several serine proteinase inhibitors. Importantly however, the 
inhibitory effect of PMSF can be reversed by dithiothreitol, supporting the presence of a 
cysteine in the active site. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.34 TLCK bound to the active site Cys144. A. The 2|Fo|-|Fc| electron density map (2.6 
Å resolution of TGEV Mpro-TLCK complex), contoured at 1σ above the mean. B. Stereo view 
showing residues interacting with TLCK bound to Cys144. 
 
To study the active-site geometry in more detail and to provide further support for the 
catalytic role of Cys144, the structure of TGEV Mpro in complex with TLCK (Fig.3.34) was 
determined by molecular replacement and refined to 2.6 Å resolution. The wild-type TGEV 
Mpro crystals were soaked into five fold molar excess of TLCK inhibitor for 14 hr. The TLCK 
did not change significantly the unit cell dimensions of native TGEV Mpro. Both data sets 
were quite isomorphous that is why the TGEV Mpro-TLCK complex structure could be solved 
by molecular replacement method. The unit cell dimensions of the crystals are a = 72.8 Å, b = 
160.1 Å, c = 88.9 Å, β = 94.3o and display space group P21. In this structure, the distance 
between the sulfur atom of Cys144 and Nε2 of His41 is 4.02 Å. The TLCK molecule binds 
covalently to the active site Cys144 in all monomers of TGEV Mpro, as well as to Cys120 and 
Cys284. These two cysteines are exposed to the solvent channel. Therefore, binding of TLCK 
failed to provide any significant information. This result led to the design of a substrate-
 98
  Results and Discussion 
 
analog inhibitor, of which the structure was solved in complex with TGEV Mpro (see 
Section 3.4.5). 
 
3.4.4 Substrate binding site 
The substrate specificity of TGEV and HCoV Mpros resembles that of many other 3C/3C-like 
proteinases (Kräusslich & Wimmer, 1988; Dougherty & Semler, 1993). The arrangement of 
the residues in the substrate-binding site of both Mpros is similar, with an rmsd value of 0.65 Å 
for all atoms (132 target pairs out of 144 Cα pairs) of Mpros residues (Figure 3.18). There are 
minor variations in the conformation of the side chain for some residues. The P1 position of 
the substrate is occupied by Gln, and small residues (Ser, Ala, Gly, Cys, or rarely Asn) are 
found at the P1' position. Coronavirus main proteinases exhibit conservation mainly of Leu in 
the P2 position of their substrates. In contrast, HAV 3Cpro prefers Ser/Thr at P2, whereas PV 
3Cpro tolerates a wide variety of amino acids at this position. At P4, Val/Thr/Ser are found in 
coronavirus Mpro substrates, whereas the HAV and PV 3C proteinases favour Leu/Ile/Val and 
Ala/Val/Pro/Thr, respectively. TGEV deviates slightly from other coronaviruses (including 
HCoV Mpro) in that, in one cleavage site, Met is found at P2, while, in two others, Ile or Lys 
occurs at P4. One can speculate that these non-canonical cleavage sites are less efficiently 
processed than the more usual substrates.  
 
In order to visualize potential interactions with the substrate, a pentapeptide 
representing the P5 – P1 residues of the N-terminal cleavage site of the TGEV Mpro (Asn-Ser-
Thr-Leu-Gln) was initially modelled into the substrate-binding cleft of the TGEV main 
proteinase (Fig. 3.35) and later the X-ray structure of TGEV Mpro in complex with a P6-P1 
peptidyl chloromethyl-ketone (Z-Val-Asn-Ser-Thr-Leu-Gln-CMK) was solved. On the basis 
of this model and the crystal structure, it was concluded that residues P5 to P3 of the substrate 
would form an antiparallel β-sheet with segment 164 – 167 of the long strand eII on one side, 
and with the segment linking domains II and III (residues from 186-191) on the other. 
Hydrogen-bonding interactions are likely between main-chain N of Thr(P3) – main-chain O 
of Glu165(Mpro), O of Thr(P3) – N of Glu165(Mpro), O of Ala(P5) – main-chain N of Gly167 
of the protein, as well as between the main-chain N of Ser (P4) and O of Ser189 (protein) (see 
Fig. 3.35). The fact that the loop connecting domains II and III (residues 183 – 198) is part of 
this binding site is consistent with the dramatic loss of proteolytic activity upon deletion of 
domain III (Lu & Denison, 1997; Ziebuhr et al., 1997b; Ng & Liu, 2000). In fact, deletion of 
the whole polypeptide chain beyond residue 183 leads to total inactivation, whereas 
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measurable residual activity (0.4%) is observed with a proteinase fragment comprising 
residues 1 – 199, supporting the important role for the domain II – domain III connecting loop 
for substrate binding (Anand et al., 2002a) (Fig. 3.36B & 3.36D). The feature of substrate 
binding explains the strong preference for Leu or Ile in the P2 position. The cavity for P2 site 
is big and hydrophobic enough to accommodate Leu side chains.  
 
Fig. 3.35 Stereo diagram of a P5–P1 pentapeptide (Asn-Ser-Thr-Leu-Gln, red, corresponding 
to the TGEV Mpro N-terminal autoprocessing site) modeled into the active-site cleft of 
TGEV Mpro. Thin lines depict hydrogen bonds. 
 
3.4.5 TGEV Mpro in complex with a substrate-analog chloromethylketone inhibitor  
Crystals of the TGEV Mpro in complex with peptide (Val-Asn-Ser-Thr-Leu-Gln) were 
isomorphous to those of free TGEV Mpro. The inhibitor was soaked into the crystals, over 
night (see Section 2.4). They therefore belong to monoclinic space group P21 with cell 
dimensions, a = 72.39 Å, b = 158.55 Å, c = 88.20 Å, β = 94.4o and diffract to 2.2 Å 
resolution. However, the diffraction data were of sufficient quality only to a Bragg spacing of 
2.37 Å. Statistics of the diffraction data are given in Table 6.1A (Appendix) and the results of 
the refinement are summarized in Table 6.1B (Appendix) (Anand et al., submitted). Initial 
electron density maps showed the peptide in the active site of monomer B of the TGEV Mpro 
(Fig. 3.36A), with a covalent bond between the Sγ atom of the Cys144 residue and the 
methylene group of the chloromethyl ketone (Fig. 3.36B). There were small difference 
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densities in four other monomers (A, C, D, and E) and relatively large density in the F 
monomer, but not enough to build the whole peptide into it at this stage. Many cycles of 
manual rebuilding and computational refinement resulted in a final model consisting of 
residues A1-300, B1-300, C1-300, D1-301, E1-299, and F1-299 residues of TGEV Mpro plus 
12 residues of peptide in monomers B and F (six residues each). Four MPD molecules fit well 
near the active sites of monomers A, C, D, E, where there was clearly not sufficient electron 
density for the peptidic inhibitor. In the initial cycles of refinement, the MPD molecules were 
removed from the model of the free enzyme to make space for the substrate to be 
accommodated. It is still unclear why the peptide bound to only two Mpro molecules out of 
six. One reason could be that MPD, which is used in the crystallization solution, competes for 
the binding in all the molecules but could not succeed in monomers B and F. The other reason 
could be insufficient amounts of soaking time or inhibitor concentration. The substrate binds 
at the surface, with only the side chain of Leu (P2) partially buried, whereas of the proteinase, 
Leu 164 and Leu 166 are buried (Fig. 3.36C). The hexapeptide Z-Val-Asn-Ser-Thr-Leu-Gln-
CMK is bound to the S6→S1 specificity subsites of the proteinase. The interactions between 
substrate and the enzyme are very similar to the previous computer model (see above 
Fig. 3.35). There are hydrogen-bonding interactions between the main-chain N of Thr(P3) and  
 
Fig. 3.36A. Difference density (|Fo|-|Fc|) at 2.7 σ above the mean for monomer B of TGEV 
Mpro was clear enough to build the peptidyl inhibitor into it. Similar density was found in 
monomer F as well. B. Shows the refined model of the covalently bound inhibitor, to the SG 
atom of Cys144, in the electron density. Figure prepared using program Swiss-PdbViewer 
(Guex et al, 1999). 
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Fig 3.36C Peptidyl chloromethyl ketone inhibitor bound to monomer B of the TGEV Mpro. The 
left panel shows the whole monomer and the right-side panel provides an enlarged view into the 
substrate-binding site. The peptidic inhibitor is shown in red. D. Cartoon diagram in similar 
orientation as above, showing the involvement of the long loop connecting domains II and III in 
positioning the substrate. One of the possible roles of domain I 
II is to fix this loop. Figure prepared using program PYMOL (DeLano, 2000). 
 
 the main-chain O of Glu165(Mpro) 2.90 (± 0.08) Å, O of Thr(P3) and N of Glu165 Mpro is 
2.94 (± 0.19)) Å, O of Ala(P5) and the main-chain N of Gly167 of the Mpro main-chain N of 
Ser(P4) - main-chain O of Met189 is 2.67 (± 0.35) Å (average over model and structure, 
average over the monomers is given below). The hydrogen-bonding interactions between 
main-chain N of Thr(P3) – main-chain O of Glu165(Mpro) is 2.93 (± 0.01) Å, O of Thr(P3) – 
N of Glu165 Mpro 2.94 (± 0.05) Å, main-chain N of Ser(P4) - main-chain O of Met189 2.68 (± 
0.01) Å (average over monomer B and F). 
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Fig 3.37A. Stereo diagram of a TGEV Mpro – CMK inhibitor (substrate analog (P6–P1): Val-
Asn-Ser-Thr-Leu-Gln, red, corresponding to the TGEV Mpro (green) N-terminal 
autoprocessing site) complex as described crystallographically. Dotted lines depict hydrogen 
bonds. Phe139 is stacking to His162. The Tyr-Met-His motif is highlighted. Figure drawn 
with Molscript (Kraulis, 1991). Substrate binding sites of HCoV Mpro are in blue. 
 
 
 
 
 
 
 
 
 
 
Fig. 3.37B. Stereo diagram of superposition of S1 subsites of TGEV Mpro and HAV 3Cpro 
showing conserved the YXH and GXH motifs, respectively. In HAV 3Cpro, Gly at this 
position prevents the disruption of β-sheet (eII-fII); In addition, there is no space for any side 
chain at this position. Gly189 adopts torsion angles φ = 164o ψ = -165o to maintain the β-sheet 
structure involving strands dII, eII and fII, whereas in TGEV Mpro the arrangement of the 
strands is different and provides more space for the Tyr side chain. P2-P1 positions of CMK 
inhibitor are shown in red. 
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3.4.5.1 Substrate specificity 
In TGEV and HCoV Mpros, His162 is a critical residue involved in hydrogen bonding to the 
P1 Gln. The specificity for Gln at the P1 position of the substrate is attributed to the presence 
of the highly conserved His191 in the S1 pocket in HAV 3Cpro (Bergmann et al., 1997). In the 
sequence alignment of Mpro with HAV 3Cpro, His 162 corresponds to His191, and the two can 
be structurally superimposed. In HAV3Cpro, two water molecules (wat4 & wat9) and the 
buried Glu132 contribute to the stabilization of the imidazole tautomer of His191 (Fig 3.37B). 
In TGEV Mpro, Nδ1 of His162 and the OH of buried Tyr160 are hydrogen-bonded so that 
His162 is locked in a neutral single tautomeric form. This further strengthens the role of 
His162 in substrate binding. In principle, Tyr160 OH can accept a hydrogen bond from 
His162 Nδ1 or donate one to it, but the OH group strongly prefers to be hydrogen-bond donor. 
In a database of high-resolution, non-homologous protein structures, 97% of the buried Tyr-
OH groups identified donated hydrogen bonds (McDonald & Thornton, 1994). Since His162 
Nδ1, is the only nearby hydrogen-bonding partner, it is likely that Tyr160 OH donates a 
hydrogen bond to Nδ1, thereby stabilizing the His162 tautomer having a proton at Nε2. This 
stabilizes the Tyr-X-His (160-161-162) motif (Fig. 3.38), which is an integral region of the 
substrate-binding pocket and is invariant in all coronavirus main proteinases.   
 
Fig. 3.38 Stereo diagram showing the aromatic cluster around Tyr160 in the TGEV Mpro 
structure. Residues are selected within a radius of 6 Å2 around Tyr160. The later is part of the 
coronavirus specific Tyr-X-His motif. 
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In HAV 3Cpro, there is no Tyr needed because of the presence of Glu132, which is 
neutralizing His191 through two water molecules. In TGEV/HCoV Mpro, this role is played 
by Tyr160. The environment of Tyr160 is rather interesting. It is located at the center of an 
aromatic cluster built by residues Tyr181, His162, Phe111, His171, Phe139 (Fig. 3.38). The 
hydrophobic residues Ile105, Ile135, and Val159 make up the remaining environment around 
the Tyr160 residue. Undoubtedly, mutation of this residue would create a large void that will 
disrupt the aromatic cluster with significant energetic consequences. Also, His162 forms a 
bridge between Tyr160 and Cys144; therefore, a mutation would directly affect binding site 
and disturb the catalytic environment (Fig. 3.31). 
 
The Tyr-X-His motif is a distinct feature of coronavirus proteinases. The important 
role of histidine162 at this position has been apparent from site-directed mutagenesis studies 
where the replacement by Ser completely abolished the proteolytic activity (Ziebuhr et al., 
1997b). This inactivation was selective since a similar replacement of His171, another 
conserved His residue in this region, was not so detrimental (Ziebuhr et al., 1997b). The Tyr-
X-His motif has a Met residue in the middle position, which is embedded at the edge of the β-
strand eΙΙ, which straddles the active-site groove. The Met at the X position is facing away 
from the aromatic cluster (Fig. 3.38) and not in direct contact with the binding groove. 
Accordingly, it could be substituted by an Ala residue without significant effects on 
proteolytic activity (Hegyi et al., 2002). The TGEV and HCoV Mpro structures clearly show 
that, despite of its unique sequence context, His162 represents the functional equivalent to the 
S1 His residue of other viral chymotrypsin-like enzymes.  
 
3.4.5.2 S1 subsite 
The S1 subsite of TGEV Mpro is formed by residue Phe139, the main-chain atoms of Ile140, 
Leu164, Glu165 and His171, as well as by the imidazole group of His162. The side chain of 
Glu165 forms an ion pair (2.96 ± 0.14 Å) with His171. In HCoV Mpro, the same residues form 
the S1 subsite except for a Leu→Ile subsititution at position 164. The ion pair between 
Gly165 and H171 is preserved in HCoV Mpro. This salt bridge is itself on the periphery of the 
molecule, forming part of the "outer wall" of the S1 subsite. Accordingly, mutants of the 
HCoV Mpro, in which the residue equivalent to His171 had been replaced by Ala, Ser or Thr, 
retained significant proteolytic activities (Ziebuhr et al., 1997b). Glu165 and His171 
correspond to glycines 216 and 226 of chymotrypsin, and to Gly194 and Leu199 of HAV 
3Cpro, all of which contribute to the walls of the S1 subsite. 
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Halfway down the S1 subsite of free TGEV Mpro, there is dumb-bell-shaped electron 
density which we have assigned to two water molecules (W989 and W990), although they are 
theoretically too close to one another (2.10 ± 0.16 Å). One of them makes a hydrogen bond 
with Nε2 of His162, while the second one, unusual for water, makes no additional contacts. In 
our model of the substrate complex, these two water molecules mark the position of the 
carboxamide group of the P1 glutamine side chain. This arrangement has been confirmed by 
the crystal structure of the peptidyl-chloromethyl ketone inhibitor complex of TGEV Mpro. A 
similar arrangement of water molecules is seen in the HCoV Mpro crystal structure.  
 
3.4.5.3 Subsites S2 to S4 
The hydrophobic S2 pocket is lined by residues Leu164 (side-chain, main-chain contributes to 
S1; HAV 3Cpro: Ala193; chymotrypsin: Trp215), Pro188 (HAV: Ile216 chymotrypsin: 
Asn245), His41 (HAV: His44; chymotrypsin: His57), and Thr47 (not present in HAV or 
CHT). This subsite is relatively large and can easily accommodate the leucine side chain, 
which is almost invariably present at the P2 position of the substrates. In HAV 3Cpro, the 
corresponding subsite is formed by different parts of the polypeptide chain. It is also smaller 
and can accommodate the side chains of serine and threonine (Bergmann et al., 1997). The S2 
subsite of PV 3Cpro is a slight depression adjacent to the His40-Glu71 couple and is formed by 
Gly163, Leu127, Gly128, Gly129 and possibly Arg130 (Mosimann et al., 1997).   
 
There is no specificity for any particular side chain at the P3 position of coronavirus 
Mpro cleavage sites (Ziebuhr et al., 2000). This agrees with the structure of peptidyl-CMK 
inhibitor complex in which the P3 residue of the model substrate is oriented towards bulk 
solvent.  
 
At the P4 position, there has to be a small amino acid residue such as Ser, Thr, Val or 
Pro because of the congested cavity formed by residues Leu164 (HAV Ala193, CHT 
Gly215), Leu166 (HAV Gly195; CHT Ser 217), Ser189 main-chain (not present in HAV or 
CHT), and Gln191 (not present in HAV or CHT). 
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3.4.5.4 S1' subsite 
The TGEV/HCoV Mpro substrates have small residues such as Ala and Ser at the P1’ position. 
Only in one TGEV replicase polyprotein cleavage site does Asn occupy the P1’ position and 
competition cleavage experiments have shown that this site is less efficiently cleaved than 
other sites, indicating the exceptional nature of this substrate (Hegyi & Ziebuhr, 2002). The 
S1' subsite of the TGEV/HCoV Mpro is formed by Leu27, His41, and Thr47, with the latter 
two residues also being involved in the S2 subsite. Asn and Cys are uncommon as P1' 
residues outside of the coronaviruses, although there is Asn at the P1' position in rhinoviruses 
(Blom et al., 1996). 
 
3.4.6 Interaction with viral RNA 
It has been shown that picornavirus 3C proteinases bind to the 5' NTR cloverleaf structure of 
the viral RNA (Andino et al., 1993; Leong et al., 1993; Xiang et al., 1995). This interaction is 
mediated through a conserved KFRDI sequence motif (residues 95-99 in HAV 3Cpro), which 
is located between domains I and II, as well as small helices and reverse turns (Matthews et 
al., 1994; Bergmann et al., 1997; Mosimann et al., 1997). The same motif is found in HAV,  
 
Fig. 3.39 Electrostatic potential over domain III including the long loop (16 residues) 
connecting domains II and III in  A. TGEV Mpro, B. HCoV Mpro  
 
poliovirus and rhinovirus proteinases (residues 95 to 99 in HAV, and residues 82 to 86 in 
poliovirus and rhinovirus). Mutational studies on poliovirus 3C initially implicated these 
residues as having a function in the picornavirus life cycle, distinct from the proteolytic 
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activity (Hämmerle et al., 1992). Recognition of the nontranslated regions of the viral RNA 
genome (5' and 3' NTR) by the 3C subunit of a protein complex appears to be important for 
the initiation of RNA replication in picornaviruses, but experimental evidence for HAV is not 
available. One face each of the N- and C-terminal helices (helix A and H), and several of the 
small helices and reverse turns that connect strands β-bI and β-cI, β-dI and β-eII, β-dII and β-
eII form the RNA recognition site of HAV 3C.  
 
Although the 3Cpro structure is primarily built of β-sheets, helical regions form most of the 
RNA recognition site. The picornavirus 3Cpro RNA recognition site is on the side of the 
molecule opposite to the proteolytic active site. The two-domain β-barrel core structure of 
HAV 3C is rather rigid and does not allow for conformational changes. Sequence as well as 
structural alignment shows that the RNA-binding motif (KFRDI) is not conserved in 
coronavirus proteinases. In HCoV Mpro and TGEV Mpro, the residues corresponding to 
positions to KFRDI (95-99) are VNTPE (93-94) and TNTPR (97-99), respectively. 
 
The α-helical C-terminal domain III could in principle, be a candidate for RNA 
recognition. The domain was surveyed in both HCoV and TGEV Mpro for positive surface 
electrostatic potential to identify potential RNA-binding sites (Fig. 3.39). Since there is no 
overall basic character nor distinct patches of basic or aromatic residues, a role in RNA 
binding seems not probable for the extra C-terminal domain of the Mpros. In summary, no 
RNA-binding motif is present in coronavirus main proteinases and all of the structural 
elements forming the RNA recognition site in picornavirus 3C proteinases are either missing 
or very different in the Mpro structures. Therefore, a role of the coronavirus main proteinases 
in RNA binding is unlikely.  
 
3.4.7 Chain termini and autoprocessing  
Autoproteolysis is one of the mechanisms RNA viruses have evolved to regulate viral gene 
expression. Polyproteins containing protein domains with distinct functions are separated co-
translationally or post-translationally by autoproteolytic processing. The TGEV/HCoV Mpro 
crystal structures provide insight into the molecular details of these processes. 
 
The following observations for monomer A of TGEV Mpro hold true for all other 
monomers. In the dimer, the N-terminal segment 1 – 8 of monomer A is squeezed in between 
domains II and III of the same monomer and domains II and III of monomer B (Fig. 3.40A, B 
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& 3.41). Residues 6A to 8A form a short β-strand interacting with strand cII of monomer B 
(at Val124B). An intermolecular ionic interaction between NH2 of Arg4A and OE2 of 
Glu286B (5.0 ± 1.55 Å) and NH1 of Arg4A and OE1 of Glu286B (5.93 ± 1.02 Å) appears to 
play a role in positioning the N-terminal residues. Because of the twofold non-
crystallographic symmetry (NCS), the same interaction occurs between Arg4B and Glu286A. 
In addition, the side-chain amino group of Lys5A makes strong intramolecular hydrogen 
bonds with Ser110A Oγ of domain II (2.83 ± 0.15 Å), and with the Glu286A main-chain 
oxygen (2.80 ± 0.07 Å) as well as with Glu291A Oε1 (2.74 ± 0.13 Å) of domain III. The 
residues N-terminal to this pair of positively charged amino acids (Arg4, Lys5) also interact 
strongly with both proteinase monomers. The side chain of Leu3A completes a hydrophobic 
patch on domain III that includes Phe206A, Ala209A, Phe287A, Val292A, Gln295A, and 
Met296A; these residues belong to helices B and E. All members of the coronavirus 
proteinase family have a hydrophobic residue in position 3, and an absolutely conserved 
glycine in position 2. The latter residue adopts the αL conformation, which is easily accessible 
only to glycine. This conformation ensures that the N-terminal segment fits in between 
domains II and III of the same monomer and domain II of the second monomer in the dimer. 
  
Even more interestingly, Ser1A is in contact with residues participating in the 
substrate-binding site of monomer B. Its main-chain NH3+ group makes a salt bridge (4.30 ± 
1.22 Å) to the carboxylate of Glu165B. This glutamate, which is absolutely conserved among 
coronaviruses, is part of the S1 subsite (see above), where it also interacts with His171. 
Although these two side chains form the 'wall' of the specificity site, they have their polar 
groups oriented towards the surface of the proteinase molecule and away from the P1 
glutamine of the substrate (Fig. 3.36D, 3.37A). Most of the interactions between the N-
terminus of molecule A and the region next to the S1 subsite of molecule B constitute a 
perfect fit. This suggests that the tight dimer seen in the crystal is stable in solution as well as 
under physiological conditions. This is also supported by the fact that the same situation is 
observed in the crystal structure of the HCoV Mpro, which also crystallizes as a dimer, but 
under different conditions and in a different unit cell (Section 3.2.5.3, Table 3.6). 
Furthermore, most of the residues stabilizing the inter-domain contacts in the TGEV Mpro are 
conserved among coronavirus Mpro enzymes. 
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Fig. 3.40 A. Stereo figure showing the N-terminal segment located between the two 
monomers A and B. Molecule A is colored from blue at the N-terminus, via green (domain 
II), to red (C-terminus), while molecule B is shown in grey. The catalytic Cys144 and His41 
residues are shown in ball-and-stick in both monomers. The N- and C-termini of molecule A 
are indicated. 
 
Fig. 3.40 B. Schematic 
representation of the inter- and 
intramolecular contacts made by 
the N-termini of molecules A and 
B of the TGEV Mpro dimer. 
Amino acid residues and domains 
of molecule A and B are shown 
in blue and brown, respectively. 
The S1 binding sites, which are 
part of domain II, are indicated 
and the water molecules (red 
dots) filling the space between 
the N-termini of molecules A and 
B are depicted by red spheres. 
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An important role for the intricate interactions made by the N-terminal residues (Fig. 3.41) is 
supported by the fact that the peptidolytic activity of TGEV Mpro drops to 0.3 – 0.6% after 
deletion of residues 1 – 5 of the polypeptide chain (Anand et al., 2002a). This observation 
suggests that the N-terminal residues are responsible for fixing the mutual orientation of 
domains II (through Lys5, Met6) and III (through Leu3, Arg4, Lys5) of its own protomer, 
thereby ensuring that the loop (residue 184-199) connecting the two domains and involved in 
binding of substrate residues P5 to P3 (see above) has the proper orientation. In addition, they 
are also involved in orienting domains II and III of the other protomer, through intermolecular 
interactions involving the amino terminal NH3+ group and Arg4, respectively. 
 
Providing a specific binding site for the N-terminal peptides may have yet another 
important function. Ser1A, which is the P1' residue of the autocleavage reaction of TGEV 
Mpro, is 11.9 ± 1.6 Å from the active site Cys144B Sγ of the second molecule in the dimer and 
approximately 13.8 Å from the N-terminal nitrogen of the P1' residue which was modeled 
into the substrate-binding site. In contrast, the active site cysteine of molecule A is as much as 
34.2 ± 0.9 Å away from its own N-terminus. Given the fact that the P' residues in serine and 
cysteine proteinases constitute the leaving group of the cleavage reaction and are usually not 
subject to stringent specificity requirements in coronavirus Mpros, it is quite conceivable that, 
after autoproteolysis, the N-terminus of one monomer slides over the active site of the partner 
monomer and adopts the position seen in the Mpro crystal structures, i.e., with Ser1A 
interacting with Glu165B at the 'outer wall' of the S1 subsite. This, in turn, would suggest that 
the dimer corresponds to the product of the autolysis reaction and that this occurs in trans. 
This interpretation is also consistent with previously published data from the MHV system. 
For example, immuno-precipitation experiments revealed that, initially, the MHV Mpro is part 
of a larger, 150-kDa precursor protein in which the proteolytic domain is flanked by 
hydrophobic domains (Schiller et al., 1998). Genetic data indicate that these precursor 
molecules are functional (Siddell et al., 2001) and one of these functions could be to direct the 
polyprotein precursors to intracellular membranes, i.e. the site of replicase activity. The 
observed delay in the release of the mature, 27-kDa MHV Mpro would argue against co-
translational processing in cis and favor the idea that the MHV p150 concentration required 
for efficient intermolecular Mpro autoprocessing is not reached early in infection. Thus, 
components of the replication complex could be anchored to membranes in an uncleaved 
form and only later, when the precursor proteins accumulate to high local concentrations 
(Schiller et al., 1998; van der Meer et al., 1999), will Mpro dimerize and release itself by 
 111
  Results and Discussion 
 
intermolecular cleavage. This would then trigger the complete spectrum of trans-processing 
reactions in order to activate the preformed replication/transcription complex or to modulate 
its functions. 
 
3.4.8 Role of Domain III 
To corroborate the hypothesis of an involvement of domain III in proteolytic activity, an 
additional set of Mpro mutants was characterized by John Ziebuhr, in which the structural 
information was used to completely remove domain III. In these experiments, the danger of 
domain III misfolding, which might have been the cause of Mpro inactivation in previous 
studies using randomly ”truncated” coronavirus main proteinases (Lu and Denison, 1997; 
Ziebuhr et al., 1997b; Ng and Liu, 2000), was removed. The TGEV Mpro deletion mutants 
tested by Ziebuhr for activity comprised (i) domains I and II (Mpro∆184–302), (ii) domains I 
and II together with the entire loop region connecting domain II and III (Mpro∆200–302) or  
 
Fig. 3.41 Stereo figure showing the intra- and intermolecular contacts of the TGEV Mpro N-
terminus. Detailed view of the interactions made by the N-terminal segment (blue) and 
domain II/III of monomer A as well as domain II/III of monomer B. Residues critically 
involved in these interactions are designated by the single-letter code and shown in ball-and-
stick representation. The N- and C-termini of molecule A are indicated. 
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(iii) Domains I and II combined with the loop region but lacking the five N-terminal residues 
(Mpro∆1–5/∆200–302). As Table 3.12 shows, Mpro∆200–302 had clearly detectable (albeit 
significantly reduced) activity (0.4% of Mpro).  Similarly, the mutant Mpro∆1–5/∆200–302 had 
significantly reduced activity (0.6% of Mpro). In sharp contrast, no activities at all were 
detectable for Mpro∆184–302 and the active-site mutant, Mpro-C144A (the latter being used as 
a negative control) (Anand et al., 2002a).  
 
Table 3.12 Enzymatic activities of TGEV Mpro mutants (Ziebuhr, personal 
communication) 
Plasmid Oligonucleotides used for cloning or mutagenesis (5’ → 3’) Protein Mpro amino acids Activity 
(%)a 
pMal-Mpro TCAGGTTTGCGGAAAATGGCAC, 
AAAAGGATCCTTACTGAAGATTTACACCATACATTTG 
Mpro Ser1 – Gln302 100 
pMal-Mpro∆184-302 TCAGGTTTGCGGAAAATGGCAC, 
AAAGGATCCTTAACCACCGTACATTTCTCCTTCAAAATT 
Mpro∆184-302 Ser1 – Gly183 <0.02 
pMal-Mpro∆200-302 TCAGGTTTGCGGAAAATGGCAC, 
AAAGGATCCTTATGACATGACATTAGTACCTTCCAATTG 
Mpro∆200-302 Ser1 – Ser199 0.4 
pMal-Mpro∆1-5/∆200-
302 
ATGGCACAGCCTAGTGGTCTTGTA, 
AAAGGATCCTTATGACATGACATTAGTACCTTCCAATTG 
Mpro∆1-
5/∆200-302 
Met6 – Ser199 0.6 
pMal-Mpro∆1-5 ATGGCACAGCCTAGTGGTCTTGTA, 
AAAAGGATCCTTACTGAAGATTTACACCATACATTTG 
Mpro∆1-5 Met6 – Gln302 0.3 
pMal-Mpro-H163L GTATACATGCATCTCTTAGAACTTGGAAATGGCTCGCAT, 
TCCAAGTTCTAAGAGATGCATGTATACAAAATAGAGAAT 
Mproo-H163L Ser1 – Gln302 
(His163 → Leu) 
98 
pMal-Mpro-C144A AGCTGGTACTGCTGGATCAGTAGGTTATGTGTTAGAA, 
CTACTGATCCAGCAGTACCAGCTATAAAAGATCCTTT 
Mpro-C144A Ser1 – Gln302 
(Cys144  → Ala) 
<0.02 
 
a Proteolytic activities were determined using a peptide-based cleavage assay (Ziebuhr et al., 
1997). The sequence of the 15-mer substrate peptide, H2N-VSVNSTLQSGLRKMA-COOH 
was derived from the N-terminal Mpro autoprocessing site (residues shown in bold-face 
indicate the scissile bond). The activity of wild-type Mpro (encompassing 302 residues) was 
taken as 100% and the mean value of three experiments, which did not vary by more than 
15%, is shown (Anand et al., 2002a). 
 
The fact that residues 184–199 proved to be indispensable for proteolytic activity is in 
agreement with the structure of the peptidyl chloromethyl ketone inhibitor complex of TGEV 
Mpro (Fig. 3.36, 3.37) in which residues of the loop are predicted to be critically involved in 
the formation of a β-sheet-type structure with the substrate (Section 3.4.4). The data also 
show that an intact N-terminus and the C-terminal domain are required for full activity. The 
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structure suggests that the additional α-helical domain III as well as the N-terminal residues 
help fix domains II and the loop 184-199 in a catalytically competent orientation.  
 
It will be interesting to investigate whether similar mechanisms are also operating in other 
3C-like proteinases with (smaller) C-terminal domains (e.g., arteriviruses and potyviruses; 
Ziebuhr et al., 2000; Hegyi et al., 2002).  
 
3.5 Relationship of coronavirus Mpro with viral and cellular homologs 
The TGEV/HCoV Mpro is unique as it represents one of the largest RNA virus proteinases 
(~30 kDa). Usually chymotrypsin-like proteinases from other viruses have only around 180 
residues. The size difference is due to the extra C-terminal region of approximately 100 
amino acids. Coronavirus Mpro displays a very low overall sequence similarity (<20%) to 
other proteases. Basically, the similarity is limited to the regions of active-site residues.  
 
The TGEV/HCoV proteinase structure represents a new class of cysteine proteinases 
which combine the common two β-barrel serine proteinase like fold with an additional C-
terminal domain as previously predicted (Bazan & Fletterick, 1988; Gorbalenya et al., 1989) 
(Fig. 3.13 & 3.43). In fact, a novel structural fold (the C-terminal domain) may be employed 
in this particular case to control the proteolytic activity, even though the mechanism of 
control cannot easily be derived from its structure. It is found that deletion mutants (Ser1-
Gly183 and Ser1-Ser199) removing all of the C-terminal residues are more than 200 fold less 
active in the standard peptide-cleavage assay (see above).  
 
A three-dimensional comparison of domains I and II of TGEV/HCoV proteinase 
reveals a significant relationship with the main-chain folds of the picornavirus HAV 3C and 
chymotrypsin-like serine proteinases. The three-dimensional structural comparison among all 
three (excluding HCoV Mpro) gave an rms deviation of ~1.8 Å for approximately 100 out of 
200 residues (Fig. 3.42). Even though the active-site histidine and cysteine residues 
superimpose, and a two β-barrel fold is present in both proteins, the differences are quite 
evident. The bII and cII strands are extremely shortened and there is different connectivity of 
dII and eII in HAV 3C. Additionally, the C-terminus folds back in chymotrypsin and HAV 
3Cpro to get in contact with domain I while there is no such interaction in TGEV and HCoV 
proteinases.  
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Chymotrypsin, trypsin and elastase have very similar three-dimensional structures but 
different specificity. They cleave adjacent to bulky aromatic side chains, positively charged 
side chains, and small-uncharged side chains, respectively. In trypsin and chymotrypsin, a 
glycine residue allows the side chain of the substrate to penetrate into the interior of the 
specificity pocket. In elastase, Val and Thr fill up most of the pocket, so that proteinase 
cleaves adjacent to small-uncharged side chains.  
 
The substrate specificity of TGEV/HCoV proteinase resembles that of many other 
3C/3C-like proteinases (Kräusslich & Wimmer, 1988; Dougherty & Semler, 1993; Blom et 
al., 1996) in so far as the P1 position of the substrate is exclusively occupied by Gln and small 
residues (Ser, Ala, Asn, Gly and Cys) are found at the P1' position. The P2 and P4 positions 
are mostly conserved, with bulky hydrophobic residues (mainly Leu) at P2 and Val, Thr, Ser 
(and Pro) at P4 being clearly favored. However, their three-dimensional structure or sequence 
is quite different from any picornavirus 3C proteinase. 
 
. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.42 A stereo diagram of the Cα trace of the least-squares superposition of TGEV Mpro 
(thick line, violet), HAV-3C (red) and chymotrypsin (green). The Cys/Ser nucleophile and the 
His general acid/base catalyst at the active site of the three enzymes are also shown. The root-
mean square deviation is 1.8 Å for 100 equivalent Cα atoms that superpose within 3.8 Å. The 
active sites superpose closely whereas other regions including surface loops and turns deviate 
more. 
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In 3C and 3C-like proteinases, Cys replaces the nucleophilic Ser and, in a subset of 
viruses, Glu replaces the Asp of the catalytic triad found in cellular proteinases (Bazan & 
Fletterick, 1988; Gobalenya et al., 1989a; Matthews et al., 1994). The coronavirus Mpro seems 
to lack a conserved acidic residue that would be equivalent to the catalytic Asp (Glu) of 3C 
proteinases 
 
In thiol proteinases such as papain, the sulphydryl group of the active site cysteine 
shows high nucleophilicity – the sulfur atom forms a thiolate anion/imidazolium couple with 
His159 at neutral pH. The oxygen of the Asn175 side-chain is hydrogen bonded to His159 
forming an Asn175-His159-Cys25 triad reminiscent of to the Asp-His-Ser triad in 
chymotrypsin as described above (Section 3.4.1). The Asn175-His159 hydrogen bond is 
approximately collinear with the Cγ-Cβ bond of His159, allowing some rotation of the 
imidazole ring about this axis without disrupting the bond. Indeed, the function of Asn175 
may be modulation of the rotation of the imidazole ring during catalysis. The electrostatic 
contribution of the oxyanion pocket in cysteine proteinase catalysis appears to be somewhat 
less than that in serine proteinase catalysis (Menard et al., 1995). In papain, the oxyanion 
pocket dipoles are derived from the main-chain amide of Cys25 and the side-chain amide of 
Gln19. 
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Fig. 3.43 Overall fold of TGEV Mpro together with the structures of viral and cellular 
homologs. (A) TGEV Mpro with the two β-barrel domains and the α-helical C-terminal 
domain. β-strands and helices are represented as arrows and cylinders, respectively. The 
structures of HAV 3Cpro (PDB code: 1HAV) (B) and α-chymotrypsin (4CHA, residues 12-15 
and 147-148 are excised) (C) are shown for comparison. 
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In chymotrypsin-like proteinases, the oxyanion hole serves to stabilize the negative 
charge developing on the P1-carbonyl oxygen atom during the formation of the tetrahedral 
intermediate. The oxyanion hole consists of a type-II reverse turn preceding the nucleophile 
and has two main-chain amides pointing towards the P1-carbonyl oxygen atom. The structure 
of the oxyanion hole in the A monomer of TGEV/HCoV proteinase is shown in Figure 3.31A 
& 3.31B. Thr143 forms a hydrogen bond with Ala140 (main-chain). This hydrogen-bond 
seems to stabilize the oxyanion hole by anchoring the two consecutive type-II reverse turns 
formed by residues 140-143 to the hairpin loop between strands bII and cII (residues Thr117-
Cys120). The NH of T143 forms an H-bond to I140 C=O. Additionally, the T143OγH form 
H-bond to I140 C=O. Gly142 C=O receives an H-bond from N128δ2. The next type II turn is: 
T143-C144-G145-S146. Similar hydrogen bonds from S146 to C=O of T143 as in the other 
preceding type II turn are present here. The hydrogen-bonding pattern is similar to that in 
bacterial chymotrypsin-like proteinases such as α-lytic proteinase (αLP; Fujinaga et al., 1985) 
and SGPA. These chymotrypsin-like serine proteinases have the sequence Gly193-Asp194-
Ser195-Gly196 around the nucleophile, which corresponds to Gly142, Thr/Ala143, Cys144 
and G145 of TGEV/HCoV proteinase. The threonine forms a hydrogen bond to the main-
chain N at residue -3 from the nucleophile in its own reverse turn in order to stabilize the 
oxyanion hole (the proximal Tyr117 OH forms an equivalent hydrogen bond in HCoV Mpro). 
This threonine is not present in picornavirus proteinases nor in chymotrypsin. Cys144 is 
situated in the i+1 position of the type-II β-turn.  His41 is situated in the 310 helix located 
after β-strand (cI). This β-strand is in a position to form an antiparallel, β-sheet-type hydrogen 
bonding interaction with a bound substrate. 
 
3.6 CONCLUSIONS 
The 60-selenium atom substructure that has been solved for phasing is amongst the largest 
that has been successfully used in de novo MAD structure determination (Deacon and Ealick, 
1999). This should encourage the use of selenomethionine as an anomalous scatterer to solve 
even larger structures. The present work, is the first successful report of the three-dimensional 
structure of the family Coronaviridae. 
 
The three-dimensional structure of TGEV Mpro shows that coronaviruses have evolved 
proteinases in which a thiolate-imidazolium catalytic dyad has been combined with the two-β-
barrel fold present in chymotrypsin-like serine proteinases. In agreement with previous 
studies (Allaire et al., 1994; Bergmann et al., 1997), the Mpro structure supports the 
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hypothesis that the catalytic centers (and mechanisms) used by the eukaryotic prototype 
cysteine and serine proteinases may only represent variations of a common theme.  
 
 
The additional α-helical domain III, together with the N-terminal residues, appears to 
be the involved in proteolytic activity by maintaining the proper positioning of the presumed 
substrate-binding loop, 184-199. In the model, the three-domain structure ensures the release 
of the Mpro N-terminus by intermolecular autoprocessing, and, at the same time, prevents 
product inhibition of Mpro by providing a proper interaction site for the N-terminal and C-
terminal segment. Once bound at this site, residues 1 – 5, in turn, help fix the Mpro domains II 
and III and the loop intervening in a catalytically competent orientation. 
 
The structure also shows that binding of the coronavirus main proteinases to the viral 
RNA is unlikely, in contrast to the findings for picornavirus 3C proteinases.  
 
Finally, the architecture of the substrate-binding site explains the pronounced substrate 
specificity of coronavirus main proteinases and provides a basis for the rational design of 
specific inhibitors that might be used to control and prevent the spread of coronavirus 
infections. 
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4. SUMMARY 
 
 In this thesis, the ~33kDa structures of porcine transmissible gasteroenteritis virus main proteinse 
(TGEV Mpro) and human coronavirus virus main proteinase (HCoV Mpro), the largest RNA virus 
proteinases known to date, have been determined by X-ray crystallography. The purified proteins 
were provided by Dr. Ziebuhr (Würzburg). The structure solution was based on a multifarious 
approach, which included the generation of SeMet-substituted protein crystals and usage of a 
nonconventional cryprotectant (mustard oil). Data were collected from single crystals held in a 
stream of nitrogen gas at 100K, using synchrotron beamlines at DESY (Hamburg) and ELETTRA, 
(Trieste). The phase solution for the TGEV Mpro structure was obtained based on MAD data, which 
were used to locate 60 selenium sites using direct methods (SnB). The identification of the 60 
selenium sites proved to be a challenging test of the robustness of current phasing strategies for 
SeMet-based MAD structure determination. Taking TGEV Mpro as a model, the structure of HCoV 
Mpro has been solved by the molecular replacement method.  
 
Both TGEV and HCoV Mpro form tight dimers; TGEV Mpro has three dimers in the 
asymmetric unit whereas HCoV Mpro has only one. All dimers are related by twofold non-
crystallographic symmetry. Each monomer has three domains; the first two domains have β-barrel 
folds similar to those of chymotrypsin-like serine proteases, and the third domain is a unique 
arrangement of five antiparallel α-helices. Domains I and II contain six β-strands each. In domain I, 
there is a short helix between strand cI and dI (the HCoV Mpro has an additional short N-terminal 
helix).  
 
The three-dimensional structure of TGEV Mpro shows that coronaviruses have evolved 
proteinases in which a thiolate-imidazolium catalytic dyad has been combined with the two-β-
barrel fold present in chymotrypsin-like serine proteinases. In agreement with previous studies 
(Allaire et al., 1994; Bergmann et al., 1997), the Mpro structure data strongly support the hypothesis 
that the catalytic centers (and mechanisms) used by the eukaryotic prototype cysteine and serine 
proteinases may only represent variations of a common theme. The active sites of both Mpros are 
identical and the catalytic site residues are made up of Cys144 and His41. In the case of TGEV, 
Cys144 is oxidized up to sulfonic acid whereas in HCoV Mpro, it is oxidized up to the sulfenic acid. 
The distance (in TGEV Mpro) between Cys144 and His41 is larger than the corresponding Cys-His 
distances in the picornavirus protomers.  
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To study the active-site geometry in more detail, the structure of TGEV Mpro in complex 
with TLCK has also been solved. The TLCK is found to be covalently bound to the active-site 
Cys144 but also to Cys120 and Cys284 which are exposed to solvent. Therefore, binding of TLCK 
did not reveal significant information about the residues involved in the active site. This lead to the 
design of a sequence-specific substrate-analog peptidyl (P6-P1) inhibitor. The structure of TGEV 
Mpro in complex with this inhibitor was solved by the molecular replacement at 2.37 Å resolution. 
 
The TGEV-CMK inhibitor complex (substrate analog, P6-P1, Val-Asn-Ser-Thr-Leu-Gln) 
structure shows the complementary nature of the binding surfaces. It reveals that the P4-P1 residues 
of the peptide assume a common main chain conformation when bound to these proteinases. The 
residues P5 to P3 form an antiparallel β-sheet with segment 164-167 of the long strand eII on one 
side, and with the segment 186-191 (which links domain II and III) on the other.  
 
The N-terminal segment plays an important role in fixing the dimer by interacting with 
domains II and III of its own monomer and domains II and III of the other monomer in the dimer. 
Most of the interactions are between the N-terminal segment of one monomer with the substrate 
binding-site residues of the other monomer. This suggests an important role of this stretch of 
residues in the autoprocessing function of these proteinases. The additional α-helical domain III 
appears to be the driving force for dimerization of Mpro. In this model, the three-domain structure 
ensures the release of the Mpro N-terminus by intermolecular autoprocessing and, at the same time, 
prevents product inhibition of Mpro by providing a proper interaction site for the N-terminal 
segment created after autocleavage. It remains to be investigated whether similar mechanisms are 
also operating in other 3C-like proteinases with (smaller) C-terminal domains (e.g., arteriviruses 
and potyviruses; Ziebuhr et al., 2000; Hegyi et al., 2002; Barrette-Ng et al., 2002). In picornavirus 
3C proteinases for example, the refolding of the released N-terminus into a stable helix is assumed 
to prevent the self-inactivation of 3Cpro following presumed intramolecular N-terminal cleavage 
(Khan et al., 1999). The structure also shows that binding of the coronavirus main proteinases to 
the viral RNA is unlikely, in contrast to the findings for picornavirus 3C proteinases.  
The current structure analyses of the coronavirus main proteinases provide considerable 
insight into the structure-function mechanisms of this family of enzymes and also help in 
understanding the role of Mpro in the coronavirus life cycle. The results are instrumental in the 
structure-based development of lead compounds for anticoronaviral therapy of a variety of 
coronavirus diseases in humans, domestic animals, and livestock.  
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6. APPENDIX 
 
6.1 Crystal parameters and refinement statistics 
 
Table 6.1A Crystal parameters and statistics of diffraction data for TGEV Mpro – CMK 
(substrate analog chloromethyl ketone) inhibitor complex 
 
X-ray source Synchrotron radiationa
Space group P21
Unit cell (Å, o) a = 72.39, b = 158.55, c = 88.20, β = 94.40 
Resolution (Å) 50-2.37 (2.41-2.37) 
Total no. of reflections 562107 
No. of reflections used 562107 
Unique reflections 78630 
Completeness (%) 99.0 
Average intensity I/σ(I) 9.9 (3.4) 
Rmergeb (%) 5.8 
Rpimc (%) 2.2 
a X-ray diffraction at Joint IMB Jena-University of Hamburg-EMBL synchrotron beamline 
X13 at Deutsches Elektronen-Synchrotron, Hamburg, equipped with a Mar CCD detector 
b,c For definition see Section 2.2.12 
 
 
 
Table 6.1B Refinement and model statistics of TGEV Mpro – CMK substrate analog 
complex 
 
No. of non-hydrogen atoms (average B value (Å2)) 
Protein 13911 (43.0) 
Water 925 (51.3) 
MPD 32 (78.6) 
Sulfate 135 (59.8) 
R-factora 19.2 
Free R-factor 23.6 
Rmsd from ideal geometry 
Bonds (Å) 0.006 
Bond angles (o) 1.3 
a, b For definition see Section 2.2.12 
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6.2 Inter-subunit H-bonds 
 
Table 6.2.1 Inter-subunit (intra-dimer) H-bond contacts (< 3.5 Å) for all monomers: 
Main chain–main chain* 
 
                             Residue involved                                  Distance (Å) 
Phe  139A O Ser  1B O 2.88 
Phe  139A N Ser  1B O 3.49 
Ala     7B N Val   124A O 3.20 
Ala     7B O Val   124A N 2.85* 
Val   124B N Ala     7A O 2.78 
Val   124B O Ala     7A N 3.21 
Phe   139B O Ser     1A N 2.88 
Ser   279B O Gly   281A N 3.05 
Phe   139C O Ser     1D N 2.59 
Phe   139C N Ser     1D O 3.32 
Ala     7D N Val   124C O 3.21 
Ala     7D O Val   124C N 3.00* 
Val   124D N Ala     7C O 2.79 
Val   124D O Ala     7C N 3.27 
Phe   139D O Ser     1C N 2.59 
Ser   279D O Gly   281C N 2.82 
Gly   281D N Ser   279C O 3.08* 
Ala     7E N Val   124F O 3.38 
Ala     7E O Val   124F N 2.72* 
Val   124E N Ala     7F O 2.71 
Val   124E O Ala     7F N 3.13 
Phe   139E O Ser     1F N 3.47 
Ser   279E O Gly   281F N 3.48 
Gly   281E N Ser   279F O 3.49* 
Phe   139F O Ser     1E N 3.47 
*All these H-bond are present in HCoV Mpro (AB dimer) as well, with exceptions of * 
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Table 6.2.2 Inter-subunit (intra-dimer) H-bond contacts (< 3.5 Å):  
Main chain–side chain* 
 
                                  Residue name                              Distance (Å) 
Ser  1A N Glu  165B OE1 2.77 
Arg   4A NH1 Gly     126B O 2.98 
Arg   4A NH1 Lys     136B O 3.21 
Arg   4A NH2 Gly     126B O 2.60 
Gly   11A N Glu      14B OE2 2.81 
Gly  126A O Arg    4B NH1 2.94 
Arg  130A NH2 Glu   193A OE2 2.99 
Gly   126A O Arg     4B NH2 3.20 
Phe   139A O Ser     1B OG 2.97 
Arg   4B NH1 Gly     126A O 2.94 
Arg   4B NH2 Gly     126A O 3.20 
Gly    11B N Glu    14A OE2 2.59 
Glu    14B OE2 Gly    11A N 2.81 
Gly   126B O Arg     4A NH1 2.98 
Gly   126B O Arg     4A NH2 2.60 
Lys§   136B O Arg     4A NH1 3.21 
Ser   138B OG Gly     2A O 3.25 
Arg   4C NH2 Gly     126D O 3.21 
Arg   4C N Gln    295D OE1 2.70 
Gly    11C N Glu    14D OE2 2.67 
Glu    14C OE2 Gly    11D N 2.72 
Lys§   136C O Arg     4D NH2 2.41 
Ser     1D OG Gly   137C O 2.53 
Gly    11D N Glu    14C OE2 2.72 
Glu    14D OE1 Gly    11C N 2.67 
Gly   126D O Arg     4C NH2 3.21 
Ser   138D OG Gly     2C O 3.09 
Glu   165D OE1 Ser     1C N 3.08 
Arg   4E NH1 Gly     126F O 2.87 
Arg   4E NH2 Gly     126F O 2.57 
Glu    14E OE2 Gly    11F N 2.85 
Gly   136E O Arg     4F NH1 3.23 
Ser   136E O Arg     4F NH2 3.28 
Glu   139E O Ser     1F N 3.47 
Glu   165E OE1 Ser     1F OG 3.28 
Glu   165E OE2 Ser     1F OG 3.39 
Arg   4F NH1 Lys     136E O 3.23 
Arg   4F O Gln    295F NE2 2.82 
Gly    11F N Glu    14E OE2 2.85 
Glu    126F O Arg    4E CZ 2.80 
Gly   126F O Arg    4E NH1 2.87 
Ser   126F O Arg    4E NH2 2.57 
Ser   138F OG Met     6E CE 3.09 
* Interactions satisfying H-bond critria in HCoV Mpro (AB dimer) are marked in bold 
**An extra interaction in HCoV Mpro: is SerA 10 N - GluB14 OE1 2.70 Å 
§ replaced by Arg in HCoV Mpro
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Table 6.2.3 Inter-subunit (intra-dimer) H-bond contacts (< 3.5 Å):  
Side chain–side chain* 
 
                                Residues involved                          Distance (Å) 
Ser  1A OG Glu  165B OE1 2.77 
Ser  1A OG Glu  165B OE2 2.86 
Arg   40A NH2 Asp  186A  OD2 2.89 
Arg  40A NH2 Asp  186A OD1 3.47 
Arg   40A NE Asp  186A  OD1 2.44 
Lys 103A NZ Glu  152A OE2 2.87 
Glu   165A OE1 Ser   1B OG 3.50 
Arg   40B NH2 Asp  186B  OD2 2.92 
Arg   40B NE Asp  186B  OD1 2.57 
Asp  34B OD2 Lys  89B NZ 3.13 
Arg  130B NH2 Glu  193B OE1 2.92 
Ser   138A OG Arg   4B CG 3.45 
Ser   138B OG Gln   295A OE1 3.07 
Glu  152B OE2 Lys  103B NZ 3.05 
Glu   165B OE1 Ser     1A OG 3.08 
Glu   165B OE1 His   171B NE2 2.72 
Glu   165B OE2 Ser     1A OG 2.86 
Glu   14C OE2 Ser   10 D OG 2.81 
Arg    40C NE Asp   186C OD1 2.60 
Arg    40C NH2 Asp  186C OD2 3.05 
Arg    40C NH2 Asp  186C OD1 3.35 
Arg    40C NH2 Arg   4D NH2 3.22 
Arg   130C NH2 Glu  193C OE1 3.02 
Ser     138C OG Arg  4D NE 3.20 
Ser    138C OG Asp   186C OD2 3.05 
Glu   152C OE2 Lys   103C NZ 3.05 
Glu   165C OE1 His   171C NE2 3.16 
Arg     4D NE Ser   138C OG 3.20 
Arg     4D NH2 Ser   138C OG 3.22 
Arg     40D NE Asp   186D OD1 2.61 
Arg     40D NH2 Asp   186D OD2 2.98 
Arg     40D NH2 Asp  186D OD1 3.22 
Gly    11D N Glu    14C OE2 2.72 
Ser   138D OG Gln   295C OE1 2.85 
Glu   165D OE2 Ser    1C OG 3.34 
Arg     40E NE Asp   186E OD1 2.63 
Arg     40E NH2 Asp   186E OD2 3.26 
Lys  103E NZ Glu  152B OE2 3.40 
Arg  130E NE Glu  193E OE1 3.21 
Glu  152E OE2 Lys  103E NZ 3.40 
Glu   165E OE1 Ser    1F OG 3.28 
Glu   165E OE2 Ser    1F OG 3.39 
Ser  1F OG Glu  165E OE1 3.39 
Arg     40F NE Asp   186F OD1 2.69 
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Arg     40F NH2 Asp   186F OD2 2.74 
Arg     40F NH2 Asp   186F OD1 3.45 
Ser    138F OG Gln   295F OE1 3.35 
Glu  152F OE2 Lys  103F NZ 3.12 
Glu  165 F OE1 His   1 71F NE2 2.95 
* Interactions satisfying H-bond critria in HCoV Mpro (AB dimer) are marked in bold 
 
**Three extra interactions in HCoV Mpro:  Glu286 OE2 - Arg4 NH2 2.85Å 
      Lys294§ NZ - Gln122# OE1 3.29 Å 
      Ser138 OG –Arg4 N 3.50 Å 
§ replaced by Arg in TGEV Mpro
# replaced by Gly in TGEV Mpro
 
 
Table 6.2.4 Inter-dimer H-bond contacts (< 3.5 Å):  
                               Residues involved Distance (Å) 
Lys   101D NZ Asp  245B OD1 3.03 
Glu 185D OE1 Val 50E N 2.87 
Gln 191 D NE2 Arg 49E NH1 3.26 
Lys 234E NZ 179B  OE2 2.82 
Arg   216E NH1 Arg   275B NH2 2.46 
Val   219E O Gly   274B N 2.88 
Lys  234E NZ Glu  179B OE2 2.82 
Gly   273E O Arg   275A NH2 2.82 
Arg   275E NH1 Gly   273A O 2.99 
Asn    55F ND2 Gly   182C O 2.96 
Ser    58F OG Gln   132C OE1 2.61 
Ser    78F OG Lys   234C O 2.96 
Arg    80F NE Lys   234C O 3.13 
Arg    80F NH2 Phe   238C O 2.87 
Lys  101F NZ Asp  245A OD2 3.90 
 
 
Table 6.3A Buried water molecules in the Mpro crystal structure 
having accessible surface area (ASA) <1.0 Å2§ 
 
Water No. B-factor H-bonding partners    
TGEV Mpro 
Dimer AB (Å2)  
TGEV Mpro
Dimer CD 
 
TGEV Mpro
Dimer EF 
 
HCoV 
Mpro
W   2 30.1 202 O, 284 O, 286 N, 287 N 13 658  
W   3 30.5 
202 O, 284 O, 286 N, 287 O, 287 
N 57 14  
W   4 29.4 5 O, 126 N 63 53 208 
W   7 22.4 126 N, 5 O  70 75  
W  11 33.1 41 ND1, 163 ND1, 40 N 258 321 48 
W  15 39.8 
41 N, 41 ND1, 163 ND1, 186  
OD1 40 N 204 28 
128 
W  23 36.5 
19 NH1, 19 O, 66 OG, 66 O, 68 
N, 68 OG  197 56 
 
W  41 34.7 102 O, 102 N 264 565  
W  47 34.7 110 O 327 687  
W  53 33.1 5 O, 126 N 758 493  
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W  54 34.4 133 O, 173 O, 173 N, 181 O 795 8  
W  58 44.4 
131 N, 132 N, 193 OE1, 196 
OD1  1003 
 
W  59 44.5 128 OD1, 129 O, 285 OD1 158 925  
W  77 38.4 9 O, 12 N, 11 N 381 76  
W 100 34.0 9 O, 10 O, 11 N, 12 N 46 42 45 
W105 37.9 
19 O, 19 NH1, 66 O, 68 N, 68 
OG 423 313 
 
W 193 33.5 108 O, 202 OD1 33 60  
W 217 44.1 
128 OD1, 285 O, 285 OD1, 285 
OD2 243 - 
 
W 231 39.1 
108 O, 201 OD1, 201 OD2, 202 
OD1  150 
 
W 310 44.7 128 O, 136 N, 286 OE1 122 754  
W 549 47.4 45 N, 46 N, 46 O, 56 OE1 - 367  
W 551 57.6 14 OE1 389 412  
W 570 35.7 14 O, 17 O, NZ 69  191 69  
W580 
53.5 
40 NH2, 185 OE2, 186 OD2, 
NE2 187 
266 
696 
 
      
W 611 38.1 14 OE1 830 648 153 
W704 40.3 132 O, 182 O, 184 O 538 113 28 
W 772 49.9 138 O, 138 OG 308 997  
W 880 34.8 4 NH2, 5 O 290 709  
W944  22.9 124A O, 124B O 234 156  
W 964 41.9 4 NH1, 5 O 249 386  
§ Buried in both structures; Buried only in one structure; highlighted are the 
conserved water molecules in the active-site cavity 
 
 
Table 6.3B Buried water molecules in TGEV Mpro structure but not conserved in 
all TGEV Mpro dimers: 
 
W  22 21.9 103 O, 103 N, 158 O, 176 N    
W  25 31.6 131 N, 196 OD1    
W  49 35.2 131 N, 197 O, 196 ND2    
W  55 30.1 222 O, 220 N, 260 O, 220 OG1    
W117 40.0 103 O, 103 N, 158 O, 176 N   5 
W120 43.3 154 O, 156 N    
W121 41.1 128 N, 136 O, 286 OE1 OE2    
W122 44.5 128 O, 286 OE1    
W 198 37.9 107 N, 130 O, 131 O    
W 222 54.0 279 O, 281 N, 282 N    
W 223 45.7 169 O, 136 N    
W 292 50.6 108 N, 129 O, 285 OD1    
W 293 40.3 107 O    
W 313 52.4 19 NH1, 19 O, 66 O, 68 N, 68 OG    
W 321 40.6 
40 N, 41 N, 41 ND1, 163 ND1, 186 
OD1   
 
W 322 43.9 87 O, 80 N, 78 OG    
W 336 43.3 272 O    
W 345 42.7 199 OG    
 139
  Appendix 
W 347 52.4 104 O, 109 OE2, 109 OE1    
W359 41.8 175 ND2, 179 O   168 
W367 48.8 45 N, 46 O, 45 OG, 46 N    
W384 46.4 169 O, 1 OG    
W 386 46.0 5 O    
W 411 40.9 45 N, 45 OG, 46 O, 46 N, 56 OE1    
W 416 46.7 197 O    
W 418 42.8 220 N, 222 O, 267 NH2, 260 O    
W 459 39.5 40NH1, 83 O    
W467 48.1 108 N, 107 O    
W 477 41.0 133 O, 173 N, 181 O    
W 569 36.6 131 N, 196 OD1, O 197    
W 587 48.6 193 O, 195 O, 195 N    
W 612 53.1 103 O, 158 O, 176 N    
W 658 54.5 284 N, 285, 286, 287, 202 O    
W 724 49.2 4 NH2, 136 O, 286 OE2     
W 753 54.2 130 O, 131 O, 133 N    
W 902 48.6 119 O, 69 NZ,    
W 966 52.3 295 NE2, 291 O    
W 990 40.0 162 NE2   38 
W997 55.3 138 O, 138 OG    
§ Buried in both structures; Buried only in one structure; highlighted are the 
conserved water molecules in the active-site cavity 
 
 
 
Table 6.3C Buried water molecules in the HCoV Mpro crystal structure 
 
W5 1.75 103 O, 158 O, 176 N    
W14 4.53 132 O, 194 N, W100    
W16 5.06 202 O, 206 N    
W21 6.29 130 O, 131 N, 131 OG1, 196 ND2    
W25 7.24 41 N, 163 OE1, 186 OD1    
W32 9.06 140 O, 143 N, W19    
W39 10.24 W49, 138 O, W145    
W45 11.60 9 O, 10 O, 10 N, 11 N, 12 N,     
W53 12.41 202 O, 286 N, 287 N    
W93 18.36 6 N, 291 OE2    
W128 21.97 40 N, 41 N, 41 ND1, 84 O,     
W152 25.19 138 O, 117 OH, W9    
W168 27.78 W162    
W170 27.98 145 O    
W215 49.22 175 OG, 179 O    
 § Buried in both structures; Buried only in one structure 
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Table 6.3D Spatially conserved exposed water molecules in the HCoV and TGEV Mpro 
crystal structures having accessible surface area (ASA) >4.0 Å2
 
Water No.   Water No.  
HCoV Mpro HCoV Mpro interactions TGEV Mpro TGEVMpro interactions 
W6………. W125, 178 O W88………. 178 O 
W7………. 102 N W642……... 102 N 
W12……… W151, 180 N, 27 OH W24………. 22 O 
W20……… 276 OE1 W904……... SO4 O2, O3 
W28……… 182 O W704……... 182 O, 184 OH 
W31……… 180 N W749……... 180 O 
W41……… 184 O, W125 W242……... 185 OE2, 186 N 
W51……… 103 NE, 109 OE1 W79………. 104 O, 109 NZ, 109 OE1 
W62……… 103 O, 104 N W181……... 103 N 
W63……… 15 NZ W168……... 11 O, 14 OE1 
W144…….. W87 W567…….. 153 N, 154 N 
W161…….. 94 ND2 W408…….. 15 O, 94 OD1, 96 ND2 
W191.......... 186 OD2, 186 N W134…….. 186 N, 186 OD2,  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 6.4 List of salt bridges 
 
Residue name Number Atom name Residue name Number  Atom name Distance (Å)*
TGEV Mpro       
Ser 1A N Glu 165B CD 3.68 
Arg 4A NH1 Glu 286B OE1 5.31 
Lys 5A NZ Glu 291A OE1 2.90 
Glu 35A OE2 Lys 89A NZ 3.22 
Arg 40A NE Asp 186A OD1 2.44 
Lys 103A NZ Glu 152A OE1 2.71 
Arg 130A NH2 Glu 193A OE1 2.73 
Glu 193A OE1 Arg 130A NH2 2.73 
Lys 234A NZ Glu 240A OE2 2.54 
Ser 1B N Glu 165A CD 4.50 
Arg 4B NH1 Glu 286A OE1 3.75 
Asp 34B OD1 Lys 89B NZ 2.76 
Arg 40B NE Asp 186B OD1 2.70 
Lys 103B NZ Glu 152B OE1 2.76 
Arg 130B NE Glu 193B OE1 3.21 
Glu 152B OE1 Lys 103B NZ 2.76 
Asp 263B OD2 Arg 267B NH2 2.84 
Glu 291B OE1 Lys 5B NZ 2.74 
Ser 1C OG Glu 165D OE2 3.34 
Arg 4C NH1 Glu 286D OE1 3.45 
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Asp 34C OD1 Lys 89C NZ 3.14 
Arg 40C NE Asp 186C OD1 2.60 
Arg 130C NE Glu 193C OE1 2.89 
Glu 152C OE1 Lys 103C NZ 2.43 
Asp 245C OD1 Arg 61B NH1 2.52 
Glu 291C OE1 Lys 5C NZ 2.59 
Ser 1D N Glu 165C CD 6.15 
Arg 4D NH2 Glu 286C OE2 4.77 
Arg 40D NE Asp 186D OD1 2.61 
Lys 101D NZ Asp 245B OD1 3.03 
Arg 130D NE Glu 193D OE1 2.89 
Ser 1E N Glu 165F CD 5.88 
Arg 4E NH1 Glu 286F OE1 4.67 
Lys 5E NZ Glu 291E OE1 2.61 
Asp 34E OD2 Lys 89E NZ 3.33 
Glu 35E OE2 Lys 89E NZ 3.20 
Arg 40E NE Asp 186E OD1 2.63 
Lys 103E NZ Glu 152B OE1 2.55 
Arg 130E NH1 Glu 193E OE1 2.82 
Glu 152E OE1 Lys 103E NZ 2.55 
Ser 1F OG Glu 165E OE2 3.28 
Arg 4F NH1 Glu 286E OE1 5.03 
Glu 35F OE2 Lys 89F NZ 3.29 
Arg 40F NE Asp 186F OD1 2.69 
Lys 101F NZ Asp 245A OD2 3.90 
Arg 130F NE Glu 193F OE1 3.51 
Glu 152F OE1 Lys 103F NZ 2.90 
*Only the shortest distances between any oxygen and any nitrogen atom of a given salt bridge is 
listed 
 
HCoV Mpro  
Lys 5A NZ Glu 286A OE2 3.58 
Arg 19A NE Asp 118A OD2 3.43 
Arg 19A NH2 Asp 118B OD1 3.47 
Arg  40A  NE Asp 186A OD1 2.82 
Arg  40A  NH2 Asp 186A OD2 3.24 
Arg  40A  NH2 Asp 186A OD1 3.49 
Arg  61A  NH1 His 63A NE2 3.76 
Arg  61A  NH1 His 63A ND2 3.79 
Arg  103A  NH1 Glu 157A OE2 2.90 
Arg  61A  NH2 His 63A OE1 3.46 
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Asp  118A  OD2 Arg 19A NE 3.32 
Asp  118A  OD1 Arg 19A NH2 3.28 
Glu  165A  OE2 His 171A NE2 3.60 
Glu  222A  OE1 His 263A NE2 3.03 
Glu 286A OE2 Arg 4B NH2 2.99 
Arg 4B NH2 Glu 286B OE2 2.99 
Arg 19B NE Asp 118B OD1 3.27 
Arg 19B NH2 Asp 118B OD2 3.27 
Arg  40B  NE Asp 186B OD1 2.82 
Arg  40B  NH2 Asp 186B OD2 3.24 
Arg  40B NH2 Asp 186B OD1 3.49 
Arg  61B  NH1 His 63B NE2 3.67 
Arg  61B  NH1 His 63B ND2 3.70 
Arg  103B NH1 Glu 157A OE1 3.46 
Arg  103B  NH2 Glu 157A OE2 2.90 
Asp  118B  OD2 Arg 19B NE 3.17 
Asp  118A  OD1 Arg 19A NH2 3.10 
Glu  165B OE2 His 171B NE2 2.75 
Glu  222B  OE1 His 263B NE2 3.07 
Glu 286B OE2 Arg 4A NH2 2.85 
*Conserved salt bridges are indicated in bold 
 
 
Table 6.5 Interactions with sulfates, MPD and dioxane molecules in TGEV Mpro 
structure 
 
SO4 1S O3 Glu 172A OE2, OE1 3.40, 2.77 
SO4 2S S Arg 130C NH2 3.72 
SO4 2S O1 Arg 130C NH2, NH1 2.79, 3.79 
SO4 2S O3 Arg 130C NH2, NH1 3.67, 3.04 
SO4 3S S Glu 193A N 3.64 
SO4 3S O1 Asn 168A ND2 3.22 
SO4 3S O3 Wat, Glu, Asn 160W, 193A, 168 A OH2, N, ND2 2.75, 2.89, 3.83 
SO4 3S O4 Glu, Gly 193A, 194 A N, N 3.28, 3.12 
SO4 4S S Arg, Wat 130A, 760W NH1, OH2 2.90, 3.70 
SO4 4S O1 Arg, Asn 130A, 196A NH1, ND2 2.92, 3.41 
SO4 4S O2 Wat, Wat 904W, 760W  OH2, OH2 3.34, 3.82 
SO4 4S O3 Arg, Wat, Lys, Wat
130A, 904W, 136A, 
760W 
NH1, OH2, NZ, 
OH2 
2.61, 3.73, 3.82, 
2.79 
SO4 4S O4 Arg, Lys, Wat 130A, 136A, 760W NH1, NZ, OH2 2.88, 3.62, 3.89 
SO4 5S S Asn, Glu, Gly 168C, 193C, 194C ND2, N, N 3.69, 3.80, 3.84 
SO4 5S O1 Asn, Wat 168C, 350W ND2, OH2 2.99, 3.23 
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SO4 5S O2 Glu, Gly, Wat 193C, 194C, 350W N, N, OH2 3.57, 2.87, 3.81 
SO4 5S O3 Glu 193A N 2.95 
SO4 5S O4 Wat, Asn, Glu 164W, 168C, 193C OH2, ND2, N 2.75, 3.21, 2.84 
SO4 6S S Asn, Wat, Glu 168B, 691W, 193B ND2, OH2, N 3.60, 3.87, 3.80 
SO4 6S O2 Asn, Wat, Glu 168B, 303W, 193B ND2, OH2, N 3.12, 2.91, 2.95 
SO4 6S O3 Asn, Wat 168B, 691W ND2, OH2 2.95, 2.99 
SO4 6S O4 Gly, Wat, Glu 194B, 691W,193B N, OH2, N 3.01, 3.63, 3.40 
SO4 7S S Glu, Asn 193E, 168E N, ND2 3.75, 3.45 
SO4 7S O2 Glu, Wat, Asn 193E, 361W, 168E N, OH2, ND2 2.94, 3.27, 3.11 
SO4 7S O3 Wat, Asn 641W, 168E OH2, ND2 3.32, 2.68 
SO4 7S O4 Glu, Gly, Wat 193E, 194E,641W N, N, OH2 3.41, 3.22, 3.68 
SO4 8S S Arg, Wat 130D, 438W NH2, OH2 3.62, 3.65 
SO4 8S O2 Wat 438W OH2 2.62 
SO4 8S O3 Arg, Arg 130D, 130D NH2, NH1 3.88,3.25 
SO4 8S O4 Arg, Asn, Wat, Arg
130D, 196D, 438W, 
130D 
NH2, ND2, 
OH2, NH1 
2.47, 3.21, 3.66, 
3.48 
SO4 9S S Wat, Arg,Wat, Wat
774W, 130E, 392W, 
888W 
OH2, NH2, 
OH2, OH2 
3.34, 3.76, 3.50, 
3.66 
SO4 9S O1 
Wat, Wat, Arg, 
Wat, Wat 
774W, 778W, 130E, 
329W, 888W 
OH2, OH2, 
NH1, OH2, OH2 
2.72, 3.62, 3.59, 
2.34, 3.38 
SO4 9S O2 Wat, Wat 392W, 888W OH2, OH2 3.62, 2.78 
SO4 9S O3 Wat, Wat  426W, 774W OH2, OH2 3.47, 2.80 
SO4 9S O4 Wat, Asn, Arg, Arg
426W, 196E, 130E, 
130E 
OH2, OD1, Nh2, 
NH2 
3.80, 3.73, 3.76, 
2.66 
SO4 10S S Asn, Glu, Gly 168F, 193F, 194F ND2, N, N 3.46, 3.54, 3.67 
SO4 10S O1 Asn, Wat, Glu, Gly
168F, 951W, 193F, 
194F ND2, OH2, N, N 
2.69, 3.32, 2.45, 
3.68 
SO4 10S O2 Asn, Glu, Gly 168F, 193F, 194F NH2, N, N 3.59, 3.81, 3.10 
SO4 10S O3 Asn 168F ND2 3.59 
SO4 10S O4 Glu, Gly 193F, 194F N, N 3.83, 3.60 
SO4 11S S Arg, Trp 216A, 217A N, N 3.68, 3.72 
SO4 11S O1 Arg, Trp 216A, 217A N, N 3.83, 2.89 
SO4 11S O2 Wat, Arg, Trp 679W, 216A, 217A OH2, N, N 3.72, 3.11, 3.44 
SO4 11S O4 Arg, Gly 216A, 214A N, O 3.55, 3.48 
SO4 12S S Asn, Glu 168D,193D ND2, N  3.73, 3.71 
SO4 12S O1 Asn, 168D ND2 2.99 
SO4 12S O3 Asn, Glu, Wat 168D, 193D,138W ND2, N, OH2 3.38, 2.95, 2.89 
SO4 12S O4 Glu, Gly 193D, 194D N, N 3.43, 3.15 
SO4 13S S Thr, Arg, Arg, Wat
276E, 275E, 275E, 
349W 
N, NE, NH2, 
OH2 
3.67, 3.73, 3.77, 
3.82 
SO4 13S O1 Arg 275E NE 3.75 
SO4 13S O2 Arg, Wat 275E, 349W NH2, OH2 3.14, 3.84 
SO4 13S O3 
Thr, Thr, Arg, Arg, 
Wat, Thr 
276E, 276E, 275E, 
275E, 349E, 276E 
N, E, NE, NH2, 
OH2, OG1 
2.85, 3.29, 2.92, 
3.32, 2.96, 3.69 
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SO4 13S O4 Thr, Thr 276E, 276E N, OG1 3.68, 2.77 
SO4 15S S Thr, Thr 276C, 276C N, OG1 3.64, 3.72 
SO4 15S O1 
Arg, Thr, Thr, Thr, 
Wat, Arg 
275C, 276C, 276C, 
276C, 450W, 275C 
NE, N, OG1, O, 
OH2, NH2 
3.32, 2.76, 3.40, 
3.49, 3.44, 3.45 
SO4 15S O2 Arg, Arg 275C, 275C NE, NH2 3.52, 3.86 
SO4 15S O4 Thr, Thr 276C, 276C N, OG1 3.36, 3.18 
SO4 16S S Arg, Trp 216D, 217D N, N 3.71, 3.74 
SO4 16S O1 Wat 999W OH2 2.73 
SO4 16S O2 Arg, Arg, Trp 216D, 275D, 217D N, NH2, N 3.45, 3.72, 3.34 
SO4 16S O3 Gly 214D O 3.41 
SO4 16S O4 Arg, Trp 217D N 2.99 
SO4 17S S Thr, Thr 276D, 276D OG1, N 3.73, 3.70 
SO4 17S O2 Arg, Arg 275D, 275D NH2, NE 3.72, 3.55 
SO4 17S O3 Thr, Thr 276D, 276D OG1, N 3.07, 3.27 
SO4 17S O4 
Arg, Thr, Arg, Thr, 
Thr 
275D, 276D, 275D, 
276D, 276D 
NH2, OG1, NE, 
N, O 
3.50, 3.65, 3.14, 
2.94, 3.36 
SO4 18S S Leu, His 62E, 63E N, ND1 3.66, 3.72 
SO4 18S O2 Val, Wat, Leu 60E, 699W, 62E O, OH2, N 3.57, 3.89, 2.83 
SO4 18S O3 Leu, His, His 62E, 63E, 63E N, N ND1 3.60, 3.84, 2.66 
SO4 18S O4 Val, Arg, His 60E, 61E, 63E O, NH2, ND1 3.68, 2.66, 3.70 
SO4 19S S Dox, Arg 3X, 216F O1, NH1 3.56, 3.21 
SO4 19S O2 Arg 216F NH1 3.47 
SO4 19S O3 Dox, Arg 3X, 216F O1, NH1 3.49, 2.82 
SO4 19S O4 Dox, Arg 3X, 216F NH1 3.02, 2.86 
SO4 20S S Phe 176B O 3.89 
SO4 20S O3 Wat 919W OH2 3.89 
SO4 20S O4 Phe 176B O 2.77 
SO4 21S O2 Arg 294C O 3.65 
SO4 21S O3 Ala 115D O 3.59 
SO4 21S O4 Ser 123D OG 3.64 
SO4 22S S Ser 104A N 3.63 
SO4 22S O3 Ser 104A N 3.15 
SO4 22S O4 Ser, Wat, Ser 104A, 181W, 104A OG, OH2, N 3.22, 3.82, 3.00 
SO4 23S S Arg, Trp 216C, 217C N, N 3.73, 3.74 
SO4 23S O1 Arg, Trp 216C, 217C N, N 2.42, 2.50 
SO4 23S O2 Arg, Wat, Arg 275C, 366W, 275C NH1, OH2, NH2 3.75, 2.80, 3.90 
SO4 23S O3 Gly 214C O 3.64 
SO4 23S O4 Wat, Arg 450W, 275C OH2, NH2 3.23, 3.66 
SO4 24S S Leu, Arg 62F, 61F N, NH2 3.77, 3.49 
SO4 24S O1 
Leu, His, Arg, Arg, 
Arg  
62F, 61F, 62F, 61F, 
61F 
N, ND1, 
NE,NH1, NH2 
3.49, 3.06, 3.75, 
3.74, 3.20 
SO4 24S O3 Leu, Arg 62F, 61F N, NH1 3.14, 3.85 
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SO4 24S O4 Arg, Arg 61F, 61F NH1, NH2 3.61, 2.68 
SO4 25S S Arg 130F NH2 3.14 
SO4 25S O1 Arg 130F NH2 2.84 
SO4 25S O2 Arg 130F NH2 3.43 
SO4 25S O4 Lys, Arg 136F, 130F NZ, NH2 3.18 
SO4 26S S Arg, Wat, Ser 19B, 288W, 21B NH2, OH2, OG 3.47, 3.55, 3.71 
SO4 26S O1 
Arg, Wat, Arg, Ser, 
Wat 
19B, 288W, 19B, 
21B, 494W 
NH2, OH2, 
NH1, OG, OH2 
2.94, 3.16, 2.62, 
3.01, 2.93 
SO4 26S O2 Arg, Wat 19B, 288W NH2, OH2 3.80, 2.77 
SO4 26S O3 Wat 486W OH2 3.84 
SO4 26S O4 Arg, Ser 19B, 21B NH2, OG 3.19, 3.59 
SO4 27S S Ser, Arg  21A, 19A OG, NH2 3.39, 3.64 
SO4 27S O1 Ser 21A OG 3.39 
SO4 27S O2 Ser, Arg 21A, 19A OG, NH2 3.87, 2.99 
SO4 27S O3 Ser, Arg, Arg, Ser 21A, 19A, 19A, 66A
OG, NH2, NH1, 
OG 3.64, 3.01 
MPD 1M O4 His 41A, 163A NE2, O 3.36, 2.92 
MPD 2M O2 Thr, Pro 47B, 188B O, N 3.18, 3.85 
MPD 2M O4 Thr, Asp 47B, 186B O, O 3.76, 3.79 
MPD 3M O2 Wat 681 OH2 3.18 
MPD 4M O2 Gln, Pro 187D, 188D O, N 3.90, 3.47 
MPD 4M O4 Wat 640 OH2 3.50 
MPD 5M O2 Thr 47E O 3.72 
MPD 5M O4 His 41E CG 3.55 
MPD 6M O4 His 41F ND1 3.55 
DOX 1X O1 
Gly, Wat, Wat, 
Wat 
273B, 1006W, 
199W, 1005W 
N, OH2, OH2, 
OH2 
3.54, 2.97, 3.76, 
3.51 
DOX 1X O2 Trp, Arg, Wat, Wat
217E, 216E, 524W, 
199W N, N, OH2, OH2 
3.50, 3.57, 2.89, 
2.86 
DOX 3X O1 SO4, SO4 19S, 19S S, O4 3.56, 3.02 
DOX 3X O2 Gly, Thr, Thr 244F, 276F, 276F O, N, OG1 3.55, 2.92, 3.58 
DOX 4X O1 Asn, Met 112A, 6A OD1, O 3.61, 3.76 
DOX 4X O2 Wat 926W OH2 3.67 
DOX 5X O1 Gly, Ser, Arg 133A, 131A, 130A N, O, O,  3.46, 2.72, 3.82 
DOX 6X O2 Wat 620W OH2 3.13 
DOX 7X O1 Wat 898W OH2 3.70 
DOX 7X O2 Phe, His 139B, 162B O, NE2 3.48, 3.83 
DOX 8X O1 Ser 223C O 3.08 
DOX 8X O2 Ser 228C OG 2.70 
DOX 9X O1 Asn 213D OD1 2.99 
DOX 9X O2 Wat, Lys, Wat 461W, 136C, 998W OH2, NZ, OH2, 3.45, 2.73, 3.82 
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